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Abstract 
The use of norbornenes and fused [n]polynorbornanes in supramolecular chemistry is well 
established.  The ability to functionalise these scaffolds with a range of functional groups makes them 
attractive for additional supramolecular explorations with metals.  Three aspects of study were 
pursued in which metals were combined with norbornylogous frameworks, i) anion binding through 
zinc:dipicolylamino binding units, ii) complex formation using polynorbornane dicarboxylate ligands 
and a range of transition metals (Zn, Fe, Cu, Co and Ni) and iii) an ionic organogelator that required 
sodium to elicit gel formation. 
 
A family of fused [n]polynorbornanes functionalised with bis-Zn(II):dipicolylamino binding groups 
were synthesised and investigated for their anion binding abilities.  In order to determine the utility 
of these systems, investigations into the development of an indicator displacement assay were 
undertaken through the incorporation of colorimetric and fluorescent dyes.  The indicator 
displacement assays were found to respond strongly to pyrophosphate. 
 
The ability of fused [n]polynorbornanes to act as ligands for metals has been further investigated by 
the development of a family of bis-amino acid functionalised [5]polynorbornanes.  These 
dicarboxylate ligands were investigated for their ability to form larger complexes when combined with 
a range of transition metals.  Promising results were obtained including the formation of a M2L2 
metallocycle that demonstrates that these frameworks are well suited as ligands for the formation of 
metal-organic complexes. 
 
During the above study, a phenylalanine functionalised norbornene was synthesised and found to 
possess several interesting properties when investigated as its sodium salt.  The salt was found to form 
aqueous biphasic systems when mixed at high concentration with kosmotropic salts.  Additionally, the 
phenylalanine-based salt was found to be extremely soluble in water, believed to be caused by the 
formation of a supramolecular polymer.  Finally, the salt was found to be a potent organogelator, 
capable of gelling several organic solvents at concentrations as lows as 0.5 wt%.  During 
characterisation of the organogels, unusual hollow hexagonal structures were observed using SEM as 
well as an interesting sodium-mediated helical assembly in the crystal structure.      
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Plain English Summary 
The combination of rigid molecular frameworks with metals has been investigated. 
In chapter 2, a family of compounds have been synthesised that can interact with (acting as a ‘host’ 
for) smaller molecules (‘guests’) in solution.  By using a dye, the interaction with biologically relevant 
guests was visibly indicated. 
In chapter 3, a family of compounds were designed to adopt a ‘staple’ shape and interact with metals 
in solution.   The shape of these ‘staples’ was varied and found to have an impact on the assemblies 
formed.  Further modification can potentially result in larger, more complicated assemblies being 
formed.  Such large assemblies can function as catalysts, or gas storage devices. 
In chapter 4, the ability of a salt (formed by a rigid framework interacting with a metal) to separate 
water into layers was evaluated.  The ability of this salt to form gels in a variety of organic (non-water 
based) solvents was also confirmed and investigated in detail.  The salt was found to be a very effective 
gelator, able to gel solvents at concentrations as low as 0.5 wt%.  Additionally, the salt formed an 
interesting metal-mediated helical assembly. 
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1. Introduction 
This introduction will provide a broad overview of both host:guest chemistry and molecular self-
assembly before outlining the synthetic routes available for the synthesis of norbornene and fused 
[n]polynorbornane frameworks.  Examples of their use in supramolecular chemistry will then be 
provided.  Particular emphasis will be placed upon metal complexation and templation. 
Supramolecular chemistry or ‘chemistry beyond the molecule’ is focused on chemical assemblies 
created from discrete subunits through the use of non-covalent forces such as electrostatic 
interactions, van der Waals forces, π-π stacking and hydrogen bonds.1-4  The field of supramolecular 
chemistry has rapidly expanded in the last 30 years and now encompasses research topics as diverse 
as anion recognition, molecular machines, catalysis, organo- and hydrogelators, biomolecular imaging, 
metal extraction as well as the mimicking of biological processes.3-8  
Broadly speaking, supramolecular chemistry can be split into two main areas; host:guest chemistry 
and molecular self-assembly.2  The distinction between the two is a matter of size and degree, with 
host:guest chemistry generally focusing on large ‘host’ molecules that can recognise and reversibly 
bind smaller ‘guest’ molecules resulting in a discrete, supramolecule (Figure 1-1a).9  In contrast, 
molecular self-assembly focuses on the non-covalent joining of molecules into larger continuous 
structures, a process which is both spontaneous and reversible (Figure 1-1b).10-12 
 
Figure 1-1: Two fields of supramolecular chemistry a) host:guest chemistry figure reproduced with permission from ref13 
and b) self-assembly figure reproduced with permission from ref12 
Supramolecular host:guest chemistry in biology is illustrated by enzyme:substrate interactions, where 
a large host enzyme recognises and binds the smaller guest substrate in order to catalyse a chemical 
reaction (Figure 1-2a).14  A simple biological example of molecular self-assembly in nature is the 
formation of the lipid bilayer (through hydrophobic interactions), that makes up the cell membrane 
(Figure 1-2b).15 
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Figure 1-2: Representation of a) an enzyme:substrate interaction, b) a lipid bilayer 
1.1 Host:guest chemistry 
As previously mentioned, host:guest chemistry typically involves the recognition of a small molecule 
by a larger host through the use of non-covalent forces, however other examples of host:guest 
chemistry exist where intermolecular forces do not play a major role in the binding of the guest, such 
as zeolites and clathrates, where the host:guest complexation is entropically driven.9,16  More extreme 
examples include molecular encapsulation, such as by carcerands or endohedral fullerenes where the 
guest molecule is completely enveloped by the host molecule and is physically incapable of exiting the 
host.17-19 
1.1.1 Origins of host:guest chemistry 
The understanding of host:guest chemistry from the supramolecular chemistry standpoint began in 
1756 with the discovery of zeolite by Axel Cronstedt, a microporous mineral capable of storing and 
releasing water.20,21  Over the next two hundred years, similar discoveries were made, notably the 
clathrate hydrates by Priestly in 1778 and Davy in 1810.22,23  However, while it was supposed that 
these complexes were inclusion complexes, it was not until the 1950s when the first crystal structures 
were obtained by von Stackelberg and Müller that the inclusionary nature of the complexes was truly 
confirmed.9,24-27 
In the late 18th century Fischer postulated the classic lock and key method of enzyme:substrate 
interactions, founding the principles of molecular recognition and host:guest chemistry.28,29  The 
postulation of intermolecular forces by van der Waals in 1873 and the subsequent discovery and 
investigation into these forces, such as the hydrogen bond by Latimer in 1920, laid further foundations 
of supramolecular chemistry.30-33 
The early 20th century brought with it the development of X-ray crystallography techniques which 
allowed the elucidation of noncovalent forces such as those in the structure of NaCl, solved in 1914 
by Bragg and coworkers.34,35  By the mid 1940’s the term clathrate had been introduced and defined 
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by Powell et al. as cage molecules that imprison other molecules.36  in the 1960’s, the first synthesis 
of crown ethers was performed by Pedersen, and the synthesis of purposely designed hosts was later 
pursued separately by Cram, Lehn and Vogtle.37-39  These researchers are regarded as the founders of 
modern supramolecular chemistry and it was Lehn who is credited with coining the term 
‘supramolecular chemistry’ in 1978.7 
The discovery of crown ethers by Pedersen in 1967 came about fortuitously when approximately 90% 
pure partially protected catechol 1 was reacted with 2-chloroethyl ether 3 and a small amount of a 
crystalline by-product 5 was isolated (Scheme 1-1).38 
 
Scheme 1-1: Synthesis of ligand 4 and unexpected by-product 5 reported by Pedersen38 
This by-product was investigated and identified as dibenzo-18-crown-6 5.  During characterisation 
attempts, it was noted that sodium ions from any source enabled the crown ether to be soluble in 
methanol, a solvent in which it was otherwise not soluble.  Pedersen quickly deduced that the six 
oxygen atoms bound the sodium ion in the centre of crown ether and then used this to rationalise the 
formation of the large 18-membered ring as being driven by the templating effect caused by the ion-
dipole interactions between the sodium ion and partially formed crown ether.38  This was one of the 
first reported cases of the binding of alkali metal ions and their use as a template for the formation of 
a specific reaction product.40  
Pedersen synthesised a total of 33 crown ethers with varying sizes and found that selectivity between 
different ions was proportional to the size of the crown ether, with larger cations being bound more 
strongly by larger crown ethers.41   
In 1969 Lehn, Sauvage and Dietrich reported the synthesis of a three-dimensional version of a crown 
ether, generating a new class of host:guest compounds capable to binding metal ions, which they 
termed cryptands (Figure 1-3).42,43  Due to their three-dimensional nature these cryptands bind alkali 
ions much more strongly than the two-dimensional crown ethers.  Similar to the crown ethers, 
selectivity for different ions was found to be affected by the size of cryptand.1 
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Figure 1-3: Cryptand 6 reported by Lehn et al.42 
The increasing importance of supramolecular chemistry was demonstrated in 1987 when the Nobel 
Prize for chemistry was awarded to Cram, Lehn and Pedersen for their pioneering work in developing 
the field of supramolecular chemistry.1,41,44-46  In 2016, supramolecular chemistry was again recognised 
when the Nobel Prize in chemistry was awarded to Sauvage, Stoddart and Feringa for their work in 
the design and synthesis of molecular machines, supramolecular constructs capable of performing 
“physical” tasks when energy is supplied.47 
The Nobel Prize was awarded to the trio for their work in the construction of mechanically interlocked 
molecules from the early 1980’s to the beginning of the 21st century.48  The first breakthrough came 
in 1983 when Sauvage and co-workers reported the first synthesis of catenane using a two-step 
templation method (Figure 1-4a).49  In 1994, the Stoddart group reported the first switchable 
molecular shuttle employing a linear molecule featuring two aromatic regions (Figure 1-4b).50,51  A 
tetracationic ring threaded onto on the chain could then be ‘shuttled’ onto a specific region by 
protonation with TFA (trifluoroacetic acid).  The Feringa group in 1999 reported the first rotary 
molecular motor whereby uni-directional rotation could be observed upon application of heat or light 
(Figure 1-4c).52  
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Figure 1-4: The seminal works reported by the groups of Sauvage, Stoddart and Feringa respectively, for which they were 
jointly awarded the 2016 Nobel Prize in Chemistry. 
Key to the expansion of the field of host:guest chemistry was the development and understanding of 
two key principles, preorganisation and complementarity, which are crucial for the design of effective 
host molecules. 
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1.1.2 Preorganisation and complementarity 
Fischer proposed in the 1890’s that the binding site of an enzyme provided an exact match to the 
substrate, a theory known as the ‘lock-and-key’ binding.14  This theory assumed that only a substrate 
that exactly matched the shape of the binding site of the host molecule would be able to bind to the 
host.28  Similarly, in supramolecular chemistry, it was assumed that a host would be most effective at 
binding a specific guest if it was synthesised with a binding cleft that provided as close a match to the 
shape of the guest as possible (Figure 1-5).53,54 
 
Figure 1-5: A simplified representation of the 'lock-and-key' mode of host:guest interaction 
In 1958, Koshland Jr. updated the traditional ‘lock-and-key’ mechanism and postulated the currently 
accepted ‘induced-fit’ mode of binding for enzymes, in which the binding site of the enzyme (or host) 
is not an exact match for the guest, but instead has enough flexibility to undergo subtle conformation 
adjustments in order to maximise binding interactions (Figure 1-6).28,55   
 
Figure 1-6: A simplified representation of the 'induced-fit' mode of host:guest interaction 
In supramolecular chemistry, preorganisation refers to how the size/shape of a binding pocket of the 
host matches the size/shape of the guest.  A highly preorganised host will be able to form a stable 
complex with a guest much easier than a host that requires a large degree of conformational change 
in order to accommodate the guest.2  Preorganisation is often achieved in supramolecular chemistry 
through the use of rigid frameworks that allow for the design and construction of hosts of known 
dimensions.56,57   
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However, a preorganised host possessing a binding site that provides a good match for a desired guest 
is still ineffective if it cannot interact with the guest.  In order to do this, binding sites on the guest 
must be matched with complementary binding sites that have been deliberately installed on the 
host.58,59  A truly effective host is one that possesses both preorganisation and complementarity for 
the target guest. 
In order to elicit strong binding multiple binding sites can be installed.  Multiple binding sites work 
together to bind the host much more strongly than individual sites could working independently in a 
phenomenon known as cooperativity, where the “whole is greater than the sum of its parts”.60 
1.2  Preorganised scaffolds for host:guest chemistry 
As mentioned above, rigid frameworks are useful in supramolecular chemistry.  These preorganized 
scaffolds allows for the synthesis of hosts with defined three-dimensional geometries.  One major 
advantage of using preorganised hosts in supramolecular chemistry is the fact that they can, in many 
cases, be accessed by following well established synthetic pathways.61,62 
1.2.1 Examples of preorganised frameworks in supramolecular chemistry 
Throughout the history of supramolecular chemistry, a wide range of molecular architectures have 
been employed as frameworks for the development of host molecules.  As such, a detailed discussion 
is beyond the scope of this document and only a brief overview will be provided for some of the more 
popular frameworks including cucurbiturils, resorcinarenes, calixarenes, pillararenes, porphyrins, 
calixpyrroles, cyclic peptides, cyclodextrins, crown ethers and fused[n]polynorbornanes, which have 
frequently found use due to their predictable geometries and ease of functionalisation (Figure 1-7).63 
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Figure 1-7: Some popular rigid frameworks in supramolecular chemistry 
Curcubiturils are macrocyclic molecules consisting of glycoluril monomers linked by methylene units, 
with the number of glycoluril units typically represented as cucurbit[n]uril (abbreviated to CB[n]).64,65  
Cucurbiturils were first synthesised in 1905 by the Behrend group, but it was not until the work of 
Mock et al. (who also coined the term cucurbiturils, from cucurbitaceae the botanical name of the 
pumpkin family) in 1981, that the true molecular structure was elucidated.66,67  The original synthetic 
pathway for obtaining cucurbiturils, the acid catalysed condensation of glycoluril 27 and formaldehyde 
28 (Figure 1-8), traditionally favoured the cucurbit[6]uril and it was not until 2000 that other members 
of the cucurbiturils family, namely CB[5], CB[7] and CB[8], were successfully isolated by the Kim group, 
albeit as side products in the formation of CB[6].68 
 
Figure 1-8: Synthetic pathway for the synthesis of CB[6] 
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Cucurbiturils have found use as a popular framework in supramolecular chemistry as they possesses 
two distinct regions capable of taking part in host:guest interactions.69  Firstly, the interior of the 
macrocycle acts as a hydrophobic cavity that can interact with and bind with smaller molecules.  
Indeed, in the first report of the successful synthesis of CB[10], the molecule was only able to be 
isolated as an inclusion complex with CB[5] encapsulated within the cavity (Figure 1-9).70  Secondly, 
the carbonyls at the “rim” of the macrocycle can bind guest molecules through charge-dipole or 
hydrogen bond interactions.64  Several in-depth reviews are available on the use of cucurbiturils in 
supramolecular chemistry.64,65,71-73 
 
Figure 1-9: A CB[10] molecule encapsulating a CB[5] molecule which in turn encapsulates a chlorine ion.  Figure 
reproduced with permission from ref69 
Resorcinarenes, calixarenes and pillararenes are structurally similar macrocycles formed by the 
condensation of an aromatic compound and an aldehyde (Figure 1-10).74,75  Generally speaking, 
resorcinarenes are formed through the condensation of 1,3-dihydroxybenzene (resorcinol) with an 
aldehyde, calixarenes by condensing a phenol with an aldehyde and pillararenes utilise hydroquinone 
and an aldehyde.75  Similarly to cucurbiturils, these macrocycles feature a hydrophobic interior, with 
the ability for functionalisation at both the top and bottom of the macrocycle allowing for additional 
binding sites to be installed.  A number of reviews on the use of these macrocycles in supramolecular 
chemistry is available for further reading.76-83 
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Figure 1-10: Synthetic pathways to access calixarene, resorcinarene and pillararene frameworks 
Porphyrins are macrocycles consisting of four pyrrole groups joined by methylylidine bridges (Figure 
1-11).*  Porphyrins can also be found in nature, both as biological and geological compounds.84-87  The 
seminal work behind the synthesis of porphyrins was reported by Rothemund in 1935, when he 
synthesised porphyrins by condensing and oxidising pyrroles with aldehydes.88,89  Porphyrins possess 
the ability to strongly chelate metal ions in the central void, making them popular for use in 
supramolecular applications.90-95  Structurally similar to porphyrins, the calixpyrrole was first 
synthesised by Baeyer in 1886 through the acid catalysed condensation of pyrrole and acetone  (Figure 
1-11).96  At the time, however, Baeyer did not fully understand the structure he had synthesised and 
it was not until 1916 with the work of Chelintzev and Tronov that the cyclic tetramer structure was 
proposed.97  However, calixpyrroles remained relatively underutilised in the literature until the 1990’s 
when the Floriani group, shortly followed by Sessler, Gale et al., started to investigate the usage of 
these macrocycles in supramolecular chemistry.92,98  Since then, the calixpyrrole framework has been 
extensively investigated and has been the subject of a number of in-depth reviews.92,93,99-105 
 
Figure 1-11: Synthetic pathways for the synthesis of calixpyrroles (R ≠ H) and porphyrins (R = H) 
                                                          
* The =C< group is also frequently referred to as a methine group in the literature.  However, in order to avoid 
confusion with the methanetriyl group (>CH‒, also referred to as a methine group), only the IUPAC systematic 
name ‘methylylidine’ will be used here. 
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Cyclodextrins are a family of amphiphilic macrocycles consisting of sugar molecules, more properly 
known as cyclic oligosaccharides that possess a hydrophilic exterior and a somewhat hydrophobic 
interior capable of complexing with other hydrophobic molecules.105  There are three main classes of 
cyclodextrins, named for the number of sugar molecules incorporated into the ring; 5-membered rings 
are known as α-cyclodextrins, 6 membered rings as β-cyclodextrins and 7 membered rings are referred 
to as γ-cyclodextrins (Figure 1-12).106  The first reported synthesis of a cyclodextrin was achieved by 
Villiers in 1891 by treating starch with a bacteria, although the exact bacteria responsible is a matter 
of conjecture.107,108  Enzyme-catalysed synthesis of cyclodextrins is the most popular way of generating 
the macrocycles and enzymes have been tailored to produce specific classes.109   The ability of 
cyclodextrins to form inclusion complexes with a variety of molecules has been known since the work 
of Pringsheim in the late 1920s and has been well documented in the literature.101,108,110-118 
 
Figure 1-12: The three main classes of cyclodextrins 
Cyclic peptides are polypeptide chains that are covalently linked in order to form a ring (Figure 1-13).  
Cyclic peptides are predominately synthesised in the laboratory through Solid Phase Peptide Synthesis 
(SPPS).119-121  This technique, pioneered by Merriweather, uses resin beads functionalised to enable 
peptide chains to be synthesised on the bead.122,123  This allows for easy filtration and washing steps 
and, when coupled with an excess of reagents, allows for peptide sequences to be synthesised and 
isolated much more rapidly than was previously possible with solution phase synthetic techniques.  
Cyclic peptides are attractive options for supramolecular frameworks as they are less susceptible to 
breakdown than their non-cyclic counterparts.124,125  Cyclic peptides have been utilised for a variety of 
supramolecular applications, especially by the Joliffe Group.126-128 
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Figure 1-13: Different methods of forming cyclic peptides.  Figure reproduced with permission from ref129 
1.3 Molecular self-assembly 
Molecular self-assembly is a process by which sub-units spontaneously assemble into an ordered, 
organised structure without being directed by an external source.10,15  This process can occur at both 
inter- and intramolecular levels, however, commonly only the intermolecular process is referred to as 
molecular self-assembly, with intramolecular self-assembly more commonly referred to as ‘folding’ as 
illustrated by the formation of protein tertiary structure or the behaviour of foldamers.10,11,15,130,131  
Foldamers are long chain-like molecules or oligomers that can assemble through non-covalent 
intramolecular forces into a wide variety of different structures  (Figure 1-14).131 
 
Figure 1-14: Examples of structures formed by foldamers.  Figure reproduced from ref131 
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1.3.1 Gels and gelators 
One phenomenon in supramolecular chemistry that involves molecular self-assembly is that of gel 
formation, in which a liquid phase is immobilised by the self-assembly of a three-dimensional network 
lattice.101,132,133  These lattices can also be formed through chemical reactions, in particular, when a 
polymer network is formed from monomers.134,135  However, polymer gels are typically irreversible 
and cannot be turned back into a liquid phase unlike self-assembled gels.132,136  As such, polymer gels 
will not be discussed here however several in-depth reviews are available on the subject.136-138 
 Broadly speaking, there are two main classes of gels depending on the nature of the liquid phase to 
be gelled.  If the liquid phase is water, the subsequent gel is referred to as a hydrogel and is formed 
by a hydrogelator.139,140  Conversely, the gelation of an organic solvent results in the formation of an 
organogel and the gelating agent is known as an organogelator.101,141,142  Both classes of gelator have 
found use in a wide variety of fields ranging from drug delivery media to sensing applications and from 
pollution remediation to cosmetics.101,133,142,143  A more in-depth discussion of organogels and their 
applications will be provided in Chapter 4 ‘An ionic Low Molecular Mass Organogelator based on a 
Phenylalanine Functionalised Norbornene’. 
1.3.2 Metal-organic frameworks and cages 
Another example of self-assembly in supramolecular chemistry is that demonstrated by the formation 
of metal-organic frameworks (MOFs) and coordination cages.  MOFs are formed by the self-assembly 
of metal ions and organic ligands into an extended lattice that may extend in two or three dimensions, 
depending upon the ligands and metal ions used.144-146  These assemblies are traditionally polymeric 
in nature, and their extent is generally only limited by the amount of raw reagents mixed together.144  
Coordination cages (sometimes referred to as metallosupramolecular cages or metal-organic cages 
[MOCs]) are similar to MOFs but the self-assembly process results in the formation of distinct cages 
rather than continuous networks.145,147,148  Both MOFs and coordination cages generally contain voids 
or pores that make up a large percentage of the total volume.145,148,149 
Coordination cages have found use in supramolecular chemistry in a wide variety of applications, 
being demonstrated as chemical sensors, containers for gas storage and also for purification 
purposes.145,147,150,151  Additionally, due to the constrained the nature of the cage, the internal pore 
generally provides an uncommon chemical environment and as such, coordination cages have been 
reported as catalysing unusual and otherwise unfavoured reactions.148,152  The Fujita group has 
reported several examples of reactions occurring inside coordination cages that would not otherwise 
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occur such as the cyclisations of α-diketones (standard conditions result in cleavage)  and the 
cycloaddition of otherwise inactive aromatic compounds (Figure 1-15).153,154 
 
Figure 1-15: Unusual reaction products observed inside a coordination cage reported by the Fujita group.  Cage model 
reproduced with permission from refs.153,154 
Another example of an unusual reaction taking place inside of a cage has been reported by the Ward 
group who designed a coordination cage capable of acting as a highly efficient catalyst of the Kemp 
Elimination of benzisoxazole to afford 2-cyanophenolate, with the reaction occurring at a rate 2 × 105 
faster than the uncatalyzed reaction (Figure 1-16).155 
 
Figure 1-16: Formation of 2-cyanophenolate inside a cage reported by the Ward group.  Cage model reproduced with 
permission from ref155 
Furthermore, cages have been reported to be able to stabilise highly reactive molecules, the most 
famous example of which is the entrapment of white phosphorus (P4) in a cage as reported by Nitschke 
and co-workers  (Figure 1-17a)*.156,157  White phosphorus is a highly reactive, extremely pyrophoric 
                                                          
* The ⊂symbol used in Figure 1-17a is used to represent when a molecule is encapsulated by another.  In this 
instance, 51 is encapsulated by 50.  
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compound that has been used as an incendiary weapon.101,158,159  Another example of the stabilisation 
of reactive compounds was demonstrated by Fujita et al. who reported the synthesis of stable 
cyclotrisiloxanes inside of a cage, compounds previously only considered to be fleeting intermediates 
during the condensation of polyalkylsiloxanes (Figure 1-17b).160 
 
Figure 1-17: a) Synthesis and assembly of a coordination cage and subsequent encapsulation of P4 reported by Nitschke 
et al.157 b) A coordination cage developed by the Fujita group capable of stabilizing cyclotrisiloxanes 53 and 54.  160 
A more in-depth discussion of MOFs and MOCs will be provided in Chapter 3 Amino Acid-
Functionalized fused [5]polynorbornanes as Ligands for Metals 
1.3.3 Interwoven metal-organic assemblies 
On occasion, the self-assembly of the metal ions and organic linkers results in interwoven or otherwise 
linked structures.  These interwoven frameworks can then be covalently linked to form Borromean 
rings, molecular knots, catenanes and rotaxanes among others.161-165  These interwoven metal-organic 
assemblies have been used to develop molecular switches and even molecular machines.162,166-170  An 
example of a molecular switch was reported by Zhang et al. which could be turned on and off by 
treatment with 365 nm light and O2 gas respectively (Figure 1-18).171 
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Figure 1-18: The interwoven network capable of acting as a molecular switch reported by Zhang et al.  Figure reproduced 
with permission from ref171 
Borromean rings are formed when three rings are interwoven in such a manner that they cannot be 
separated without breaking apart one of the rings.161,172,173  The first example of a molecular 
Borromean ring was reported by Stoddart and co-workers in 2004 and required extensive use of self-
assembly using π-π interactions and Zn2+ ions complexing to nitrogen atoms in order to assemble the 
completed ring system (Figure 1-19).161 
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Figure 1-19: Top) The molecular Borromean ring synthesised by Stoddart and co-workers.  Bottom) An isolated ring.  
Colour image reproduced from ref161 
Catenanes are a class of linked compounds featuring interlocked rings which cannot be separated 
without completely breaking one of the rings (Figure 1-20).162,165,174,175  Traditional synthesis of 
catenanes was carried out by performing ring-closing reactions in the presence of another ring and 
hoping that a small amount of catenane could be formed.7,176,177  The use of metal-mediated 
templation now allows yields of over 90%, far beyond what was achievable using traditional non-
templated means.178,179 
 
Figure 1-20: A homo catenane reported by Stoddart et al.180 
If one of the rings of a catenane is opened, but large blocking groups are placed on either end of the 
chain to prevent the remaining ring from dissociating from the chain or ‘axle’, a rotaxane is formed 
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(Figure 1-21).174,175  Similarly to catenanes, the earliest rotaxanes were formed through statistical 
methods, by joining together the two ends of the axle together in the presence of the ring and 
hoping that some rotaxanes were formed.165,174,181  Again, similarly to catenanes, the formation of 
rotaxanes can be greatly enhanced through self-assembly and intermolecular forces.182,183 
 
Figure 1-21: A rotaxane reported by Stoddart and coworkers184 
Molecular knots are a type of interlocked molecular architecture formed from a long ring that crosses 
over itself in such a way that it cannot expand without breaking the ring.174,185,186  The first reported 
molecular knot or ‘knotane’ was reporter by Sauvage and co-workers in 1989, when they were able 
form a double helix-type structure through the self-assembly of two bis-1,10-phenanthroline 
containing moieties with two copper ions.  Once formed, the interwoven moieties were linked 
together by glycol residues to form the trefoil knot 62 (Figure 1-22).187 
 
Figure 1-22: Templation and synthesis of a molecular knot by Sauvage et al.187 
1.4 Norbornenes and fused [n]polynorbornanes 
A norbornene is a bicyclic, bridged hydrocarbon compound (Figure 1-23).  The bridged nature of the 
compound instils considerable rigidity to the molecule, allowing for compounds derived from 
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norbornene units to have predictable three-dimensional geometries.188  Furthermore, the alkene 
portion of norbornene 63 allows for further functionalisation, making norbornene derived compounds 
an attractive small preorganised scaffold for supramolecular chemistry.189,190 
 
Figure 1-23: A norbornene unit 
A derivative of norbornene 63, norbornadiene 64, consists of two alkenes at either end of the 
molecule (Figure 1-24).  The alkenes are located at opposite ends of the norbornane molecule, 
allowing for functionalisation of the norbornane frameworks in multiple directions.  Norbornadiene 
64 is relatively rare among dienes as the presence of the bridge means it cannot isomerise to a 
conjugated form easily, as any isomer will violate Bredt’s rule.191-193  One structural isomer of 
norbornadiene 64 does exist, that of quadricyclane 65, formed by subjecting norbornadiene 64 to a 
photochemical reaction (Figure 1-24).194,195 
 
Figure 1-24: Isomerisation of norbornadiene to quadricyclane 
The bridge present in norbornene compounds results in two distinct environments above and below 
the norbornene cyclohexene ring.  The different types of environment are named according to IUPAC 
rules relative to their proximity towards the bridges of the norbornene framework, typically those that 
are located ‘below’ the framework are referred to as endohedral due to their proximity to the largest 
bridge and those that are located above the ring are referred to as exohedral and are located on the 
same plane as the smaller bridge (Figure 1-25).196-198 
 
Figure 1-25: The exo- and endohedral planes of norbornene 
Norbornenes have found usage as rigid backbones in supramolecular chemistry as their fused nature 
results in functionalised norbornene units having predictable three-dimensional shapes as seen in the 
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1972 work of Filipescu who employed norbornene units as spacers to separate chromophores (Figure 
1-26)199,200  The framework used by Filipescu in 67 features two norbornane units fused together in an 
exo,endo fashion, one of the earliest examples of fused [n]polynorbornanes in supramolecular 
chemistry. 
 
Figure 1-26: Two norbornene based chromophores reported by Filipescu200 
Another attractive feature of norbornenes is the ease with which they can be accessed.  A simple Diels-
Alder reaction (developed by Otto Diels and Kurt Alder in 1928, for which they were awarded the 1950 
Nobel prize) is a [4 + 2] cycloaddition between a conjugated diene and an alkene which generates a 
norbornene product.201  An example of the Diels-Alder reaction is shown below in Figure  1-27 where 
cyclopentadiene 68 and maleic anhydride 69 are combined to afford norbornene anhydride 70 or 
71.202 
 
Figure 1-27: Formation of norbornene anhydride via the Diels-Alder reaction 
The formation of norbornene anhydride is a useful tool in the development of scaffolds for 
supramolecular chemistry as the ratio of endo:exo isomer formation can be easily controlled through 
temperature.  At room temperature, secondary orbital overlap lowers the transition state energy and 
results in the favoured formation of the kinetic endo product rather than the thermodynamic exo 
product (Figure 1-28).203,204 
 
Figure 1-28: Secondary orbital overlap promoting the formation of endo-norbornene anhydride 
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1.4.1 Uses of norbornenes in supramolecular chemistry 
Due to their preorganised nature and well-defined synthetic pathways, norbornenes have found use 
as scaffolds for the development of anion receptors.188,205-207  Norbornenes functionalised with 
thiourea residues were reported to bind a range of anions including acetate and dihydrogen 
orthophosphate (Figure 1-29a).206,208  With the aim of developing a vancomycin mimic, peptide-
functionalised norbornenes have been developed to bind acetate and acetyl-D-alaninate (Figure 1-
29b).209  A series of norbornenes functionalised with amide-triazole residues was recently synthesised 
and found to bind to fluoride and phosphate anions (Figure 1-29c).210 
 
Figure 1-29: a) A thiourea functionalised norbornene developed for anion recognition by Pfeffer et al shown binding two 
molecules of acetate.206 b) A norbornene based vancomycin mimic developed by Pfeffer and Long shown binding acetyl-
D-alaninate.209  c) A norbornene based anion sensor developed by Haridas et al shown binding a fluoride anion.210   
A polymeric norbornene macromolecule functionalised with ferrocene moieties linked via amide 
bonds was reported by Astruc and co-workers and was reported to bind adenosine triphosphate 
(ATP) (Figure 1-30).211  
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Figure 1-30: The Ferrocene containing norbornene polymer reported by Astruc and coworkers211 
The conversion of norbornadiene to quadricyclane and back again has been investigated by Erhart, 
Kuisma and co-workers among others as a solar thermal storage device (Figure 1-31).195,212-214  Herges 
et al. took advantage of the quadricyclane:norbornadiene isomerism to design a system wherein the 
sodium binding nature of norbornadiene 77 can be switched off upon conversion to quadricyclane 
78.215 
 
Figure 1-31: Norbornadiene:quadricyclane system for the binding of sodium reported by Herges and coworkers215 
1.4.2 Synthesis of fused [n]polynorbornane frameworks 
Fused [n]polynorbornane frameworks have found increased use in supramolecular chemistry due to 
their well-defined geometries and the well-established synthetic strategies that exist for obtaining 
them.188,216,217   
One of the most popular methods of synthesising fused [n]polynorbornane frameworks, the method 
employed in this work, utilises three reactions.  The first two reactions, a [2 + 2] Mitsudo cycloaddition 
coupled with a Weitz-Scheffer epoxidation are used to generate cyclobutane epoxides.188,217  In the 
third reaction, the cyclobutane epoxide is then reacted with a norbornene alkene to generate the 
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fused polynorbornane framework in an Alkene + Cyclobutane Epoxide (ACE) cycloaddition (Figure 1-
32).218,219   
 
Figure 1-32: Use of the Mitsudo reaction, Weitz-Scheffer epoxidation and ACE cycloaddition to generate fused 
[n]polynorbornane frameworks 
The Mitsudo cycloaddition, first reported in 1979 by Mitsudo and co-workers, is a method of forming 
cyclobutenes through a [2 + 2] cycloaddition (Figure 1-33).220  The catalytic cycle begins with the loss 
of two ligands from the ruthenium complex RuH2(CO)(PPh3)3 82 to give the active ruthenium species 
83.  This ruthenium species is then able to complex both the alkene and alkyne before undergoing 
oxidative addition to form ruthenocycle 86.  The ruthenocycle then undergoes reductive elimination 
to form the desired cyclobutene 79.220-222 
 
Figure 1-33: Catalytic cycle of the Mitsudo reaction 
Due primarily to the difficulty in forming epoxides from electrophilic alkenes using the typical 
electrophilic oxidation reagents (such as mCPBA), the Weitz-Scheffer epoxidation is a common 
method of achieving this transformation for electron withdrawn alkenes (Figure 1-34).223  The 
epoxidation employs both a hydroperoxide (herein tert-butyl hydroperoxide 87) and a base to 
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generate a peroxy anion which attacks the electron deficient alkene of 79.  The resulting enolate anion 
90 then takes part in intramolecular nucleophilic displacement, breaking the weak O-O bond to form 
the desired epoxide 80 and an alkoxide (t-BuO-).224   
 
Figure 1-34: Mechanism of the Weitz-Scheffer epoxidation 
The final reaction used to generate fused [n]polynorbornane frameworks is the ACE cycloaddition, a 
1,3-dipolar [4π + 2π] pericyclic cycloaddition between a carbonyl ylide and an alkene (Figure 1-
35).225,226  The ylide itself is formed from cyclobutane epoxide which undergoes thermal ring opening.  
The selectivity of the reaction is ensured by the steric constraints of the norbornene bridge, which 
only allows approach from below. 
 
Figure 1-35: Mechanism of the ACE cycloaddition 
These three reactions can be combined to generate a wide range of [n]polynorbornane framework 
lengths and when used in conjunction with bridged linkers, long rigid frameworks can be accessed 
(Figure 1-36).218,219  However, molecular modelling by Warrener et al. revealed that as the fused 
[n]polynorbornane framework is lengthened, a pronounced curvature of the backbone develops.227  
To circumvent this issue, rigid bridged units can be incorporated into the backbone in order to enforce 
linearity as illustrated by bridged polynorbornane 95. 
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Figure 1-36: Formation of fused [n]polynorbornane frameworks of differing lengths 
By functionalising these frameworks with appropriate groups, fused [n]polynorbornanes can be used 
in a wide variety of supramolecular applications. 
In recent years, the adoption of microwave irradiation has been found to dramatically accelerate the 
synthesis of fused [n]polynorbornane frameworks, with both the Mitsudo cycloaddition and the ACE 
cycloaddition able to be performed with dramatically reduced reaction times (from days to minutes 
in the case of the Mitsudo cycloaddition).218,219  The use of microwave irradiation has also been 
reported to result in significantly less thermal decomposition than conventional heating, as a result 
of the significantly reduced reaction times.218,219 
1.4.3 Fused [n]polynorbornanes in supramolecular chemistry over the last 10 years 
Fused [n]polynorbornanes have found use in a variety of different supramolecular chemistry 
applications.  Anion receptors based on functionalised fused [n]polynorbornanes have been reported 
by Pfeffer and co-workers, examples of which are shown in Figure 1-37, that take advantage of the 
ease of functionalisation of fused [n]polynorbornanes to generate hosts with two, three and four 
binding arms.188,205,208,217,228-230 
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Figure 1-37: [3]polynorbornane hosts developed for anion recognition205 
A series of porphyrin-based molecular tweezers using porphyrin-functionalised polynorbornane 
frameworks was developed by Johnston and co-workers (Figure 1-38).231,232  The smaller bis-porphyrin 
functionalised tweezer 99 has been reported to bind diamino compounds such as DABCO and an 
extension of this work resulted in the larger tetraporphyrin-functionalised 100 which features two 
independent binding sites.  It has been proposed by Johnstone and co-workers that the aromatic linker 
allows for rotation of the two polynorbornane frameworks enabling 100 to be able to bind diamines 
of varying sizes.232 
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Figure 1-38: Norbornane-based molecular tweezers reported by Johnston et al.231 
Work by Pfeffer, Clever and co-workers generated a family of functionalised fused [n]polynorbornanes 
that were found to form a variety of metal-organic complexes and cages (Figure 1-39).233,234  The 
second generation of ligands, featuring bis-functionalised [5]polynorbornane frameworks afforded a 
mixture of butterfly complexes and coordination cages, however the butterfly complexes were the 
predominate product for both 101 and 102, a feature attributed to the curvature of the 
polynorbornane framework.234  A third generation of ligands, featuring an enforced straightening of 
the backbone through the incorporation of a linkage between the two innermost bridges.  The 
resultant bis-functionalised [6]polynorbornane frameworks readily formed coordination cages and a 
subsequent 4th generation featuring additional endohedral functionality was also found to form 
coordination cages, with M2L4 and M3L4 cages being formed for all ligands except for 105 and 106.233  
The development of these ligands will be further discussed in section 3.4 
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Figure 1-39: Development of a series of fused [n]polynorbornane ligands for coordination cage formation developed by 
Pfeffer, Clever and co-workers.233 
A polynorbornane framework functionalised with bis-9-aminoacridine moieties was reported by 
Waring and co-workers and was found to act as a DNA intercalator (Figure 1-40).235  During this work, 
it was determined that the [3]polynorbornane framework provided the optimal distance between the 
9-aminoacridine groups to enable the compound to function as a DNA intercalator.  Compound 111 
was reported to have an unwinding angle of 27°. 
 
Figure 1-40: A DNA intercalator based on a [3]polynorbornane framework developed by Waring et al.235 
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The rigid nature of norbornenes and fused [n]polynorbornanes coupled with the ability to 
functionalise the frameworks to obtain predictable geometries allows them to be adapted for a variety 
of supramolecular applications. 
1.5 Project objectives 
In this thesis, fused [n]polynorbornane and norbornene frameworks will be functionalised for use in a 
variety of supramolecular applications involving metal ions.  The following systems will be discussed 
in the upcoming chapters: 
1. An indicator displacement assay for pyrophosphate 
The synthesis and evaluation of a family of bis Zn(II):dipicolylamino functionalised fused 
[n]polynorbornane frameworks.  The ability of these anion hosts to bind a wide range of 
biologically relevant anions will be evaluated through 1H NMR spectroscopy and UV-Vis 
titrations and assessed for the potential development of an indicator displacement assay. 
2. Metal-organic frameworks using amino acid functionalised fused [n]polynorbornane 
frameworks 
A series of rigid ligands functionalised with amino acid residues will be synthesised and 
evaluated for their ability to form complexes with metal-organic ions.  By incorporating chiral 
and achiral ligands, the effect of chirality of cage formation will be investigated.  The formation 
of complexes will be evaluated through 1H NMR spectroscopy and X-ray crystallography. 
3. An ionic organogelator 
The development of a chiral, ionic organogelator based on an amino acid functionalised 
norbornene that can also form aqueous biphasic systems when mixed with kosmotropic salts.  
The effect of counter-ion substitution will be investigated as well as the effect of changing side 
groups of the amino acid moiety.  Characterisation of the physical properties of the gels using 
rheology, calorimetry and SEM imaging will be reported.  The structure of the gel network will 
be investigated using X-ray crystallography. 
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2. An Indicator Displacement Assay for Pyrophosphate 
This chapter begins with an outline of anion recognition and sensing, with an emphasis on sensing 
using indicator displacement assays.  A discussion of biological pyrophosphate and its importance in 
medicine will then be provided, followed by a review on the detection of pyrophosphate through the 
use of bis zinc(II):dipicolylamino binding units.  Finally, the design, synthesis and evaluation of a new 
family of fused [n]polynorbornane based sensors for pyrophosphate incorporating bis 
zinc(II):dipicolylamino binding units capable of functioning as indicator displacement assays will be 
provided 
2.1 Anions and their importance 
Anions (negatively charged molecules) are prevalent in nature, especially in biological systems.236,237  
Many enzyme substrates and cofactors are anionic.  DNA, the building block of life, is a polyanion 
courtesy of the phosphate anions that form phosphodiester bonds between nucleotides.238,239   ATP, 
the fuel source used by cellular processes is an anion and also forms anionic by-products.236-238,240  
Despite their essential roles, excessive amounts of anions in the body can also be responsible for a 
wide range of health problems.241,242 
Anions can also be problematic in nature, acting as pollutants and carcinogens.    The chromate anion, 
listed as EPA priority pollutant, known to act as a carcinogen and cause gene mutations, is formed as 
a by-product from the consumption of nuclear fuels as well as from mining and other industrial 
processes.243  Sulfate anions, another by-product from multiple industrial processes have been proven 
to cause health problems in humans.244  Nitrate anions, formed through industrial processes such as 
paper manufacturing and also used in fertilisers, have been linked to health problems in infants as 
well as the eutrophication of water supplies.245,246  
For these reasons, the ability to selectively bind a specific anion and furthermore, to signal that the 
binding event has taken place, is of great interest to researchers working in a wide range of fields, 
including medicinal, agricultural, industrial and pharmaceutical chemistry. 
2.1.1 The importance of biological pyrophosphate 
Pyrophosphate (ppi) is a phosphorus oxyanion formed in the human body whenever a molecule of 
adenosine triphosphate (ATP) is hydrolysed to provide energy for biological processes (Figure 2-1).  
One such process that releases ppi is the addition of nucleotides to growing DNA and RNA strands, a 
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process in human cells that can proceed at up to 50 nucleotides per second.247,248  The release of ppi 
from the addition of nucleotides can be monitored as a method of real time DNA sequencing.249,250 
 
Figure 2-1: Hydrolysis of ATP to liberate adenosine monophosphate and ppi 
Due to the numerous biological processes that generate ppi as a by-product, measuring changes in 
ppi concentration in different parts of the body can be used as a diagnostic tool for a wide range of 
clinical conditions.  High levels of ppi in synovial fluid have been observed in people suffering from 
chondrocalcinosis (calcium pyrophosphate dihydrate crystal deposition disease).251-253  Levels of ppi in 
cells can also be used as indicators for monitoring cancer.254-257   
2.2 Methods for anion binding and sensing 
The first anion receptors were developed in the 1960’s at around the same time as the development 
of crown ethers by Pederson and cryptands by Lehn (see section 1.1.1).  The first reported example 
of anion recognition was in 1968 when Park and Simmons reported a macrocyclic ammonium cage 
that bound chloride anions through a combination of H-bonding and electrostatic interactions (Figure 
2-2).258 
 
Figure 2-2: Chloride binding macrocycles 112 and 113 reported by Park and Simmons258 
However, over the next twenty years, anion recognition was largely ignored in favour of investigating 
the complexation of group I and II cations.237,259  Part of the reason for this lack of attention is to do 
with the increased difficulty of designing a host capable of binding anions when compared to binding 
cations.  Anions are typically larger than comparable cations, resulting in a lower charge to radius ratio, 
meaning that bonding interactions between host and anionic guest are weaker and less effective than 
those between host and cationic guest.260 Anions are also sensitive to pH and solvent effects and care 
must be taken to ensure the right conditions are used to maximise binding interactions.261,262  As such, 
the successful design and synthesis of a host capable of binding to anions in aqueous conditions 
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remains a challenge.  Additionally, anions can possess a wide range of geometries, meaning the 
successful design of an anionic host requires a more sophisticated structural design than for cations 
(Figure 2-3).237 
 
Figure 2-3: Examples of anion geometries 
Anion receptors can employ a variety of interactions to complex the desired anion.  As anions are 
negatively charged, one popular method of binding anions is through electrostatic interactions, for 
example, using quaternary ammonium complexes.263,264  This type of binding was investigated by 
Schmidtchen in the early 1980’s with the synthesis of a family of macrotricycles capable of forming 
strong complexes with halide anions  (Figure 2-4).265,266  However, the first generation of these 
receptors suffered from competition by the counterions, and to circumvent this, Schmidtchen 
designed a series of zwitterionic macrotricycles that demonstrated a greater affinity for halide anions 
than the previous generation.266 
  
Figure 2-4: A family of halide binders reported by Schmidtchen265,266 
Another popular method of binding anions is by H-bonding interactions.  H-bonding interactions are 
popular in the design of anion receptors due to the directionality of the hydrogen bond.  The 
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unidirectionality of hydrogen bonds allows for the easy design of complementary hosts that are 
selective for a specific anion geometry.  An excellent example of hydrogen bond interactions that 
result in selective recognition is demonstrated by the assembly of DNA nucleotides into a double helix.  
The four base pairs, adenine, guanine, cytosine and thymine, only recognise and interact with a 
specific partner (adenine-thymine and guanine-cytosine) because of specific hydrogen bond 
interactions (Figure 2-5). 
 
Figure 2-5: Nucleotide base pairs demonstrating the importance of Hydrogen bond interactions in molecular recognition. 
One of first anion receptors capable of binding an anionic guest purely through H-bonding interactions 
was reported by Pascal and co-workers in 1986.267  The H-bonding interactions were provided by 
amide moieties incorporated into a cyclophane-based cryptand that was reported to bind fluoride in 
deuterated dimethyl sulfoxide (DMSO-d6) however the exact method of binding was not determined 
and evidence of the binding was not supplied (Figure 2-6).*  
 
Figure 2-6: Cryptand 119 reported by Pascal et al.267 
The ability of metals and Lewis acids to bind anions courtesy of orbital overlap has resulted in a wide 
range of anion receptors containing metals such as mercury and tin as well as Lewis acids such as 
boron and silicon being developed.259,268-272  The earliest reported example of an anion sensor that 
                                                          
* Despite an in-depth literature search as well as a structure search through SciFinder, no evidence of follow up 
studies involving compound 119 appear to have been carried out. 
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utilised metals to coordinate anions was the family of tin-containing macrocycles reported by Azuma 
and Newcomb in 1984 that were capable of complexing chloride anions (Figure 2-7).273,274 
 
Figure 2-7: Tin-based macrocycles 120-131 reported by Azuma and Newcomb273,274 
A less common method of binding anions utilises the hydrophobic effect (the phenomenon of 
nonpolar compounds to aggregate in aqueous solution, resulting in the exclusion of water molecules 
from the resultant aggregates275), as illustrated by Inoue and co-workers who reported that γ-
cyclodextrin was capable of binding naphthalenesulphonates in water (Figure 2-8).113,276  The main 
driving force behind the binding of the anion was reported to be the displacement of water molecules 
from the β-cyclodextrin cavity by the naphthalene moiety.  This is an example of entropy driven 
binding, as the formation of aggregates results in a decrease in the number of ordered water 
molecules around the hydrophobic molecules, causing an increase in the overall disorder (or entropy) 
of the system.277 
 
Figure 2-8: γ-Cyclodextrin 36 
The binding of anions can be accomplished through a multitude of means, however in order to 
function as a sensor, the host still requires a means through which to communicate the occurrence of 
the binding event.  Due to space constraints, only a brief overview of several types of sensor will be 
provided in this section, however, several reviews are available for interested readers.259,261,270,278-281 
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2.2.1 Electrochemical sensing of anions 
Electrochemical sensing of anions involves a host that upon binding the target anion, undergoes a 
change in its electrochemical properties, usually achieved through the incorporation of a redox-active 
group.270  There are three broad classes of electrochemical recognition of a receptor:anion complex.  
Firstly, the anion can be adsorbed into a membrane by a nonelectroactive host, causing a change in 
potential across the membrane that can then be measured.282  Secondly, the change in electron 
potential of a redox-active host upon complexation with an anionic guest can be measured to 
determine the strength of binding.283  Finally, an electrode made of a chemical matrix possessing both 
redox properties and a binding site capable of complexing anions can be used to demonstrate the 
formation of a receptor:anion complex.284,285 
One example of the electrochemical sensing of anions can be seen in the work of Beer and Keefe in 
1989 who developed a series of polycobaltocenium macrocycles, one of which, macrocycle 132 
capable of demonstrating a cathodic shift upon the addition of bromide anions (Figure 2-9).286  It was 
observed by the authors that while complexes 133 and 134 were also capable of binding bromide 
anions, precipitation of the host:guest complexes made it impossible to obtain electrochemical 
readings. 
 
Figure 2-9: A family of polycobaltocenium macrocycles developed by Beer and Keefe286 
Ferrocene has been a popular choice for the development of electrochemical anion sensors.    
Examples of ferrocene-containing anion sensors include the chiral urea-based sensor 135, developed 
by Moody, Tucker et al. and reported to bind (S)-benzensulfonyl proline 1.7 times more strongly than 
the (R) enantiomer (Figure 2-10a).287  The Kim group reported a bis-ferrocene functionalised aryl 
triazole 136 that functioned as a sensor for dihydrogen phosphate (Figure 2-10b).288  An 
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imidiazoliophane macrocycle functionalised with two ferrocene moieties was synthesised by the Beer 
group and found to act as an electrochemical sensor for halide anions (Figure 2-10c).289  
 
Figure 2-10: Ferrocene based anion sensors reported by a) Moody, Tucker et al.287 b) The Kim group288 and c) The Beer 
group289 
2.2.3 Luminescent, fluorescent and colorimetric anion sensors 
Luminescent and fluorescent anion sensors are those where the formation of the receptor:anion 
complex results in a change in photophysical properties, either absorption, luminescent or fluorescent 
which can then be measured to determine the formation of the complex.290,291  Luminescence refers 
to the emission of light from a process not involving heat, thus making luminescence a type of cold-
body radiation.292  Fluorescence is a type of luminescence where the molecule is excited by the 
absorption of a photon.293  Many anion sensors have been developed that incorporate luminescent or 
fluorescent moieties such as anthracene, pyrene, naphthalene and tris(2,2’-bipyridyl)ruthenium(II) 
([Ru(bpy)3]2+), far more than can be covered in this brief overview.  An overview of several seminal 
sensor systems will be provided, however readers interested in more in-depth discussions are invited 
to refer to several reviews currently available.261,290,291,294-297  
There are three broad classes of luminescent and fluorescent sensors (Figure 2-11).  The first class 
consists of a signalling unit being covalently linked to a binding site, with the receptor then functioning 
as part of the signalling unit (Figure 2-11a).  The second class is similar to the first, but the signalling 
unit is separated from the binding site by a short linker and the receptor does not function as part of 
the signalling unit (Figure 2-11b).  The final type is referred to as chemodosimeters, and upon the 
binding of the anion, a chemical reaction takes place (either involving or catalysed by the anion) and 
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it is the product formed by this reaction that then acts as the signalling unit (Figure 2-11c).  Unlike the 
previous two classes, chemodosimeters are usually irreversible.   
 
Figure 2-11: The three main classes of luminescent and fluorescent sensors. a) where the receptor functions as part of the 
signalling unit upon binding the guest, b) where the signalling unit is separated from the receptor by a short linker and c) 
where the binding of the guest causes a chemical reaction which generates the signalling unit 
Some of the earliest reported anion sensors were the anthracene-based polyamines 138 and 139 
synthesised by Czarnik in 1994 (Figure 2-12).298-300  These receptors were reported to give fluorescent 
responses upon addition of a wide variety of anions including phosphate, sulfate and acetate.  In the 
same work, Czarnik also reported polyammonium functionalised anthracene sensor 140.  This sensor 
was specifically designed to bind pyrophosphate over phosphate and indeed, demonstrated a 2200-
fold increase in selectivity for pyrophosphate over phosphate. 
 
Figure 2-12: Anthracene-based anion receptors 138-140 developed by Czarnik298-300 
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In the late 1990’s Beer and co-workers reported several luminescent [Ru(bpy)3]2+ based anion sensors 
(Figure 2-13).301  These sensors were capable of forming strong complexes with phosphate anions and 
these anions could be detected both electrochemically and optically, showing a pronounced blue shift 
upon addition of both anions.  It was also observed that acyclic receptors 141 and 142 were also 
capable of strongly binding chloride anions, results that were not obtained with the cyclic and 
calix[4]arene containing receptors 143 and 144. 
 
Figure 2-13: [Ru(bpy)]2+ anion sensors 141-144 reported by Beer and coworkers301,302 
In the early 2000’s the groups of Gale and Gunnlaugsson independently reported sensors for fluoride 
anions that demonstrated changes in the fluorescent properties of the sensors due to deprotonation 
of the amino moieties (Figure 2-14).  Gunnlaugsson reported thiourea based sensor 145, that 
underwent fluorescent quenching upon addition of one equivalent of fluoride, acetate or phosphate 
ions, and upon addition of an extra equivalent of fluoride underwent a colour change from yellow to 
purple.303  Similar results were observed for naphthalimide 146 but not for the analogous 147, which 
does not contain a free amine, demonstrating the importance of the amino group for the ability of the 
sensor to function.304  At the same time, Gale and co-workers reported the pyrrole based sensor 148 
which gave responses in the presence of several anions including fluoride.305  A follow-up study 
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afforded a more selective sensor, 149, which only developed a deep blue colour in the presence of 
fluoride or hydroxide anions.306 
 
Figure 2-14: Fluoride sensors reported by the groups of Gunnlaugsson (145-147)303,304 and Gale (148 and 149)305,306 
Colorimetric anion sensors experience a change in colour upon complexation with an anion.281,307 By 
measuring the change in absorbance of specific wavelengths, the formation and strength of binding 
of the receptor:anion complex can be determined.  The fluoride sensors reported separately by the 
groups of Gale and Gunnlaugsson, because of the marked colour changes observed upon addition of 
fluoride, could act as both fluorescent and colorimetric anion sensors. 
2.2.4 Indicator displacement assays for anion sensing 
Indicator displacement assays (IDAs) are a sensing platform where the luminescent/fluorescent 
moiety is not covalently incorporated into the molecule, instead being present as a separate weakly 
bound guest.  This weak interaction with the host typically modulates the optical properties of the 
indicator guest.  When the target anion binds (through stronger interactions than the indicator) to the 
host, the weakly bound indicator is displaced from the host, restoring its original colour/emission 
(Figure 2-15).308   
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Figure 2-15: Schematic of an IDA showing the initial quenching of the indicator and subsequent displacement and 
restoration of emission 
Early work in the development of indicator displacement assays was carried out by Inouye and co-
workers who developed a calixarene known to form a tetraanion in alkaline media (Figure 2-16).309  
This polyanion has been demonstrated to bind tetraalkylammonium cations such as acetylcholine.  It 
was discovered by Inouye that a pyrene modified N-alkylpyridium cation 150 could also be bound by 
the calixarene host 151, and upon binding, the orange fluorescence was quenched.  Addition of 
acetylcholine displaced the dye from the host and restored the original orange colour of the indicator. 
 
Figure 2-16: The IDA reported by Inouye et al.309 
The first example of an indicator displacement assay for anions was reported by Anslyn and Metzger 
in 1998.310  In this work, a receptor containing three guanidinium residues that had been previously 
found to bind citrate was complexed with fluorescent indicator 5-carboxyfluorescein (Figure 2-17).311  
Upon addition of receptor 152 to a buffered solution (H2O:MeOH 1:3, 5mm HEPES buffer, pH 7.4) of 
indicator, a significant increase in UV absorbance was observed.  Upon addition of citrate, the 
increased signal was quenched and returned to its original levels, a process that could be repeated up 
to 5 times without any reduction in signal output. 
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Figure 2-17: An IDA for citrate reported by Anslyn and Metzger310 
Since these seminal works, the indicator displacement assay has been a popular method of anion 
sensing and interested readers are invited to refer to several reviews for more information.260,279,308,312 
2.3 Previous sensors for pyrophosphate 
Due to its biological importance, there has been a multitude of receptors reported for the binding and 
recognition of ppi, far more than can fit in this thesis.  A brief overview of several popular classes will 
be provided, however readers interested in more detailed discussions of ppi binding and sensing are 
invited to refer to several comprehensive reviews.254,313-315 
Hydrogen bonding has been used in the design of several receptors for ppi (Figure 2-18).  Espinosa 
and Molina reported two urea based receptors 153 and 154 that capable of binding ppi in a MeCN:H2O 
(70:30) solvent mix.316  The pyrene-functionalised receptor 154 was found to give a much stronger 
response than nitrophenyl-functionalised receptor 153 as a result of excimer formation.  Caltagirone 
et al. also employed bis-urea based receptors to sense ppi, reporting nitrophenyl-functionalised 
receptors 155 and 156 as well as naphthyl-functionalised receptors 157 and 158.317  Addition of ppi to 
DMSO solutions of the receptors resulted in a colour change from yellow to orange for the nitrophenyl 
analogues and emission quenching for the naphthyl analogues. 
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Figure 2-18: ppi sensors employing hydrogen bonding316,317 
Imidazolium-containing receptors have been employed as sensors for ppi, among other phosphate-
containing molecules (Figure 2-19).  An anthracene dimer linked by two imidazolium residues 159 was 
reported by Kim and Yoon, and was found to undergo switching-off through photoinduced electron 
transfer (PET) upon binding of ppi and phosphate.318,319  Bis-imidazolium receptor 160 based on a 
functionalised quinoxaline was reported by Kim et al. Receptor 160 was found to form an excimer in 
the presence of anions except for ppi, which instead generated a large transfer band (believed to be 
the result of proton transfer, however precipitation made NMR observation of this process 
impossible), enabling the receptor to function as a receptor for ppi.320  A bis-anthracene receptor 161 
containing two imidazolium moieties was reported by Yoon and co-workers and was found to undergo 
fluorescent quenching upon addition of ppi.321  A bis-tetraphenylethylene based receptor 162 
containing two imidazolium residues was reported by Zheng et al. and was found to act as a sensor 
for ppi in the presence of half an equivalent of zinc.322 
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Figure 2-19: Imidazolium-based ppi sensors319-323 
A method of ppi recognition that has gained popularity in recent years is the use of metal complexes.  
Zinc complexes are successful in binding ppi both in the laboratory and in the body (refer to section 
2.4.1 for more information).  Several enzymes, notably the alkaline phosphatases and P1 nucleases, 
make use of zinc to bind phosphates.  One example of a zinc complex that has been used to bind ppi 
was reported by Bencini, Lippolis and co-workers, with their terpyridine-based receptor 163:Zn(II) 
(Figure 2-20).324  Upon complexation with zinc, a large increase in fluorescence was observed, which 
was selectively quenched upon addition of ppi.324  Another zinc based ppi sensor is that of the 
anthracenedione based receptor 164:Zn(II), reported by Luxami et al.325  Upon addition of ppi to a 1:1 
Zn(II):164 complex, a colour change from pink to blue was observed.   
 
Figure 2-20: Zinc based ppi sensors324,325 
Copper has also been used to develop receptors for ppi, albeit less frequently than zinc (Figure 2-21).  
Chen and co-workers reported the bis-Cu(II) complex 165:Cu(II)2, with which they developed an 
indicator displacement assay using pyrocatechol violet as an indicator.326  This ensemble was reported 
to be highly selective and specific for ppi, only producing a colour change upon addition of ppi, with 
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no colour change observed when phosphate, sulfate, acetate, carbonate and halide anions were 
added.  Zhu et al. reported a chromene based copper complex 166:Cu(II) capable of acting as a near 
infrared fluorescent sensor for ppi in water.327  This complex was found to be selective for ppi over a 
wide range of other anions including phosphate. 
 
Figure 2-21: Metal-based ppi sensors326,327 
2.3.1  Zn(II):Dipicolylamino based pyrophosphate sensors 
One popular method of binding ppi is by utilising the zinc(II):dipicolylamino (Zn(II):DPA) binding motif 
(Figure 2-22).  The dipicolylamino group has been used extensively for binding zinc, and is well known 
to be selective for zinc in preference to other metals.328-330  The affinity the DPA group possesses for 
zinc, when coupled with the previously mentioned affinity of zinc for ppi has combined to allow the 
Zn(II):DPA moiety to become a popular tool in the recognition and sensing of ppi.254,315,329  The 
strongest binding is obtained when two Zn(II):DPA groups are used to cooperatively bind the ppi 
anion.331,332 
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Figure 2-22: a) the dipicolylamino group b) A bis DPA group, c) a bis Zn(II):DPA group and g) a bis Zn(II):DPA group 
binding ppi 
Some of the earliest Zn(II):DPA based sensors for ppi were developed by Hamachi and co-workers who 
synthesised anthracene based receptors 168:Zn(II)2 and 169:Zn(II)2 which were found to bind strongly 
to phosphorylated molecules (Figure 2-23).331,333  However, these receptors lacked selectivity towards 
ppi.  
 
Figure 2-23: Bis-Zn(II):DPA functionalised anthracenes used for ppi sensing reported by the Hamachi group331,333 
The first Zn(II):DPA based sensor selective towards ppi over other phosphorylated molecules was 
reported by Hong et al. who developed azophenol-based receptor 170:Zn(II)2 (Figure 2-24).334  This 
receptor underwent a colour change from yellow to red upon the addition of ppi, a colour change that 
was not observed upon addition of other small anions including phosphate.  In follow-up studies, Hong 
and co-workers synthesised analogues 171:Zn(II)2 and 172:Zn(II)2 containing a naphthyl and a pyrene 
group respectively.335,336  Both these sensors were reported to bind ppi preferentially to ATP.  
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Figure 2-24: Ppi sensors reported by Hong et al.334-336 
Anthracene and other structurally similar frameworks have proved a popular choice in the 
development of Zn(II):DPA functionalised sensors for ppi by the Hamachi group (Figure 2-25).  The 
xanthone-based sensor 173:Zn(II)2 and acridine-based sensor 174:Zn(II)2 have been reported by 
Hamachi et al. and found to bind a range of phosphorylated molecules with an affinity for guanidine 
triphosphate (GTP).337,338  However, xanthone-based sensor 173:Zn(II)2 was not assessed against ppi, 
and while acridine-based sensor 174:Zn(II)2 was assessed for its ability to bind ppi, a different binding 
stoichiometry was observed for ppi as opposed to all other phosphorylated molecules, making 
comparisons difficult.337,338  A range of other sensors were also developed by the group including 
175:Zn(II)2 and 176:Zn(II)2 however, these were primarily assessed for their ability to act as a sensor 
for polyphosphate containing nucleotides, and their ability to bind ppi was not assessed.339,340  The 
Yoon group has reported several sensors based on fused aromatic systems, including xanthene-based 
sensor 177:Zn(II)2 and acridine-based sensor 178:Zn(II)2.341,342  Both sensors were found to selectively 
bind ppi, with acridine 178:Zn(II)2 exhibiting different fluorescent responses to ppi and phosphate. 
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Figure 2-25: Examples of ppi sensors using Zn(II):DPA functionalised fused aromatic scaffolds337-342 
The Zn(II):DPA binding unit has also been used to develop indicator displacement assays (IDAs) for 
anion sensing.  The first report of an IDA capable of anion recognition was developed by Kim et al. 
who developed receptor 179:Zn(II)2, based on a phenol scaffold (Figure 2-26).343  This receptor when 
complexed with pyrocatechol violet, was able to act as a colorimetric sensor for phosphate anions in 
aqueous media.  A follow-up study on the compound, carried out by Smith and co-workers used 
coumarin sulfonate indicator 180 and determined that the complex had a much greater affinity for 
ppi over phosphate, enabling the 179:Zn(II)2:180 complex to act as a colorimetric sensor for ppi.344  
 
Figure 2-26: The receptor 179:Zn(II)2 and dyes Pyrocatechol Violet and 180 used to develop an IDA for ppi343,344 
The Jolliffe group have made use of cyclic peptides appended with bis-Zn(II):DPA binding units, such 
as 181:Zn(II)2 (Figure 2-27), which have been found to act as selective sensors for ppi when coumarin 
sulfonate 180 was used as an indicator.345  Resin-bound peptide 182 functionalised with bis-Zn(II):DPA 
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groups have also been reported by Barrow, Pfeffer and Long and found to act as an indicator 
displacement assay for ppi when complexed with pyrocatechol violet.346  In a follow-up to their 
previous study using receptor 170:Zn(II)2, the Hong group functionalised the DPA units themselves, 
appending acetamide groups onto the aromatic rings to afford receptor 183:Zn(II)2  which was 
developed into an IDA using pyrocatechol violet as the indicator.347  As the receptor was able to bind 
ppi through both metal coordination and hydrogen bonding, a remarkably high binding coefficient 
was obtained (5.39 × 1010 M-1 in water).   
 
Figure 2-27: Other examples of Zn(II):DPA based ppi sensors345-347 
The Jolliffe group has also reported intramolecular indicator displacement assays for ppi using cyclic 
peptides functionalised not only with bis-Zn(II):DPA binding units, but also a coumarin indicator 
molecule as seen in compound 184:Zn(II)2 (Figure 2-28).  These intramolecular IDAs were shown to be 
more selective than the corresponding IDAs where the indicator was not covalently bound to the 
receptor.312 
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Figure 2-28: An intramolecular IDA for ppi developed by the Jolliffe group312 
More in-depth reviews of the use of Zn(II):DPA binding units in ppi sensing are available for interested 
readers.315,329 
2.4 Development of a fused [n]polynorbornane based indicator displacement assay 
for pyrophosphate 
It was envisaged in this project that the combination of rigid fused [n]polynorbornane frameworks 
and the bis Zn(II):DPA binding moiety would result in a small library of host compounds whose differing 
cleft sizes would be able to demonstrate affinity for phosphorylated compounds of specific length, 
including pyrophosphate.  Three different framework sizes were envisaged, the [3], [5] and 
[6]polynorbornane frameworks 185-187 (Figure 2-29) 
 
Figure 2-29: The three host compounds developed in this study 
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2.4.1 Synthesis  
As discussed in Section 1.4 Norbornenes and fused [n]polynorbornanes, the synthesis of a range of 
different fused [n]polynorbornanes can be obtained from a common starting material, norbornene 
anhydride 70, using a combination of three reactions, (i) the Ruthenium catalysed [2 + 2] Mitsudo 
cycloaddition, (ii) the Weitz-Scheffer epoxidation and (iii) the ACE cycloaddition. 
2.4.1.1 Retrosynthetic analysis 
All three host compounds were envisaged to be accessible from fused [n]polynorbornane frameworks 
functionalised with amine groups (Example for the [3]polynorbornane host 187 shown in Figure 2-30).  
The use of reductive amination to install dipicolylamino functionality is well known in the literature 
and synthetic protocols for this transformation are well established.315,348-350  However, in order to 
avoid competing side reactions in both the Mitsudo [2 + 2] cycloaddition and the Weitz-Scheffer 
epoxidation, a protecting group for the amine group was required.  The tert-butylcarbamate (boc) 
protecting group was chosen for its ability to tolerate the elevated temperatures required for both 
the Mitsudo [2 + 2] and ACE cycloadditions as well as the peroxide and base employed in the Weitz-
Scheffer epoxidation. 
 
Figure 2-30: Retrosynthetic analysis of the functionalisation of boc-protected [3]polynorbornane 185:Zn(II)2 
As all three host compounds can be accessed from the corresponding boc-protected fused 
[n]polynorbornane frameworks, the retrosynthetic pathway in Figure 2-30 can be applied to all three 
hosts, and the retrosynthetic pathway for the three boc protected fused [n]polynorbornane 
frameworks is shown below (Figure 2-31).   The common precursors 190 and 70 demonstrate the 
versatility of the synthesis of fused [n]polynorbornanes as all three frameworks can be accessed from 
the same starting material. 
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Figure 2-31: Retrosynthetic analysis of the three hosts employed in this chapter.  The common synthetic precursor, 
norbornene anhydride 70 is shown in red 
All three boc-protected precursors (188, 192 and 194) are known compounds and the methods for 
accessing them have been well established.208,217,351  As such, the synthesis of these compounds will 
be only briefly discussed.   
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2.4.1.3 [5]polynorbornane framework synthesis 
In order to access the protected [5]polynorbornane framework 192, a ‘linker’ is required.  A twin [2 + 
2] Mitsudo cycloaddition between norbornadiene and DMAD afforded tetraester 193 in 83% yield 
(Scheme 2-6).  However, this reaction required 96 hours of heating in a sealed pressure vessel.  In 
contrast, yields of around 70% were also obtained using microwave irradiation, which only required 5 
minutes of heating time. 
 
Scheme 2-1: Formation of tetraester 193 through a twin [2 + 2] Mitsudo cycloaddition 
Tetraester 193 was then subject to Weitz-Scheffer epoxidation (Scheme 2-7).  Despite being a twin 
epoxidation, tetraester 193 was converted to bisepoxide 92 in good yield (53%) and high purity, after 
a simple trituration in i-PrOH. 
 
Scheme 2-2: Formation of bisepoxide 92 through a twin Weitz-Scheffer epoxidation 
After accessing bisepoxide 92, the boc-protected [5]polynorbornane framework was synthesised 
through a twin ACE cycloaddition between bisepoxide 92 and boc-protected norbornene imide 190 
(Scheme 2-8). Following microwave irradiation, the desired [5]polynorbornane 192 was obtained in 
70% yield. 
 
Scheme 2-3: Synthesis of boc-protected [5]polynorbornane framework 192 
2.4.1.2 [3]polynorbornane framework synthesis 
Synthesis of the boc-protected [3]polynorbornane framework 188 was accessed following a known 5-
step procedure from anhydride 70.217217  
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The advantages of using anhydride 70 as a starting material include the ease of synthesis and ability 
to scale up the reaction.  The reaction was performed on a 15 gram scale by combining 
cyclopentadiene and maleic anhydride at 0 °C for 2 hours to afford the desired compound in 85% yield 
(Scheme 2-1). 
 
Scheme 2-4: Synthesis of norbornene anhydride 70 
As the anhydride functional group does not tolerate the conditions used in the Weitz-Scheffer 
epoxidation reaction, the amine functionality was installed early.  Mono boc-protected EDA 198 was 
incorporated into the norbornene framework using base-catalysed imide formation and after a 30 
minute reaction the desired boc-protected norbornene imide 190 was obtained in 72% yield (Scheme 
2-2). 
 
Scheme 2-5: Formation of mono boc-protected amine 198 and subsequent formation of boc-protected norbornene imide 
190 
Extension of the norbornene framework was accomplished through ruthenium catalysed [2 + 2] 
Mitsudo cycloaddition between boc-protected norbornene 190 and dimethylacetylene dicarboxylate 
(DMAD).  The desired diester 191 was isolated after a 2 minute microwave-assisted reaction followed 
by purification using column chromatography in 72% yield (Scheme 2-3). 
 
Scheme 2-6: Formation of norbornene diester 191 through a [2 + 2] Mitsudo cycloaddition 
Epoxidation of diester 191 was accomplished by using t-BuOOH as the peroxide source and t-BuONa 
as the base catalyst (Scheme 2-4).  The Weitz-Scheffer epoxidation was found to be a sensitive 
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reaction, requiring strictly anhydrous conditions and careful monitoring of the reaction time in order 
to prevent transesterification.  After purification by column chromatography, the desired 
monoepoxide 189 was isolated in 52% yield. 
 
Scheme 2-7: Formation of monoepoxide 189 through a Weitz-Scheffer epoxidation 
Once monoepoxide 189 was isolated, microwave mediated ACE cycloaddition between 189 and boc-
protected norbornene imide 190 afforded the boc-protected [3]polynorbornane framework 188 in 
65% yield after only a 5 minute reaction (Scheme 2-5).   
 
Scheme 2-8: ACE cycloaddition of monoepoxide 189 and boc-protected norbornene 190 to afford boc-protected 
[3]polynorbornane 188 
2.4.1.4 [6]polynorbornane framework synthesis 
As mentioned in Chapter 1, extended fused [n]polynorbornane frameworks develop a pronounced 
curve.  In order to avoid excessive curvature, specific "spacers” must be employed in order to reinforce 
the polynorbornane backbone.  Hedaya’s diene 195, first reported in 1974, *  features a 
[2]polynorbornene section with an additional bridge that links the two norbornene units together in 
order to generate a highly rigid structure (Figure 2-32).352,353 
 
Figure 2-32: Hedaya's diene 
                                                          
* Interestingly, diene 195 was synthesised by two separate groups, the Hedaya and Paquette groups, 
independently of each other and each group submitted papers regarding the synthesis of the diene which 
were received by the Journal of the American Chemical Society in the space of a few days.  For this reason, 
diene 195 is also referred to as Paquette’s diene. 
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Synthesis of diene 195 is a challenging process, requiring extremely low temperatures and anhydrous 
conditions.  Sodium hydride mediated deprotonation of cyclopentadiene followed by addition of 
iodine to the reaction mixture promotes dimerization between the cyclopentadienyl anions, installing 
the important carbon-carbon bond that will eventually form the bridge between norbornene units 
(Scheme 2-9).  Addition of DMAD results in two [4π + 2π] Diels-Alder cycloadditions that result in the 
formation of the desired diene 195. 
 
Scheme 2-9: Synthesis of Hedaya's diene 195 
Unfortunately, the synthesis is prone to several side reactions and yields of the desired diene are most 
often under 10-15%, although yields as high as 23% have been reported.353  The most common side 
products are where the esters are installed on the end of the diene as opposed to the internal esters 
present in Hedaya’s diene (Figure 2-33).  In order to separate Hedaya’s diene 195 from the unwanted 
external ester-containing dienes, selective hydrolysis of the external esters through treatment with 
NaOH can be employed.  The internal esters of diene 195 are sterically protected from hydrolysis at 
low temperatures (0 °C) unlike the external esters.  The hydrolysed by-products can then be separated 
using an aqueous workup. 
 
Figure 2-33: Other reaction products formed during the synthesis of Hedaya's diene 195 
While diene 195 is difficult to synthesise in high yields, the reaction components are inexpensive and 
readily available and the reaction is amenable to being performed on large scales, and in this project, 
diene 195 was obtained in gram quantities despite only being isolated in 4% yield. 
Once isolated, diene 195 was reacted with two equivalents of monoepoxide 189 in a twin ACE 
cycloaddition to afford the boc-protected [6]polynorbornane framework 194.  Using identical 
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conditions to the synthesis of boc-protected [5]polynorbornane framework 192, microwave 
irradiation was employed and the desired [6]polynorbornane 194 was isolated in 70% yield. 
 
Scheme 2-10: Synthesis of boc-protected [6]polynorbornane 194 
2.4.1.3 Functionalisation of frameworks 
Once the [3], [5] and [6] boc-protected polynorbornane frameworks had been synthesised and 
isolated, attention was then turned towards functionalising the frameworks in order to develop the 
desired bis-Zn(II):DPA frameworks.  All three scaffolds were functionalised following the same 
procedure (Scheme 2-11).  First, the boc protecting groups were cleaved by treatment with 
trifluoroacetic acid (TFA).  Once the reaction was complete, the solvent was removed and the crude 
products subject to reductive amination using 2-pyridine carboxaldehyde and sodium 
triacetoxyborohydride.   
 
Scheme 2-11: General procedure for the deprotection and functionalisation of the boc-protected fused 
[n]polynorbornane frameworks 
Initially, extreme difficulty was encountered in purifying the reaction mixture as a by-product, 2-
pyridine methanol, was difficult to separate using column chromatography, possessing a similar Rf 
value to the desired product as well as similar solubility in a range of organic solvents.  Eventually, a 
two-step procedure was developed whereby the crude reaction mix was subjected to acid-base 
extraction before Kugelrohr distillation was employed to remove the 2-pyridine methanol by-product 
without the need for column chromatography, affording the pure bis-dipicolylamino functionalised 
fused [n]polynorbornane frameworks in high yields (72 – 83%).   
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All 3 hosts displayed similar NMR properties and so only the [6]polynorbornane host 185 will be 
discussed.  Successful installation of the bis-DPA binding units can be observed through the 
appearance of 4 aromatic resonances appearing between 7 – 9 ppm, corresponding to the aromatic 
protons of the pyridyl rings, as well as a peak at 3.75 ppm corresponding to the methylene spacers of 
the DPA units (Figure 2-34).  All three compounds were fully characterised through 2D NMR 
techniques and mass spectroscopy to confirm successful installation of the bis-DPA units. 
 
Figure 2-34: 1H NMR spectra of bis-DPA functionalised framework 185 (DMSO-d6) 
A crystal of bis-DPA functionalised [6]polynorbornane 187 suitable for X-ray analysis was obtained by 
slow evaporation of an EtOAc solution of 187 (Figure 2-35).  The crystal structure clearly shows the 
linearity of the backbone enforced by the incorporation of Hedaya’s diene.  The flexibility of the linkers 
between the framework and the DPA units is also apparent as the DPA units are folded under the 
framework moving into close proximity of the internal esters. 
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Figure 2-35: Crystal structure of 187 and unit cell showing the packing of the crystal lattice 
Finally, the bis-DPA frameworks were treated with two equivalents of Zn(NO3)2 to afford the complete 
bis Zn(II):DPA functionalised hosts for testing.  Clear evidence of the binding of Zn(II) by all 3 hosts was 
clearly observed in the NMR titration spectra (shown below for the [5]host 186:Zn(II)2, Figure 2-36).  
Clear changes can be seen in the aromatic region (7 – 9 ppm) as all the C-H resonances assigned to the 
pyridine rings undergo a downfield chemical shift through a slow exchange process.*  A downfield shift 
was also observed for the resonances assigned to the protons of the methylene linkers, which also 
undergo splitting, from a singlet peak to a doublet of doublets.  This splitting is a result of differing 
chemical environments caused by the metal complexation, as one of the protons is oriented towards 
the zinc ion, and the other will therefore be oriented away.  
 
                                                          
* Somewhat counter-intuitively, in NMR terms a downfield shift is represented by an increase in the chemical 
shift of a signal (i.e. from 2 ppm to 3 ppm) and an upfield shift is represented by a decrease in the chemical shift.  
This is a relic from the early days of NMR technology, where the continuous wave method was employed that 
scanned the magnetic field from left to right (from low to high values).  When the scanning frequency capability 
was developed, the direction was then reversed (from right to left or high to low frequency) but the original 
terminology was retained.354 
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Figure 2-36: 1H NMR stackplot of the titration of host 186 with Zn(II)(DMSO-d6).  The slow exchange of the residues 
assigned to the pyridyl protons is highlighted in blue and the residues assigned to the methylene protons is highlighted 
in red 
A poor quality crystal structure was obtained for the smallest host, 185:Zn(II)2, which revealed that, 
contrary to expectations, the Zn(II):DPA binding units faced outwards, away from the binding cleft 
(Figure 2-37).  This unexpected conformation is most likely a result of steric effects and charge 
repulsions, indeed, for 185:Zn(II)2, the smallest framework, if both binding units were pointed towards 
each other, the zinc ions would be in extremely close proximity.  Despite repeated efforts, the other 
complexes were resistant to crystallization, preferring instead to precipitate from solution, and only 
the smallest framework was able to be crystallized, albeit as a twinned sample.   
As a result of the conformation adopted by 185:Zn(II)2, it is possible that this particular host will bind 
intermolecularly, forming a larger aggregate, as opposed to the desired 1:1 host:guest complex. 
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Figure 2-37: A representation of the charge-charge repulsion of the zinc atoms causing 185:Zn(II)2 to adopt an 
unexpected conforimation as evidenced by a poor quality crystal structure clearly showing the orientation of the zinc 
atoms 
2.4.2  Evaluation of the hosts 
Once the three hosts had been synthesised and isolated, they were assessed for their ability to bind a 
range of anions through 1H NMR titrations.  Next, investigations into the development of an indicator 
displacement assay using UV-Visible spectroscopy and a range of dyes was carried out. 
2.4.2.1  1H NMR evaluation of the hosts 
Titration of the hosts with ppi resulted in clear changes in a number of resonances as observed through 
1H NMR spectroscopy that could be tracked and evaluated.  Analysis of the smallest host, 185:Zn(II)2, 
showed a pronounced shift (From 8.65 ppm to 8.95 ppm) in the resonance assigned to one of the 
aromatic protons located on the pyridine ring (Figure 2-38).  However, evidence of slow exchange for 
this proton was also observed, indicating that the binding of ppi by the host is of a more complex 
nature than the initially envisioned 1:1 complex.  A change in chemical shift was also observed for the 
resonances assigned to the methylene spacers. 
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Figure 2-38: 1H NMR stackplot of the titration of 185:Zn(II)2 with ppi (DMSO-d6:D2O 1:1) 
Interestingly, when ppi was titrated against the larger two hosts, 186:Zn(II)2 and 187:Zn(II)2 (As 
186:Zn(II)2 and 187:Zn(II)2 behaved in a similar fashion, only 186:Zn(II)2 will be discussed),  while 
changes were once again observed in the 1H NMR spectra, a different aromatic resonance was 
observed to shift compared to the smallest host, 185:Zn(II)2 (The stackplot for 186:Zn(II)2 is shown in 
Figure 2-39).  Furthermore, this shifting observed in the aromatic region was in an upfield direction, 
as opposed to the downfield shift observed in the spectra of 185:Zn(II)2.  Finally, the chemical shift 
change observed for the resonances assigned to the methylene protons was different to that observed 
for the smallest host, as instead of both peaks shifting in the same direction as observed in the spectra 
of 185:Zn(II)2, the two peaks instead moved in opposite directions and coalesced.   
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Figure 2-39: 1H NMR stackplot of the titration of 186:Zn(II)2 with ppi (DMSO-d6:D2O 1:1) 
This difference in chemical shift changes observed in the titration provided further evidence that the 
smaller host potentially adopts a different and likely non-complementary conformation to that 
favoured by the two larger hosts, for which, the Zn(II):DPA binding units are capable of pointing 
towards each other without the steric interactions observed for the smaller host.  A small peak was 
also observed to emerge from underneath the residue located at 8.6 ppm, which underwent a 
chemical shift change similar to that observed for the [3]polynorbornane host 185:Zn(II)2 in Figure 2-
38.  This shift could possibly be the result of a degree of conformational isomerism whereby a small 
percentage of zinc is bound on the outside of the binding host, however more in-depth NMR 
experiments are required to fully understand this behaviour. 
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The differences in binding mode were also supported by the binding isotherms, obtained by plotting 
the chemical shift of the aromatic proton highlighted in blue on the above stackplots.  A sigmoidal 
curve was observed with a mid-point at approx. 0.5 equiv. of ppi added for the smaller host 185:Zn(II)2 
before the curve flattens out approaching 1 equiv of ppi (Figure 2-40 top).  For the larger 186:Zn(II)2 
(Figure 2-40 bottom) a sigmoidal appearance can also before observed, as well as a clear change in 
the direction of the peak shift can be observed approaching 0.8 equiv. of ppi.  From these results, it 
seems likely that both hosts adopt a 2:1 host:guest ratio before switching to a 1:1 host:guest ratio 
after the addition of additional guest.  However, the sigmoidal nature of the curves is likely an 
indication of a degree of aggregation which makes the initial data points unreliable and so far these 
curves have proved difficult to obtain a reliable fit for, and subsequently, no accurate binding 
constants can be determined.   
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Figure 2-40: Binding isotherms of 185:Zn(II)2 (top) and 186:Zn(II)2 (bottom) with ppi, tracking the shift of the highlighted 
aromatic proton 
To gain additional insight into the binding behaviour of the three hosts, a range of other anions were 
used as guests in titration studies, including phosphate, terephthalate and isoterephthalate as well as 
some larger rigid dicarboxylates like azobenzene dicarboxylate, naphthalene dicarboxylate and 
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biphenyl dicarboxylate.  While evidence of binding was observed for all small anions, none were able 
to cause a similar change in chemical shift in the aromatic protons such as that elicited by ppi, although 
it was noted that sodium hydrogen phosphate was bound more strongly by the smallest host, 
185:Zn(II) than by either of the two larger hosts.*  The addition of the larger anions resulted in the 1H 
signals of the host disappearing during the titrations.  As such, no reliable observations could be made 
and the large rigid dicarboxylates were not investigated further. 
The 1H NMR titrations clearly demonstrated the ability of the three hosts to form complexes with ppi 
and other anions.  The smallest host 185:Zn(II) appears to adopt a different conformation to the two 
larger hosts due to steric constraints which force the zinc ions to point in opposite directions (as 
evidenced in a crystal structure), however this did not prevent the host from interacting with ppi.   The 
three hosts bind in different host:guest stoichiometry, depending upon the amount of guest present, 
making accurate determination of binding constants difficult. 
An interesting observation was made in the titration of [5]polynorbornane host 186:Zn(II)2 with 
terephthalate.  It was observed that, despite the aromatic protons only undergoing a small change in 
chemical shift, the endo C-H protons located in the middle of the polynorbornane backbone 
underwent a much larger upfield shift (Figure 2-41).  This change suggested that the bound 
terephthalate anion was held underneath the framework. 
                                                          
* For all host guest 1H NMR titrations please refer to Appendix B. 
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Figure 2-41: 1H NMR stackplot of the titration of [5]polynorbornane host 186:Zn(II) with terephthalate and proposed 
binding mechanism of the host:guest complex (DMSO-d6:D2O 1:1) 
This model of binding is further supported by work from the group of Butler and Warrener in which 
they synthesised a ‘benzene in a bun’, a benzene ring covalently bound in between two 
[3]polynorbornane ‘buns’.355  For one compound in this paper a “benzene” ring was covalently bound 
to a [3]polynorbornane framework and as such was permanently held underneath the framework in 
close proximity to the endo protons that point “downwards” towards the aromatic ring (Figure 2-42).  
In the 1H spectrum of 204, these protons were seen at a similar chemical shift to that observed for the 
endo C-H protons located underneath the framework of host 186:Zn(II) when bound to terephthalate.   
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Figure 2-42: Right) the proposed binding mode of 186:Zn(II)2 and terephthalate. Left) A benzene ring covalently held 
under a [3]polynorbornane framework reported by Butler and Warrener et al.355 
With evidence of the ppi binding ability of the three hosts in hand, attention was then turned to 
developing an indicator displacement assay using the three hosts through the incorporation of an 
appropriate indicator. 
2.4.2.2 UV-Vis and fluorescent evaluation of the host:indicator complexes 
To use these hosts for an indicator displacement assay, a range of dyes were investigated for binding.  
Pyrogallol red, pyrocatechol violet and chromeazurol S were chosen for investigation as colorimetric 
dyes and eosin Y was chosen as a fluorescent dye (Figure 2-43). 
 
Figure 2-43: Dyes selected for investigation as potential indicators in this project 
Initially, a HEPES buffered solution (5 mM, 145 mM NaCl, pH 7.4) was chosen to mimic physiological 
conditions.  Unfortunately, the NaCl present in the buffered solution proved to be incompatible with 
the hosts resulting in the precipitation of the hosts from solution within a matter of minutes.  As having 
a known, exact concentration of host is of vital importance for accurately quantifying ppi when using 
UV-Vis or fluorescent titrations, a modified buffer was used.  Preparation of a HEPES buffered solution 
67 
without NaCl proved to be much more suitable, allowing for testing to be performed on the hosts with 
no solubility issues. 
As the hosts are based on the fused [n]polynorbornane scaffold, a large hydrophobic scaffold, the fact 
that all three hosts are water soluble without the need for a co-solvent is a promising result in the 
development of an indicator displacement assay that can function in physiological conditions. 
Colorimetric indicator assessment 
Pleasingly, all three colorimetric dyes were bound by each of the three hosts, and a clear change in 
the relevant UV-Vis or fluorescent spectra was observed.*†  
Addition of the hosts to a solution of pyrogallol red resulted in a quenching of the absorbance band at 
545 nm and the emergence of a new band at 575 nm (The results for 187:Zn(II)2 are shown in Figure 
2-44).  The overlapping nature of the peaks resulted in an apparent shift in λmax making anaylsis of the 
results difficult, however it would appear that more complex binding stoichiometries than a simple 
1:1 arrangement were present as the absorption band at 575 nm continues to increase after the 
addition of more than 1 equiv. of host. 
                                                          
* Due to the titrations for all three hosts having a very similar appearance, only the results for the largest 
framework, 187:Zn(II)2 will be displayed.  All other results will be displayed in Appendix C. 
† All UV-Vis and fluorescent titrations were performed in a buffered aqueous solution (5mM HEPES, pH 7.4) 
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Figure 2-44: UV-vis spectra of the titration of pyrogallol red with 187:Zn(II)2.  The arrows show the direction of the 
change in λmax. 
Similar results were obtained for the remaining three indicators with a definite, measurable change 
occuring when the hosts were added.  For pyrocatechol violet, a clear colour change from green to 
blue was observed (Figure 2-45), but the sensitivity of the indicator to pH (the indicator undergoes a 
change from yellow to green to violet from pH 7 to pH 7.5) means the indicator requires extreme care 
when being employed in this system in order to obtain repeatable results.356  Evidence of this can be 
observed in the absorbance spectra by the prescence of two peaks in the absorbance scan of the blank 
indicator solution, which shows that under the testing conditions, the indicator is in equilibrium 
between two forms, yellow (pKa < 1) and violet (pKa = 7.82), resulting in the indicator solution 
appearing as a green colour that changes to blue upon addition of the hosts.  Similarly to pyrogallol 
red, the overlapping peaks results in an apparent shift in the maximum peak wavelength, making 
results difficult to interpret.   
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Figure 2-45: UV-vis spectra of the titration of pyrocatechol violet with 187:Zn(II)2. The arrows show the direction of the 
change in λmax for each peak. 
The pyrocatechol violet indicator was also tested at pH 7 in an attempt to circumvent the pH problem 
and while the indicator appears as yellow solution at pH 7, the host compounds were protonated and 
converted to the HCl salts (as observed by the addition of HCl to a solution of 187:Zn(II)2 in D2O, Figure 
2-46).  The resultant HCl salts appeared unable to interact with the indicators and no colour change 
was observed when the hosts were added to pyrocatechol violet at pH 7. 
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Figure 2-46: NMR of 187:HCl2, obtained by the addition of HCl to a solution of 187:Zn(II)2 (D2O) 
Similarly, the results obtained for chromeazurol S also initially appeared promising, being the only 
indicator for which the absorbance maxima remained constant, however the host:indicator complex 
was prone to precipitation from solution.  In the initial results for the titration of chromeazurol S with 
187:Zn(II)2, an isosbestic point was observed at 480 nm, however continued addition of the host (past 
1.0 equiv.) resulted in the signal intensity weakening, most likely as a result of the observed 
precipitation.  Furthermore, the precipitation of the host:indicator complex occurred rapidly (< 1 hr) 
at all concentrations and made preparation of host:inidcator solutions of an accurate concentration 
for use in UV-Vis titrations impossible and so the indicator was not investigated further. 
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Figure 2-47: UV-vis spectra of the titration of chromeazurol S with 187:Zn(II)2.  The arrows show the direction of the 
change in λmax for each peak. 
Fluorescent indicator assessment 
For eosin Y, a clear change was observed in the fluorescence spectra when aliquots of host 187:Zn(II)2 
were added (Figure 2-48).  The initial emission band at 545 nm was quenched upon addition of the 
hosts and a new band appears at 516 nm.  This peak was much more pronounced for the largest host 
187:Zn(II)2 than for the two smaller hosts indicating that steric effects may be much more pronounced 
for the fluorescent indicator than for the three colorimetric dyes.   
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Figure 2-48: Fluorescent spectra of the titration of eosin Y with 187:Zn(II)2.  The arrows show the direction of the change 
in λmax for each peak. 
After all indicators had been assessed and found to undergo a measurable change upon interaction 
with the hosts, the host:indicator complexes were assessed for their ability to interact with 
pyrophosphate.  
As expected, addition of ppi to a 1:1 host:pyrogallol red solution resulted in reversal of the spectral 
changes (shown for the largest host 187:Zn(II)2 in Figure 2-49).  Again, the overlapping peaks and shift 
in λmax, made accurate determination of the binding constants difficult.  It was noted however, that 
even after the addition of 1 equiv. of ppi, a large proportion of the indicator remained bound and the 
spectra matching the free indicator solution was not achieved until the addition of 4 equiv. of ppi. 
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Figure 2-49: UV-Vis spectra of the titration of 187:Zn(II)2:pyrogallol red with ppi 
Similarly, the changes observed for 187:Zn(II)2:pyrocatechol host:indicator complex also reversed 
(shown for the largest host 187:Zn(II)2 in Figure 2-50).  Once again, more than 1 equiv. of ppi was 
required to completely displace the indicator, with complete displacement not being observed until 
after the addition of 3 equiv. of ppi. 
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Figure 2-50: UV-Vis spectra of the titration of 187:Zn(II)2:pyrocatechol violet with ppi 
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The 187:Zn(II)2:eosin Y host:indicator complex was also found to be behave as an indicator 
displacement assay, with the spectra corresponding to the bound indicator disappearing upon 
addition of ppi and the original intensities being restored (shown for the largest host 187:Zn(II)2 in 
Figure 2-51).  However, unlike the pyrogallol red indicator, little change in the spectra was noted until 
the addition of 0.5 equiv. of ppi, and then the original intensity of the free indicator was achieved after 
the addition of only 1.0 equiv. of guest.  The titration was repeated, with a 10 minute wait time 
between additions to allow the mixture to equilibrate and identical results were obtained.   Further 
complicating analysis, it was found that the initial host:indicator solution emitted a subdued 
fluorescence response, which was increased upon the first addition of ppi, before decreasing after 
subsequent additions. 
 
Figure 2-51: Fluorescent titration of 187:Zn(II)2:eosin Y with ppi 
2.4.2.3 Evaluation of binding 
Analysis of the binding modes of the three hosts with ppi was performed by plotting either the change 
in chemical shift of proton signals (NMR titration analysis) or the change in intensity of select 
wavelengths (UV-Vis and fluorescence titration analysis).  As briefly discussed in Section 2.4.2.1, 
analysis of the isotherms obtained from the NMR titrations indicated that the formation of a 2:1 host 
guest complex was occurring before the system switched to a 1:1 host:guest arrangement.  Such a 
change is not unusual, and indeed has been reported for fused [n]polynorbornane systems before.205  
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Unfortunately, all attempts to determine reliable binding constants has proven fruitless, as values 
obtained either possess extremely large associated errors or negative values, rendering any obtained 
estimates unreliable, and are, at best, an estimate. 
Attempts to fit the isotherms to 1:1 binding models proved ineffective, with poor fits and large error 
values, and so that approach was abandoned.  Attempts to fit the isotherms to a 2:1 host:guest binding 
model were more successful, although the aforementioned sigmoidal nature of the curves affected 
the ‘closeness’ of the fit  (Figure 2-52 top).  The binding isotherms were slightly modified to remove 
the sigmoidal nature of the curve in an attempt to provide a better fit and provide a reliable estimate 
of the binding constants, and while visually the curve appeared to be strong fit, the binding constants 
obtained were negative (Figure 2-52 bottom).  All fitting attempts gave negative binding constants 
despite the apparent good nature of the fits to a 2:1 host:guest binding model.*† 
                                                          
* All isotherms were fitted using BindFit software.357 
† Please see Appendix C for all attempted fits of the obtained isotherms. 
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Figure 2-52:  Attempted determination of binding constants from the titration of host 186:Zn(II)2 with ppi.  Top: The 
attempted global fit of the raw data for all 4 aromatic protons, Bottom: The attempted fit of a curve manually adjusted 
to remove the initial sigmoidal shape.  Titration plots were created by plotting the change in shift of the signals of the 
aromatic proton and fitting the resultant isotherm in Bindfit. 
While the analysis of the isotherms obtained from the UV-Vis titrations is not directly comparable to 
the NMR titrations (NMR titrations observe the host:guest binding whereas UV-Vis titrations observe 
the displacement of an indicator.  Direct observation of the binding of ppi by the host through UV-Vis 
titrations is unfortunately impossible as neither the hosts nor the guests possess a chromophore), 
analysis of the interactions between ppi and the host:indicator complexes can still be performed.  
Interestingly, analysis of the isotherms obtained from the UV-Vis titrations were also complex.  
Unfortunately again, reliable binding constants were unable to be obtained from the isotherms, in a 
similar manner to the NMR titration data (negative values were again obtained) meaning a more in-
depth study is needed to fully understand the complicated nature of the system when binding ppi. 
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Table 1: Binding constants for the binding of ppi by the hosts (NMR – orange) and host:indicator complexes (UV-Vis – 
blue) 
Host:Guest system Obtained K11 value 
(M-1) 
Error 
(%) 
Obtained K21 value 
(M-1) 
Error 
(%) 
185:Zn(II)2 with ppi (NMR) 2100 16.66 -200 ±0.70 
186:Zn(II)2 with ppi (NMR) 3900 4.10 -170 ±.33 
187:Zn(II)2 with ppi (NMR) 19100 30.54 -200 ±0.24 
185:Zn(II)2:Pyrogallol red 
with ppi (UV-Vis) 
112000 10.42 -24100 ±-1.50 
185:Zn(II)2:Pyrocatechol 
violet with ppi (UV-Vis) 
88900 14.08 -25000 ±-0.39 
186:Zn(II)2:Pyrogallol red 
with ppi (UV-Vis) 
292800 ±17.14 643700 ±17.33 
186:Zn(II)2:Pyrocatechol 
violet with ppi (UV-Vis) 
41100 ±1.00 -25100 ±-1.00 
187:Zn(II)2:Pyrogallol red 
with ppi (UV-Vis) 
103700 ±7.95 -18400 ±-4.22 
187:Zn(II)2:Pyrocatechol 
violet with ppi (UV-Vis) 
68500 ±0.21 -25200 ±-0.21 
Analysis of the fluorescence titrations with ppi failed to afford any reliable estimates as the program 
was unable to fit the unusual shape of the isotherms (Shown for 187:Zn(II)2:Eosin Y with ppi, Figure 2-
53). 
 
Figure 2-53: Analysis of the isotherm obtained from the titration of 187:Zn(II)2:Eosin Y with ppi. 
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It was also noted throughout the titrations (both NMR and UV-Vis/Fluorescence) that the host:guest 
and host:indicator complexes were prone to precipitation.  In particular, the attempts at performing 
the NMR titrations at constant concentrations were hampered by the tendency of the host:ppi 
solutions to precipitate.  This precipitation makes it impossible to determine to determine accurate 
concentrations and so renders the titrations unreliable.  Indeed, the precipitation may have been at 
least partially responsible for the difficulty encountered when determining binding constants. 
 
2.4.3  Development of an indicator displacement assay 
In order to determine the selectivity of the indicator displacement systems for ppi, a range of 
additional anions were investigated to determine whether any other anionic species were also capable 
of displacing the bound dyes.  These anions fell into two main classes, the first class consisting of small 
anionic species, namely the sodium salts of terephthalate, acetate, citrate, carbonate and sulfate.  The 
second class was made up of other larger phosphorylated anions, being the sodium salts of phosphate, 
adenosine monophosphate (AMP), adenosine diphosphate (ADP) and adenosine triphosphate (ATP) 
(Figure 2-52). 
 
Figure 2-54: Anions investigated in this study.  Sodium counterions have been omitted for clarity. 
Of the small anionic species, only citrate was capable of displacing the bound dyes, albeit to a smaller 
extent than pyrophosphate (Results for 187:Zn(II)2:pyrogallol red are shown in Figure 2-53).  However, 
as citrate is present in biological fluids at a much higher concentration than ppi (in blood samples, 
citrate is present at around 120 μM,358-360 and ppi at around 1.8 – 3.5 μM.361-363  A similar excess is 
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observed in urine samples with citrate levels typically being around 200 – 300 μM and ppi from 20 – 
40 μM.364-367), application of these IDAs to biological samples may suffer from interference.  It is 
notable, however, that even the addition of 10 equiv. of citrate failed to completely displace the 
indicator from the host. 
No other small anion was capable of producing a response from the host:indicator systems, including 
phosphate, demonstrating the selectivity of the system towards polyphosphorylated molecules. 
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Figure 2-55: Titration result of host 187:Zn(II)2:pyrogallol red with small anions.  Top: After the addition of 1 equiv. of 
guest. Bottom: After the addition of 10 equivalents of guest. 
A comparison of the absorption band at 572 nm shows the selectivity of the IDA over pyrophosphate 
with 1 equiv. of ppi reducing the absorbance to 73% of its original level, an amount unmatched by any 
other anion (Figure 2-54).  Citrate, the only other small anion capable of producing a significant 
response from the IDA, was only able to reduce the absorption to 81% of its original level after the 
addition of 10 equiv. of the anion. 
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Figure 2-56: A comparison of the residual absorbance at 572 nm after the addition of small anions to 
187:Zn(II)2:pyrogallol red 
Next, the host:indicator complexes were tested against a range of phospho- and polyphosphorylated 
nucleotides (Results for 187:Zn(II)2:pyrogallol red are shown in Figure 2-55).  Neither phosphate nor 
AMP were able to elicit a change in the absorbance spectra of the host:indicator solutions.  Addition 
of ADP and ATP was able to provoke a response, however, similar to citrate, the response was much 
weaker than that seen for pyrophosphate.  It was also observed that the larger ATP generated a 
stronger response than the smaller ADP.   
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Figure 2-57: Titration result of 187:Zn(II)2:pyrogallol red with phosphoanions.  Top: After the addition of 1 equiv. of 
guest. Bottom: After the addition of 10 equivalents of guest. 
Once again, a comparison of the changes in the absorbance band at 572 nm shows the selectivity of 
the IDA for ppi, with no phosphoanions other than ppi producing a response after the addition of 1 
equiv. of guest (Figure 2-56).  Even after the addition of 10 equiv. of guest, ADP and ATP still fail to 
produce a response as strong as that observed for 1 equiv. of ppi. 
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Figure 2-58: A comparison of the residual absorbance at 572 nm after the addition of phosphoanions to 
187:Zn(II)2:pyrogallol red 
Both the 185:Zn(II)2 and 186:Zn(II)2 hosts strongly bind pyrophosphate, weakly bind citrate, ADP and 
ATP, and show no response for the other investigated anions (Please refer to Appendix C for all UV:Vis 
titration results).  
The results for fluorescent indicator, eosin Y, was found to behave in a similar manner to pyrogallol 
red and pyrogallol violet, with only pyrophosphate and citrate eliciting a response, and again, the ppi 
response was much greater than the response provoked by citrate (Figure 2-57). 
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Figure 2-59: Titration result of host 187:Zn(II)2:eosin Y with small anions.  Top: After the addition of 1 equiv. of guest. 
Bottom: After the addition of 10 equivalents of guest. 
A comparison of the restoration of the fluorescence band at 545 nm shows that the IDA is very 
sensitive to ppi, with complete restoration of the fluorescence emission associated with the free 
indicator being observed after the addition of 1 equiv. of ppi (Figure 2-58).  All other anions showed 
little response after the addition of 1 equiv. of guest, with only citrate producing any statistically 
significant response.  However, it was observed that the additon of 10 equiv. of citrate was capable of 
fully displacing the indicator. 
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Figure 2-60: Comparison of the restoration of the fluorescence emission band at 550 nm after the addition of 
phosphoanions to 187:Zn(II)2:eosin Y 
As with the pyrogallol red system, the smaller phosphorylated anions, phosphate and AMP, did not 
elicit a response in the fluorescence spectra of the host:eosin Y complexes, and while ADP and ATP 
could provoke a response, it was much weaker than that seen for ppi (Figure 2-59). 
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Figure 2-61: Titration result of host 187:Zn(II)2:eosin Y with phosphoanions.  Top: After the addition of 1 equiv. of guest. 
Bottom: After the addition of 10 equivalents of guest. 
Analysis of the restoration of the fluorescence emission of the free indicator shows that the 
fluorescent IDA is more responsive to phosphoanions than the colorimetric IDA incorporating 
pyrogallol red.  Substantial responses were seen for after the addition of 1 equiv. of both ADP and ATP 
(Figure 2-60), unlike the colorimetric IDA, which showed little to no response.   
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Figure 2-62: Comparison of the restoration of the fluorescence emission band at 550 nm after the addition of 
phosphoanions to 187:Zn(II)2:eosin Y 
2.5 Summary 
A family of novel bis-Zn(II):DPA functionalised fused [n]polynorbornane based hosts were successfully 
synthesised and investigated.  All three hosts were found to bind pyrophosphate strongly, albeit in a 
complicated host:guest arrangement yet to be fully understood.  It was also discovered that the 
smallest host, the [3]polynorbornane 185:Zn(II)2, adopted an unexpected conformation, as confirmed 
by a crystal stucture, where the two binding units pointed away from each other, instead of pointing 
towards each other as originally envisaged.   
Indicator displacements assays were developed using the hosts and a range of dyes and the IDAs were 
found to be reasonably selective towards ppi, however weak repsonses were also obtained for citrate, 
ADP and ATP, somewhat mitigating the effectiveness of the assay. 
 
2.6  Future Work 
More exact determination of the binding modes needs to be determined, especially the difference 
between the binding modes adopted by the smaller 185:Zn(II)2 host when compared to the larger two 
hosts.  This may be accomplished through 1H NMR diffusion experiments which may detect the 
different sized complexes being formed.  Additionally, mass spectroscopy has been used to detect 
host:guest complexes and could be of great use in the determination of higher order binding ratios.368  
Additionally, the titrations can be redone using a constant concentration method to remove dilution 
effects.  However, the precipitation of the host:ppi complexes at high ppi concentrations (especially 
the concentrations used in NMR titrations) may make constant concentration titrations ineffective.  
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A way to counteract the interaction of citrate with the hosts would allow for the development of a 
highly selective IDA.  A more comprehensive trial of additional dyes to find one that binds more 
strongly than citrate but weaker than pyrophosphate.  Based upon the results obtained when testing 
other phosphorylated compounds, it seems probable that a phosphorylated dye (such as the large 
phosphorhodamine derivatives reported by Kolmakov and co-workers)369 may prove to be a suitable 
candidate.  Further investigations into the buffered solution are also warranted, as it may be possible 
to develop conditions that promote the binding of pyrophosphate at the expense of citrate.  However, 
as previously mentioned, care needs to be taken when adjusting pH owing to the sensitivity of anions 
and indicators to even small changes of pH.  The hosts themselves have also proven to be susceptible 
to changing pH, with acidic conditions resulting in the protonation of the DPA groups and subsequent 
decomplexation of the zinc ions.   
The internal esters of the [6]polynorbornane host 187:Zn(II)2 represent interesting possibilities for 
further functionalisation.  The ester groups of the Hedaya’s diene can be hydrolysed and the resulting 
acids cyclised to generate an anhydride functionality (Figure 2-61).  The anhydride can be 
functionalised in a variety of ways (both before and after framework synthesis), whether to 
incorporate and additional binding unit, generate steric bulk or the incorporation of a covalently 
bound dye to generate an intermolecular indicator displacement assay. 
 
Figure 2-63: Hydrolysis and cyclization of Hedaya's diene 195 
The indicator displacement assays can be combined with other IDAs to develop an array that can 
produce a reaction pattern specific to a certain anion.370-372  By combining the IDAs in this project with 
an IDA selective for citrate, the effect of citrate upon the response given can be determined and the 
response elicit by pyrophosphate, the anion of interest, can be determined. 
Finally, as these hosts have been proven to work in buffered aqueous conditions, they provide proof 
that water soluble functionalised polynorbornane frameworks can be generated.  Therefore, the 
development of additional water soluble polynorbornane-based compounds can be investigated for 
additional applications such as catalysis.  Di-zinc compounds have been investigated for catalytic 
activity, particularly in the cleavage of phosphodiester bonds and asymmetric reactions and so these 
new water-soluble hosts may prove to be viable candidates for future investigations.373-380  
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3. Amino Acid-Functionalised Fused [5]-Polynorbornanes as 
Ligands for Metals 
This chapter will begin with a discussion of the development and applications of coordination 
polymers and metal-organic frameworks.  The use of amino acids in the development of chiral metal-
organic frameworks will then be considered.  A brief overview of coordination cages will be provided, 
leading into the focus of this chapter, the synthesis and evaluation of a range of fused 
[n]polynorbornane frameworks functionalised with a range of chiral and non-chiral amino acid 
moieties which will be investigated for their ability to form metallosupramolecular architectures with 
a range of transition metals. 
3.1 Metal-organic frameworks 
Metal-organic frameworks (MOFs) are compounds formed by the self-assembly of metal ions (or 
clusters of ions) with organic linkers to form large 3-dimensional continuous structures containing, or 
with the potential to contain voids (see detailed discussion below for clarification).151,152,381,382  As a 
consequence of these voids, MOFs are of great interest for the development of gas storage 
materials.150,383-386  MOFs have also been investigated for use in separation, catalysis, chemical sensing, 
drug delivery and even as semiconductors.145,151,152,385-397 
 
3.1.1  Metal-organic frameworks vs. coordination polymers 
There is a large degree of confusion in the literature surrounding the classification of the assemblies 
as metal-organic frameworks (MOFs) or coordination polymers, with both terms being used 
somewhat interchangeably.382,398  The term ‘coordination polymer’ has the longest historical usage, 
first appearing in 1916 with the work of Shibata, although coordination polymers themselves can be 
traced back to early 1700’s with the development of the first synthetic pigment Prussian Blue, or 
Iron(II,III) hexacyanoferrate(II,III).399,400  The term ‘metal-organic framework’ was not recorded until 
1995 by Yaghi and Li.401 
The use of both terms increased markedly in the 1990s and early 2000s as first Robson and co-workers, 
followed by the Fujita, Kitagawa and Yaghi groups demonstrated that MOFs could be designed and 
synthesised to generate a wide array of structures and geometries.386,402-404   However, an unfortunate 
consequence of the rapid expansion of the field and subsequent application to a range of previously 
existing disciplines was the independent development of terminology that in many cases is 
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superfluous, as well as inconsistent nomenclature and a multitude of overlapping 
abbreviations.101,398,405,406   
In an attempt to clarify the situation in 2013, the International Union of Pure and Applied Chemistry 
(IUPAC), released a series of recommendations.405  A coordination polymer was defined as “a 
coordination compound with repeating coordination entities extending in 1, 2, or 3 dimensions”.  A 
crosslinked coordination compound was deemed to be a coordination network.  Finally, a MOF was 
defined to be a coordination network containing potential voids.  The phrase ‘potential’ was included 
to account for dynamic systems that may undergo changes in structure in response to physical or 
chemical stimuli and as a result, may not contain permanent voids.   
Therefore, MOFs are a subset of coordination polymer, and while both terms are interchangeable, to 
avoid obfuscation in this chapter, coordination networks containing voids will exclusively be referred 
to as MOFS and coordination polymers (or networks) reserved for those assemblies that do not 
contain voids. 
 
3.1.2  History of MOFs 
As mentioned in the previous section, the origin of metal-organic frameworks as a field of research 
gained considerable momentum with the work of Robson and Hoskins in 1990 who were among the 
first to recognise that “infinite, ordered frameworks” could be designed by careful selection of either 
a tetrahedral or octahedral centre with rodlike connecting units.391  In order to provide a proof of 
concept for this theory, a novel tetrahedral compound (4,4’,4”,4”’-tetracyanotetraphenylmethane) 
was synthesised which was found to form a diamond-shaped MOF when complexed with Cu(I) (Figure 
3-1).402 
 
Figure 3-1: Left) novel compound 207 synthesised by Robson and Hoskins used to form MOFs when complexed with Cu(II) 
In 1993, Fujita, Ogura and co-workers developed a MOF using the 4,4’-bipyridine ligand 208 and 
cadmium, resulting in a series of two dimensional networks that further assembled into layers 
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(Scheme 3-1).407  Fujita and Ogura then investigated the ability of the formed MOF to form clathrates.  
It was observed that the MOF was capable of specifically clathrating o-dibromobenzene and o-
dichlorobenzene, allowing the MOF to separate out the ortho- isomers from the meta- and para-
isomers.  The group also investigated the ability of the MOF to act as a catalyst, and found that the 
cyanosilyation of aldehydes could be accelerated in the presence of the MOF, but not in the presence 
of the MOF constituents separately.  Similarly to the results obtained from the clathration 
investigations, it was observed that shape specificity was important, with 2-tolualdehyde (40% 
conversion) reacting more efficiently than 3-tolualdehyde (19%).  This work was one of the earliest 
occasions that MOFs were investigated for their ability to clathrate molecules into the cavities as well 
as act as a catalyst for reactions (Previous work surrounding clathrates and inclusion complexes was 
primarily focused upon inorganic zeolites408,409). 
 
Scheme 3-1: Synthesis of a MOF reported by Fujita, Ogura et al. 
Since then, the development of metal-organic frameworks has rapidly expanded and a wide of range 
of linkers have been developed and investigated including nitrile, azolate, phosphonate and cyanide-
based linkers.150,410,411  However, the most popular class of metal-organic frameworks are those that 
incorporate carboxylate linkers.150,412,413 
 
3.1.3  Carboxylate-containing MOFs 
The ability of carboxylates to form complexes with metals has been known for many decades, with 
Koyama and Saito reporting the crystal structure of zinc oxyacetate in 1954 (Figure 3-2) following on 
from the work of Bragg and Morgan who reported the crystal structure of beryllium oxyacetate in 
1923.414,415  The structure of both compounds demonstrated a tetrahedral arrangement of 4 metal 
ions around a central oxygen atom, with 6 acetate ligands coordinating to the metal ions.  As a result 
of this metal-carboxylate complexation, ligands containing carboxylate groups have proven to be a 
popular choice in the formation of metal-organic cages.412 
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Figure 3-2: Structure of zinc oxyacetate showing the carboxylate ligands linking the zinc atoms 
 Carboxylate containing ligands have also proven popular due to their cheap and readily available 
nature, the fact that they can be easily generated in situ from the parent carboxylic acid and because 
the bidentate binding nature of the carboxylate ligand allows for strong metal-ligand bonding.150,387  
The strong metal-ligand bonds formed by carboxylates allows for the formed MOFs to be able to 
maintain their structure even during solvent evacuation.  Additionally, the sensitivity of carboxylates 
to changes in pH allow for the formation of easily reversible metal-organic frameworks.150,387 
Copper and zinc are the most common metals used for the development of carboxylate-based MOFs, 
although there has been reports of other transition metals being employed, and in recent years, the 
use of lighter metals such as beryllium, aluminium and magnesium have been investigated.150,387,416  
Interestingly, despite the isostructural nature of zinc oxyacetate and beryllium oxyacetate, examples 
of beryllium based MOFs remains relatively rare, seemingly due to the small ionic size of the beryllium 
ion as well as the toxicity of the metal.417-419 
3.2  Metal-organic cages 
Metal-organic cages and their applications were introduced in Section 1.3.2 Metal-organic 
frameworks and cages and as such only a brief discussion on the history and development of these 
cages will be provided in this section to avoid repetition.  
Typically, coordination cages* are denoted using the shorthand MxLy convention whereby x is equal to 
the number of metal ions that are involved in the formation of the cage and y is equal to the number 
of ligands involved.  If guest molecules are encapsulated inside the cage, the symbol ⊂ is used to 
denote the encapsulated species (e.g. G⊂H indicates that G is encapsulated inside H).420 
The first coordination cage was reported by Saalfrank et al. in 1988 when an M4L6 coordination cage 
was obtained as the reaction product of the treatment of malonic ester 209 with methylmagnesium 
                                                          
* Unlike metal-organic frameworks and coordination polymers, no such distinctions exists between 
coordination cages and metal-organic cages and the two terms are used interchangeably. 
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iodide (2 equiv.) followed by the addition of oxalyl chloride (0.5 equiv.) (Figure 3-3 top).421  Upon 
workup with an aqueous ammonium chloride solution, crystals were obtained which, upon analysis 
through X-ray diffraction, revealed the existence of the cage (Figure 3-3 bottom).  It was also noted 
that, despite the large size of the cage, the 13C NMR signal only showed 8 signals, clearly confirming 
the symmetry of the cage. 
 
Figure 3-3: Top) Synthesis of dianionic ligand 211 by Saalfrank.  Bottom) The coordination cage formed by ligand 211 
(ammonium counterions omitted for clarity)421 
Since this seminal work, a wide range of structurally diverse coordination cages have been developed 
and investigated including cubic, trigonal bipyrimidal, adamantoid, tetrahedral and dodecahedral 
among others.422-424  The geometry of cages is highly dependent upon, and thus controllable by the 
metal ions used as well as the choice of ligand.424,425  The size, rigidity and shape of the ligand are all 
important considerations in the development of coordination cages.422,426,427 
Coordination cages have also been reported to possess much larger sizes than the examples previously 
discussed, most notably a M30L60 cage recently reported by the Fujita group (Figure 3-4).428  In order 
to synthesise this cage, careful design considerations were required involving careful modelling 
calculations and ligand selection.  Even so, it was found that the M24L48 was the predominant kinetic 
product and heating of the reaction mixture at 70 °C was required in order to obtain the M30L60 cage.  
After several years of fruitless attempts, a crystal suitable for analysis by X-ray crystallography 
techniques were obtained and the M30L60 cage was unambiguously confirmed.  The cage, made from 
90 individual components, possesses an interval pore volume over 150000 Å, large enough to 
encapsulate proteins. 
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Figure 3-4: Formation of a M30L60 cage by the Fujita group.  Colour image reproduced with permission from ref.428 
 
3.3 Amino acids in MOF and MOC synthesis 
As amino acids possess a carboxylic acid group, they are therefore an easily accessible source of 
carboxylate groups for the formation of metal-organic complexes.429,430  Additionally, the amine group 
allows for easy incorporation of the amino acid into larger scaffolds to transform them into ligands.  
The chiral nature of most amino acids also makes them attractive in the development of chiral 
purification or separation systems.389,431,432  Finally, the different side chains can allow for further 
modification of the resultant MOFs and MOCs (including endo and exohedral cage 
functionalisation).433 
Amino acids are well represented in the literature in the formation of metallosupramolecular 
architectures, however the amine group is frequently used to coordinate with metal ions in order to 
form the metal-organic complexes.434  Additionally, the ability of the amino acid side chains to be 
modified to form chelating groups means that there is a preponderance of literature that does not 
directly relate to the ability of amino acids to form coordination complexes through just carboxylate-
metal interactions.  
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A porous MOF was reported by Ranford et al. using the amino acid derivative N-(2-Hydroxybenzyl)-L-
alanine, which, when treated with zinc(II) ions, formed a honeycomb-type coordination polymer 
(Figure 3-5).435  Interestingly, it was observed that heating the MOF resulting in irreversible 
dehydration and a change from a supramolecular polymer to a covalently bonded polymer. 
 
Figure 3-5: Top) Ligand 213 employed by the Ranford group to form MOFs.  Bottom) The change in binding from non-
covalent to covalent upon heating 
A glutamic acid functionalised xylene was reported by Rossiensky and co-workers and found to form 
MOFs upon complexation with metal ions.436  Upon addition of the metal ions (which was performed 
at 100 °C), a cyclization reaction takes place and 215 is formed (Figure 3-6), which then forms the MOF 
network through carboxylate-metal interactions.  Addition of lanthanum or praseodymium ions 
resulted in the formation of a tubular structure, whereas addition of copper (II) resulted in the 
formation of a 1-dimensional chain. 
 
Figure 3-6: Cyclization of 214 to form ligand 215 used by the Rossiensky group to form MOFs 
The chain complex reported by Rossiensky and co-workers is quite common in the formation of metal-
organic complexes using amino acid carboxylates with several other groups reporting similar 
phenomena.437-439  To this end, rigid linkers are frequently employed to develop high-dimensional 
MOFs from amino acids.440 
Zhang, Su and co-workers reported a bicyclooctene based ligand incorporating amino acid 
functionality that displayed a twisted formation (Figure 3-7).441  The resultant cages were tested for 
catalytic activity and were found to catalyse cyclopropanation reactions with a 99:1 E:Z 
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diastereoselectivity ratio, albeit with a moderate conversion (60%) and poor enantioselectivity (< 
10%).  Interestingly, best results were obtained when the cages were insoluble in the reaction solvent, 
a fact attributed by the authors to the differing microenvironments of the dissolved and non-dissolved 
cages.  
 
Figure 3-7: Helical cages showing a mirror image relationship reported by Zhang, Su and co-workers. Models reproduced 
with permission from ref.430 
The Turner group has reported the synthesis of helical cages by using leucine-functionalised 
biphenylsulfone ligands (Figure 3-8).442  Addition of copper (II) nitrate to a basic 
methanol:dimethylacetamide solution of the ligands afforded crystals suitable for X-ray diffraction 
which revealed the existence of helical cages.  The directionality of the helix was controlled by which 
enantiomer was used in the synthesis of the ligand with L-leucine affording a left-handed helix and D-
leucine affording a right-handed helix.*  These cages were capable of self-sorting behaviour, if a 
mixture of L-leucine functionalised ligands were mixed with D-leucine functionalised ligands, the 
resultant cages consisted only of single enantiomers, with no mixed cages observed. 
                                                          
* The handedness of a helix refers to the direction the helix turns.  A right handed helix climbs in a counter 
clockwise fashion and is also commonly referred to as a P (plus) or Δ helix.  Conversely, a left-handed helix turns 
in the opposite direction and is known as a M (minus) or Λ helix. 
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Figure 3-8: Helical cages bearing a mirror image relationship reported by the Turner group.  Models reproduced with 
permission from ref.442 
 
3.4  Fused [n]polynorbornanes in MOC synthesis 
 
The Clever group reported a [3]polynorbornane ligand functionalized with bis-pyridyl groups that was 
capable of forming M2L4 cages upon the addition of Pd(II) ions (Figure 3-9).443  Further studies 
conducted on the cage revealed that it was capable of encapsulating a range of bis-sulfonate guests, 
with the size of the guest having a strong effect on the strength of guest binding.444,445 
 
Figure 3-9: Polynorbornane based ligand 222 and the subsequent cage reported by Clever et al.  Colour image 
reproduced with permission from ref.445 
A follow up study by the Clever group developed a second generation of ligands that used larger donor 
groups to develop longer ligands in an attempt to form cages with larger dimensions that the first 
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generation.446  While the bent ligand 223 formed the expected M2L4 cage, the longer, more linear 
ligand 224 instead formed an M3L6 trefoil knot (Figure 3-10) 
 
Figure 3-10: Extended ligands 223 and 224 reported by the Clever group and trefoil knot formed by 224.  Colour image 
reproduced with permission from ref.446 
A collaboration between the Clever and Pfeffer groups generated a series of fused [5]- and 
[6]polynorbornane ligands that were capable of forming a range of metal-organic 
complexes.233,234,447,448  The first generation, based on picolyl- and pyridyl-functionalised 
[5]polynorbornane ligands (Figure 3-11) provided mixed results upon the addition of either Pd(II) or 
Pt(II) ions, with the formation of a M1L2 ‘butterfly’ complex being the predominate product and only 
trace amounts of the desired M2L4 cage being observed for the  picolyl-functionalised ligand 102.234  
99 
 
Figure 3-11: Fused [5]polynorbornane based ligands investigated by Clever and Pfeffer et al. 
The lack of the desired M2L4 cage structures was attributed to curvature of the [5]polynorbornane 
backbone, and a second series of ligands were devised based on the more linear [6]polynorbornane 
framework.233  The incorporation of Hedaya’s diene into the framework also allowed for “internal” 
functionalisation and 6 new ligands were synthesised.  Using these ligands, a series of M2L4 and M3L4 
cages were successfully formed (Figure 3-12), however ligands 106 and 107 with the internal picolyl 
groups were not able to form cages, a fact attributed to the steric bulk imposed by the internal group.  
The internal groups were shown to be capable of anion recognition as shown in Figure 3-12¸ where a 
M2L4 cage formed by 109 and Pd(II) ions was capable of encapsulating a hexacyanoplatinate anion. 
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Figure 3-12: Fused [6]polynorbornane based ligands 103-110 investigated by the Clever and Pfeffer groups and a M2L4 
cage formed by 109 and Pd(II) ions encapsulating a hexacyanoplatinate anion,  Colour image reproduced with 
permission from ref.448 
It was believed that the synthesis of a range of fused [5]polynorbornane frameworks functionalised 
with amino acid moieties to provide carboxylate groups could provide an attractive option for the 
development of chiral ligands for the formation of homochiral metal-organic cages and/or 
frameworks. 
3.5  Synthesis of amino acid functionalised fused [5]polynorbornane frameworks 
In order to assess the impact of chirality upon the formation of metal-organic cages with fused 
[5]polynorbornane frameworks, a range of chiral and non-chiral amino acids were selected.  Glycine 
was selected as a non-chiral control and alanine and phenylalanine were selected as the chiral amino 
acids to be incorporated into the frameworks (Figure 3-13).  A pseudo amino acid, para-amino benzoic 
acid (PABA) was also investigated as a rigid alternative to determine the effects of the flexibility of the 
amino acid backbones. 
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Figure 3-13: Amino acids chosen for this study 
Two possible synthetic pathways were initially envisaged for the synthesis of the functionalised 
[5]polynorbornane frameworks with the crucial difference being the timing of the installation of the 
amino acid moieties (Figure 3-14).  Both pathways start with anhydride 70 (further underlining its 
usefulness in the synthesis of the fused [n]polynorbornane frameworks presented in this thesis).  In 
the “early-stage” functionalisation pathway, the amino acid is reacted with the anhydride to generate 
a norbornene imide.  The imide can then be subjected to a twin ACE cycloaddition with known 
bisepoxide 92 to afford the complete [5]polynorbornane framework.  In the “late-stage” 
functionalisation pathway, the ACE cycloaddition reaction takes place first, between anhydride 70 and 
bisepoxide 92 to afford [5]polynorbornane anhydride 225.  The target compounds can then be 
accessed from anhydride 225 through twin imide formation reactions. 
 
Figure 3-14: The two possible pathways to access amino acid functionalised [5]polynorbornanes 
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The early-stage functionalisation pathway was adopted for this study as anhydride 70 is easily 
accessible in large quantities and bisepoxide 92 is best synthesised on a small scale (< 2 g).  
Additionally, the late-stage functionalisation pathway would likely to be successful only for the 
[5]polynorbornane framework.  For the [3]- and [6]polynorbornane framework, the conditions 
required for the Weitz-Scheffer epoxidation are incompatible with the anhydride functional group 
(Scheme 3-2). 
 
Scheme 3-2: Unfeasible pathway to access the [3]- and [6]polynorbornane anhydrides 
Initial attempts to synthesise these amino acid functionalised norbornene imides using microwave 
irradiation in an analogous manner to boc-protected norbornene imide 190 were unsuccessful with 
only norbornene diacid 228 being isolated (Scheme 3-3).  The lack of the desired compound formation 
was attributed to the presence of water opening the anhydride and leading to diacid formation. 
 
Scheme 3-3: Unsuccessful microwave assisted synthesis of amino acid functionalised norbornene imides 
Conventional heating was then trialled and the reaction setup was fitted with a Dean-Stark trap in 
order to remove water from the reaction.  However, this setup also proved unsuccessful.  Next, the 
reaction was repeated with the inclusion of a catalytic amount of triethylamine (NEt3) and the desired 
amino acid functionalised norbornene imides 229-231 were obtained following a simple acid wash as 
the free carboxylic acid (Scheme 3-4).449,450 
 
Scheme 3-4: Synthesis of amino acid functionalised norbornene imides 229-231 
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The NMR spectra of the chiral imides 230 and 231 revealed that incorporation of chiral amino acids 
into the framework resulted in a loss of symmetry, seen most strikingly in the alkene peaks of 231 
(Figure 3-15).  These alkene peaks are located at approx. 6.35 ppm in the starting anhydride and 
undergo an upfield shift upon incorporation of phenylalanine into the norbornene unit, with one peak 
residing at 5.61 ppm and the other peak shifting even further upfield to 5.33 ppm.  This 
desymmetrization is believed to be the result of the aromatic ring of the phenylalanine moiety sitting 
‘off-centre’ and residing underneath one of the protons.  The anisotropic aromatic ring current is then 
responsible for the significant change in chemical shift observed.  
 
Figure 3-15: 1H NMR spectra of phenylalanine functionalised 231 and norbornene anhydride 70 showing the change in 
chemical shift of the resonances assigned to the alkene protons (CDCl3).  The residues highlighted in black are the result 
of ethyl acetate that could not be removed from 231 despite rigorous drying.  No trace of EtOAc was observed in 
subsequent steps. 
During the synthesis of phenylalanine functionalised norbornene imide 231, upon treatment of a 
solution of 231 in EtOAc with a saturated aqueous solution of Na2CO3, an unusual triphasic system was 
obtained.  The characterisation and evaluation of this triphasic system will be discussed further in 
Chapter 4. An Ionic Low Molecular Mass Organogelator based on a Phenylalanine Functionalised 
Norbornene.   
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Synthesis of PABA functionalised norbornene imide 232 was performed following a similar procedure 
to amino acid functionalised norbornene imides 229-231 (Scheme 3-5).   Characterisation of all 4 
amino acid-functionalised norbornenes was consistent with that previously reported in the literature.* 
 
Scheme 3-5: Synthesis of PABA-functionalised norbornene imide 232 
Once the 4 amino acid based compounds had been isolated, the four [5]polynorbornane target 
compounds were then formed using microwave assisted ACE cycloadditions (Scheme 3-6).  However, 
owing to their polar nature some initial difficulty was encountered when attempting to purify the 
reaction mixtures using column chromatography, nevertheless, all four compounds were obtained in 
excellent purity simply by triturating the crude products with cold i-PrOH, albeit at low to moderate 
yields.   
 
Scheme 3-6: Formation of the bis-amino acid functionalised [5]polynorbornane frameworks 
3.5.1  Characterisation of the ligands 
NMR analysis of the four [5]polynorbornane bis-amino acids revealed that, similar to the imides 230 
and 231, the chiral nature of the incorporated alanine and phenylalanine moieties had a substantial 
effect upon the NMR spectra.  The chiral compounds 234 and 235, incorporating two alanine and two 
phenylalanine residues respectively, showed broad, poorly resolved peaks, attributed to their 
potential for aggregation in solution, most notably in the spectrum of 235 (Figure 3-16).  Attempts to 
                                                          
* For relevant references please refer to the specific experimental provided in Chapter 5 
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improve the spectra through Variable Temperature NMR (VT-NMR) were unsuccessful as signal 
broadening remained even at 100 °C. 
  
Figure 3-16: 1H NMR spectra of 235 showing broad peaks caused by aggregation (DMSO-d6).  The arrow indicates a trace 
amount of i-PrOH that could not be removed from the 231 sample despite rigorous drying. 
The non-chiral compounds 233 and 236, incorporating glycine and PABA respectively, showed 
straightforward NMR that were easily assigned with the help of 2D NMR techniques (Example for 236 
is shown in Figure 3-17). 
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Figure 3-17: 1H NMR (Top) and COSY (Bottom) spectra of 236(DMSO-d6) 
The four compounds were then converted to sodium salts by treating them with 2.0 equiv. of NaOH 
to afford the desired ligands for testing.  Pleasingly, the sodium salts of chiral compounds 234 and 235 
gave NMR spectra that displayed more defined peaks than the free acids, a fact which was attributed 
Hβ Hα 
4 × Me 
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H31s,33s 
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107 
to the disruption of the hydrogen bonding networks that were postulated to promote aggregation in 
the free acids (Figure 3-18).   
 
Figure 3-18: 1H Spectrum of 235:Na2 showing minimal aggregation and resolved peaks (D2O) 
A large degree of desymmetrization was observed for both chiral ligands, which was attributed to the 
lack of a plane symmetry in both molecules.  Instead, both molecules only possess a C2 rotational point 
of symmetry which resulted in hydrogen atoms located diagonally opposite each other on the 
[5]polynorbornane framework being identical to each other while the neighbouring hydrogen resides 
in a different chemical environment (Figure 3-19). 
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Figure 3-19: The planes of symmetry present in a non-chiral [5]polynorbornane framework and the C2 symmetry present 
in 244 and 245.  The hydrogens located at the ends of the framework have been colour-coded to show matching pairs 
Of significance, the ionic ligands were completely water soluble (except for bis-phenylalanine ligand 
235 which formed a suspension, most likely due to the large organic bulk of both the framework and 
sidechains) making them ideal for evaluation for MOF or coordination cage formation in water. 
It was also noted that conversion of bis-PABA ligand 236 to the disodium salt resulted in additional 
peaks appearing in the aromatic region (Figure 3-20) despite the purity of 236 used to form the salt 
(as assessed by NMR).  This was attributed to the existence of conformational isomers where the 
aromatic C-Hs of the PABA moieties reside in different microenvironments.  However, attempts to 
resolve the isomers through VT NMR were unsuccessful. 
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Figure 3-20: Top) 1H NMR spectra of 236 (DMSO-d6), Bottom) 1H NMR spectra of 236:Na2 (D2O) showing extra peak 
formation in the aromatic region  
 
3.6  Evaluation of the ligands 
A range of transitions metals, namely zinc, copper, cobalt, iron and nickel, were chosen for this study.  
Addition of each metal *  to an aqueous suspension of bis phenylalanine-functionalised 
[5]polynorbornane 235:Na2 resulted in the immediate formation of a cloudy precipitate.  Similarly, 
addition of zinc, copper and nickel to an aqueous solution of bis PABA-functionalised 
[5]polynorbornane 236:Na2 also resulted in the formation of a cloudy precipitate.  No precipitates 
were observed for either the bis glycine- and bis-alanine variants. 
1H NMR titrations were employed to help identify the metal-organic complexes.  Spectra were 
acquired of (i) the free ligands and (ii) retaken after the addition of 0.5 equivalents of the metal.  
Pleasingly, clear changes in the NMR spectra were observed after the addition of Zn(II), Co(II) and 
Fe(II).  Addition of Cu(II) and Ni(II) to the NMR sample resulted in the spectra being broadened to the 
point where the peaks were no longer visible (Figure 3-21).  This was somewhat expected, however 
as both Cu(II) and Ni(II) are paramagnetic species and are well known to have such an effect upon 
NMR spectra, although this effect was much more pronounced for Cu(II) than for Ni(II). 
                                                          
* Divalent salts of each metal were used in this study, namely Zinc (II) acetate, Copper (II) acetate, Cobalt (II) 
nitrate, Iron (II) sulphate and Nickel (II) chloride. 
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Figure 3-21: 1H NMR stackplots showing the addition of Cu(II) (top) and Ni(II) (bottom) to 235:Na2 showing the 
degradation of the signal (D2O) 
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Addition of Fe(II) 
Upon addition of Fe(II) to an aqueous solution of the glycine-functionalised ligand 233:Na2, a clear 
downfield shift for the resonance assigned to the glycine methylene protons was observed (from 3.90 
to 4.35 ppm as seen in Figure 3-22).  Additionally, this peak broadened considerably.  Interestingly, 
the endo protons on the framework also experienced a large chemical shift change and broadening, 
although the shift was upfield.   
 
Figure 3-22: 1H NMR stackplot of the addition of Fe(II) to 233:Na2 (D2O)  
Upon addition of Fe(II) to an aqueous solution of PABA-functionalised ligand 236:Na2, no significant 
change in chemical shifts was observed for the framework protons, although clear downfield shifting 
was observed for the aromatic C-H resonances (Figure 3-23). 
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Figure 3-23: 1H NMR stackplot of the addition of Fe(II) to 236:Na2 (D2O)  
However, when the experiment was repeated using the two chiral ligands 234:Na2 (Figure 3-24) and 
235:Na2 (Figure 3-25) a large degree of signal broadening was evident, making the tracking of any 
chemical shifts difficult. 
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Figure 3-24: 1H NMR stackplot of the addition of Fe(II) to 234:Na2 (D2O) 
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Figure 3-25: 1H NMR stackplot of the addition of Fe(II) to 235:Na2 (D2O) 
Addition of Co(II) 
As with Fe(II), measurable chemical shift changes were observed upon addition of the Co(II) ion to an 
aqueous solution of 234:Na2 (Figure 3-26).  It was notable, however, that the chemical shift change 
was not as significant as it was when Fe(II) was added, especially with regards to the methylene 
protons, which demonstrated little chemical shift change despite undergoing a shift of 0.45 ppm after 
the addition of 2 equiv. of Fe(II).  The observed chemical shift changes were only evident in the 
resonances assigned to the framework C-Hs.   
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Figure 3-26: 1H NMR stackplot of the addition of Co(II) to 243:Na2 (D2O) 
Addition of Co(II) to the other non-chiral ligand, bis-PABA functionalised 236:Na2, showed no chemical 
shift changes in the resonances assigned to the framework protons (Figure 3-27).  However an 
interesting observation was made that the aromatic C-H resonances of bis-PABA ligand 236:Na2 
underwent shifts in opposite directions, and after the addition of 2 equiv. of Co(II) had almost 
exchanged positions in the 1H NMR spectra (the resonances assigned to aromatic C-H protons located 
nearest the framework underwent a larger chemical shift change [0.60 ppm] than the resonances 
assigned to the aromatic C-H protons located nearest to the carboxylate moiety [0.38 ppm]). 
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Figure 3-27: 1H NMR stackplot of the addition of Co(II) to 236:Na2 (D2O) 
Addition of Co(II) to the chiral ligands had a pronounced effect upon their 1H NMR spectra, although 
interestingly, the responses were quite different.  The 1H NMR spectra of bis-alanine ligand 234 (Figure 
3-28) became non-symmetrical, most notably in the ester peaks located at 3.76 ppm.  Unfortunately, 
a large degree of signal broadening was once again observed, making accurate tracking of chemical 
shift changes difficult.  It was also observed that the resonances at 1.34 ppm, assigned to the methyl 
C-Hs of the incorporated alanine moieties, disappeared after the addition of only 0.5 equiv. of Co(II) 
and could not be observed in any subsequent spectra. 
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Figure 3-28: 1H NMR stackplot of the addition of Co(II) to 234:Na2 (D2O)  
The spectra for the bis-phenylalanine ligand 235:Na2 did not display as much desymmetrization as bis-
alanine ligand 234:Na2, with only the resonance at 2.41 ppm, assigned to axial framework C-Hs, 
undergoing clear desymmetrization (Figure 3-29).  Instead, as was observed with the addition of Fe(II), 
a large amount of signal broadening was apparent (albeit, to a lesser extent).   
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Figure 3-29: 1H NMR stackplot of the addition of Co(II) to 235:Na2 (D2O) 
Addition of Zn(II) 
Unlike the spectral changes observed when Fe(II) and Co(II) were used, addition of Zn(II) had minimal 
impact upon the 1H NMR spectra of the ligands, with only the bis-glycine ligand 233:Na2 showing any 
response.  Even then, the chemical shift changes observed were small, not comparable to the larger 
shifts observed upon addition of Fe(II) or Co(II) ions (Figure 3-30). 
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Figure 3-30: 1H NMR stackplot of the addition of Zn(II) to 243:Na2 (D2O)  
Addition of Zn(II) to the remaining ligands failed to cause any noticeable change in the 1H NMR spectra 
of the ligands, with no sign of either chemical shift changes or signal broadening as had been observed 
after the addition of Fe(II) and Co(II) (as shown in Figure 3-31 for 246:Na2, Figure 3-32 for 244:Na2, and 
Figure 3-33 for 245:Na2). 
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Figure 3-31: 1H NMR stackplot of the addition of Zn(II) to 236:Na2 (D2O)  
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Figure 3-32: 1H NMR stackplot of the addition of Zn(II) to 234:Na2 (D2O)  
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Figure 3-33: 1H NMR stackplot of the addition of Zn(II) to 235:Na2 (D2O)  
X-ray crystal structures 
Slow evaporation of the NMR samples afforded a number of crystals (233:Cu(II), 233:Ni(II), 233:Co(II), 
236:Zn(II)), most notably, dark blue crystals that were obtained from slow evaporation of an aqueous 
solution of bis-glycine ligand 233:Na2 and Cu(II).  These crystals were much darker in colour than the 
crystals of the copper source and provided visual indication that a new metal complex or 
metallosupramolecular architecture may have formed. 
X-ray analysis of the crystals of the bis-glycine ligand 233:Na2 complexes with cobalt, nickel and copper 
did not show any evidence of either MOF or MOC formation, instead revealing 1:1 complexes where 
the ligand binds the metal ions in a bidentate fashion.  The crystals obtained for the complexes of 
233:Na2 with cobalt and nickel gave very similar structures and as such, only the cobalt complex will 
be discussed here (Figure 3-34).  The cobalt ion is bound between the two carboxylate residues of a 
single unit of 233 rather than linking two units of 233, indicating that the flexibility of the amino acid 
moiety, when coupled with the curvature of the [5[polynorbornane backbone, results in the formation 
 
2.0 Equiv. 
 
1.5 Equiv. 
 
1.0 Equiv 
 
0.5 Equiv. 
 
0.0 Equiv 
123 
of a discrete, bimolecular complex being favoured.  The unit cell of the crystal structure showed a tight 
packing arrangement with no voids or larger assemblies being apparent. 
 
Figure 3-34: The crystal structure and unit cell of 233:Co(II) viewed along the c-axis 
Interestingly, the Cu(II) ion was bound in a slightly different manner to the Co(II) and Ni(II) ions, as 
evidenced by the ion being held tightly inside the binding cleft of 233 (Figure 3-35).  The crystal 
structure also displayed a different packing arrangement to the cobalt and nickel complexes, but once 
again, no voids or larger assemblies were apparent.   
124 
 
Figure 3-35: The crystal structure and unit cell of 233:Cu(II) viewed along the c-axis 
Interestingly, measurement of the curvature of the [5]polynorbornane backbone revealed that the 
binding of the Cu(II) ion caused the polynorbornane backbone to undergo extra curvature (Figure 3-
36).  The 233:Cu(II) complex has an internal angle of 130.76° (Figure 3-36 left), whereas the 233:Co(II) 
complex possesses an internal angle of 135.64° (Figure 3-36 right), meaning that the complexation 
with Cu(II) pulls the ends of the polynorbornane framework closer together.   
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Figure 3-36: Comparison of the framework curvature of left) the 233:Cu(II) complex and right) the 233:Co(II) complex. 
Crystals also formed from the slow evaporation of an aqueous solution of 236 and Zn(II) which were 
also analysed using X-ray crystallography.  Pleasingly, the resultant 236:Zn(II) complex was observed 
to form a 2:2 metallocycle (Figure 3-37).  This different stoichiometry was attributed to the rigid PABA 
moieties preventing the carboxylate groups from bending in under the framework as observed for the 
glycine functionalised 233.  Interestingly, the dimer took on a twisted confirmation, even slightly 
twisting the rigid fused [5]polynorbornane backbone.   
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Figure 3-37: Top) The crystal structure 2362:Zn(II)2 and Bottom) the twisted conformation of the framework and dimer 
(hydrogen atoms omitted for clarity) 
3.7  Summary 
A series of fused [5]polynorbornane frameworks incorporating amino acid moieties were synthesised 
and investigated for their ability to form organometallic complexes.  NMR evidence indicated that all 
four frameworks were capable of interacting with a range of transition metal ions.  Several crystal 
structures revealed that for bis-glycine functionalised 233, a 1:1 bidentate arrangement was formed 
however a crystal structure of a 236:Zn(II) complex revealed the existence of a larger 2:2 metallocycle, 
indicating that the compounds can indeed form larger arrangements. 
 
3.8  Future Work 
Further investigations into the structure of the formed complexes is required, especially with regards 
to the complexes formed by the chiral ligands 234 and 235.  The complexes can also be evaluated for 
their ability to potentially encapsulate guest molecules as well as the potential for 234 and 235 to act 
as chiral purification devices. 
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Replacement of the [5]polynorbornane framework with the longer, more rigid [6]polynorbornane 
framework is required to investigate the impact of the more rigid, straighter backbone.  Additionally, 
the ability to incorporate endohedral functionalisation into the [6]polynorbornane framework allows 
for the installation of additional carboxylate moieties, allowing more complicated architectures to 
potentially be developed. 
The incorporation of other amino acids into the frameworks will result in a range of ligands suitable 
for further testing.  In particular, amino acids such as histidine, tryptophan, arginine and lysine could 
be very interesting candidates due to the nitrogen containing side chains potentially taking part in 
metal complexation.  Aspartic acid and glutamic acid also possess an additional carboxylate source 
which has the potential to form crosslinked networks. 
As evidenced by the differing metal complexes formed by bis-glycine functionalised ligand 233 and 
bis-PABA functionalised ligand 236, the flexibility, or lack thereof, of the carboxylate moiety has a large 
effect on the geometry of metallosupramolecular complexes formed.   Therefore, the incorporation 
of carboxylate sources in fixed conformations is a promising area for further investigation. 
Furthermore, the synthesis and functionalisation of exo [5]polynorbornanes (Figure 3-38) will result 
in the development of straight ligands that can then be investigated for their ability to form 
metallosupramolecular complexes.   The use of the straight polynorbornane backbone will prevent 
the bimolecular complexation observed in the crystal structures obtained for the metal complexes of 
243. 
 
Figure 3-38: An exo [5]polynorbornane scaffold showing the linearity of the backbone 
The 236:Zn(II) dimer is notable for the accessible nature of the two metal ions which makes the dimer 
an attractive candidate for investigations into the development of mimics of metalloenzymes such as 
nitrogenase.451,452 
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4. An Ionic Low Molecular Mass Organogelator based on a 
Phenylalanine Functionalised Norbornene 
This chapter will commence with an overview of aqueous biphasic systems and their applications, 
followed by a detailed discussion of the biphasic system discovered in Section 3.2.  Next an overview 
of organogels and organogelators with an emphasis upon Low Molecular Mass Organogelators 
(LMOGs) will be provided.  The use of ionic LMOGs in the literature will be outlined leading to the 
discovery in this project, the identification and evaluation of a novel compact ionic LMOG: 
phenylalanine-functionalised norbornene 231:Na.  
4.1 Aqueous biphasic systems 
Aqueous biphasic systems (ABSs) are formed when two water soluble components mixed together in 
an aqueous solution separate from each other and form two clear distinct phases (Figure 4-1).453  
These two components are typically made up of either (i) different polymers (such as the polyethylene 
glycol [PEG]-Dextran system)454 (ii) a polymer and a kosmotropic salt455 or (iii) a kosmotropic salt and 
a chaotropic salt.456,457  In all cases, the formation of aqueous biphasic systems is highly dependent 
upon pH, temperature and component concentration, as well as the ionic strength of any salt 
involved.458-461  As the system to be discussed here is a mixture of salts, biphasic systems formed using 
polymers will not be considered further, however several reviews are available for interested 
readers.460,462,463 
 
Figure 4-1: A simplified illustration of an aqueous biphasic system 
4.1.1 Kosmotropes and chaotropes 
A kosmotropic compound is one capable of enhancing the structure of water and the stability of water-
water interactions.464,465  Kosmotropes enhance the strength of the hydrogen bond network in water 
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although this definition has been the subject of much discussion and a clear consensus has yet to be 
reached especially when ionic compounds are considered.466-468  The increased favourability of the 
water-water interactions decreases the solvation of macromolecules and subsequently enhances the 
intramolecular interactions between macromolecules, causing aggregation.  Thus, kosmotropic salts, 
particularly ammonium sulfate, are commonly used to extract “delicate” proteins from aqueous 
solutions in a “gentle” manner (without requiring acid/base treatment or application of heat), without 
the risk of damage to the protein structure or sequence.469-471  For this reason, kosmotropic salts are 
sometimes referred to as “salting-out” agents.466  Kosmotropic salts tend to be small ions with a high 
charge density, such as CO32-, SO42-, Zn2+, Al3+ and Mg2+ (Figure 4-2).472 
Conversely, chaotropic salts disrupt the structure of water and destabilise water-water interactions.  
Therefore, chaotropic salts weaken intramolecular interactions that in turn destabilises and 
discourages aggregation and increases the solubility of proteins, often to the point of denaturation.473-
475  Chaotropic agents can also be referred to as “salting-in” agents (Figure 4-2).466   
One of the most popular methods of determining if a given salt is a kosmotrope or chaotrope is to 
compare it to the Hofmiester series (Figure 4-2), established in 1888 when Hofmiester compared the 
ability of different salts to ‘salt out’ egg proteins from solution.476  An alternative method uses the 
Gibbs free energy of hydration, with kosmotropic salts typically having positive values and chaotropes 
having negative values.464  By comparing the ability of a salt to form aqueous biphasic systems with 
other salts in the Hofmiester series, an approximation of the kosmotropic/chaotropic strength of the 
salt can be obtained.  
 
Figure 4-2: A small sample of the Hofmiester series 
When a kosmotropic salt and a chaotropic salt are mixed together at a high enough concentration, a 
biphasic aqueous solution will result with the chaotrope partitioning into the less dense phase and the 
kosmotrope partitioning into the more dense phase (Figure 4-3).  As ionic liquids are frequently 
chaotropic in nature, they are commonly used in the formation of aqueous biphasic systems and 
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several papers and reviews available on the use of ionic liquids as components of aqueous biphasic 
systems.457,477,478   
 
Figure 4-3: Partitioning of kosmotropic and chaotropic salts to form an ABS 
4.1.2 Applications of aqueous biphasic systems 
As mentioned previously, aqueous biphasic systems have generated considerable interest as a mild 
‘green’ extraction method.479,480  Aqueous biphasic systems have considerable advantages over 
traditional organic/aqueous extractions in addition to the aforementioned mild extraction capabilities 
in that they avoid the use of flammable and toxic organic solvents, they can be easily tuned by varying 
pH, temperature and concentration to target different molecules, they possess the capability for 
continuous operation and they generally afford rapid phase separation without the formation of 
emulsions.460,462,479 
Aqueous biphasic systems are most frequently used for separations and purifications of sensitive 
natural products.  To date, four main classes of compounds are commonly purified using aqueous 
biphasic systems, namely, alkaloids, amino acids, proteins and pharmaceuticals.457,460  Purifications 
through aqueous biphasic system separations have also been reported for steroidal compounds, short 
chain alcohols and aromatic/phenolic compounds.481-483   
Aqueous biphasic systems have also been used in environmental remediation, particularly in the area 
of heavy metal extraction from waste water.484-487    Aqueous biphasic systems have also been 
investigated for their potential in the removal of toxic products and metabolites formed in the 
production of textiles dyes.488  The use of ionic liquids to form aqueous biphasic systems has also led 
to their being investigated as a method for the extraction and recycling of ionic liquids from water, 
allowing ionic liquids to be used in industrial processes without the risk of waste stream 
contamination.489-491  
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Aqueous biphasic systems have also been investigated for analytical purposes such as the isolation 
and subsequent quantification of biological solutes through methods such as HPLC analysis or mass 
spectrometry.462,492  The previously mentioned sensitivity of ABS formation to changes in salt 
concentration and pH, allows for aqueous biphasic systems to be tuned to partition small molecules 
based on small differences in structure.492  
4.1.3 Discovery and evaluation of an aqueous biphasic system 
As discussed in section 3.2. upon treatment of an organic solution of phenylalanine-functionalised 
norbornene 231* with a solution of saturated Na2CO3, a triphasic system rapidly formed (Figure 4-4).  
This triphasic system proved to be resistant to agitation, rapidly reforming even after multiple 
inversions and agitations in a separatory funnel. 
 
Figure 4-4: The triphasic system formed upon workup of the crude reaction mixture obtained during the synthesis of 231 
Isolation and analysis of the three layers revealed that the top layer was the organic ethyl acetate, the 
bottom layer was comprised of an aqueous Na2CO3 solution and the middle phase consisted primarily 
of an aqueous solution the sodium salt of 231 (Figure 4-5).  Interestingly, 231 has been reported in the 
literature on several occasions and isolated using similar workups, however no mention of the 
unexpected phenomenon has been reported.450,493-496 
 
Figure 4-5: The sodium salt of 231:Na obtained from the middle phase of the triphasic system 
It was discovered that the aqueous biphasic system could be reproduced simply by combining a 
concentrated aqueous solution of 231:Na (greater than 2 M) with a saturated Na2CO3 solution (Figure 
                                                          
* All mentions of 231 and sodium salt 231:Na exclusively refer to the (S)-enantiomer, formed using L-
phenylalanine unless explicitly mentioned otherwise. 
 
Organic Phase (EtOAc) 
 
2nd Aqueous Phase 
 
1st Aqueous Phase 
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4-6).  Biphasic systems were also formed when NaOH was used as the base, but only when the bases 
used were present in a large excess and both 231:Na and the base were present at concentrations 
greater than 2 M.  The requirement for high concentrations of both salts before biphasic separation 
was observed suggested the possibility of a kosmotropic/chaotropic salt separation.  The 
kosmotropic/chaotropic separation that was confirmed when an aqueous biphasic system was formed 
by mixing 231:Na and ammonium sulfate.  Ammonium sulfate is a known kosmotropic salt,497,498 
popularly used for the development of biphasic systems and the ability of 231:Na to form an aqueous 
biphasic system when combined with (NH4)2SO3 provided a strong indication that 231:Na was a 
chaotropic salt and kosmotropic/chaotropic interactions were indeed the main driving force behind 
the formation of the aqueous biphasic system.456,499-502   
 
Figure 4-6: An aqueous biphasic system formed by mixing 231:Na and saturated Na2CO3 
Further confirmation of the chaotropic nature of 231:Na was obtained through NMR diffusion 
experiments which demonstrated an increase in diffusion rate when the NMR sample concentration 
was increased from 2.5 to 5 M (Figure 4-7).  This change in diffusion was attributed to a decrease in 
the viscosity of the D2O, which in turn can be attributed to the ability of chaotropic salts to disrupt the 
hydrogen bonding network of water.464,468 
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Figure 4-7: 1H NMR diffusion experiment showing the increase in diffusion rate as concentration of 231:Na is increased 
above 2.5 M (D2O) 
It was also observed that 231:Na was incredibly water soluble (Figure 4-8).  Solutions over 2 g/mL 
were readily prepared and found to be extremely viscous.  A 3 g/mL solution formed a hydrogel that 
remained stable to inversion for over a week.  Even after a period of several months, no sign of 
precipitation or crystallisation was observed, even for the 3 g/mL solution, demonstrating the 
hydrophilicity of 231:Na.  This 3 g/mL solution represents a ratio of approximately 1 molecule of 
231:Na to 18.5 molecules of H2O, and upon application of heat, gives a free flowing solution.   
 
Figure 4-8: Concentrated aqueous solutions of 231:Na; from left to right: 1 g/mL , 2 g/mL, 2.5 g/mL and 3 g/mL.. 
During characterisation this triphasic system it was discovered that additions of small amounts of the 
concentrated aqueous solution of 231:Na to a variety of organic solvents resulted in the rapid 
formation of a clear gel.  The potent organogelating ability of 231:Na will be discussed further in 
section 4.4.   
It was noted during a search of the literature that a formation of an aqueous biphasic system from a 
salt-salt solution such as the one reported in this study typically requires the usage of an ionic liquid 
as the chaotropic agent.444-447  It is extremely rare to find reports of a small salt such as 231:Na, that is 
not liquid at room temperature, that is capable of forming an aqueous biphasic system.  As will be 
discussed in section 4.4.3 Crystal structure and the assembly process, this unusual behaviour can be 
explained by the formation of a supramolecular polymer of 231:Na, whereby the increasing assembly 
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of monomers into a growing chain results in regions of chaotrope-rich water and kosmotrope-rich 
water, which further accelerates the separation of salts and subsequent growth of the supramolecular 
polymer.  It is therefore likely that the driving force behind the formation of the aqueous biphasic 
system is the combination of the strongly chaotropic nature of 231:Na, as well as the ability of 231:Na 
to assemble in to a supramolecular polymer. 
4.1.4  Supramolecular polymers 
Supramolecular polymers differ from regular covalent polymers in that the polymer network is largely, 
if not completely made up of non-covalent interactions, such as hydrogen bonding, π-π stacking and 
metal-ligand interactions.503-505  As a result, the formation of supramolecular polymers is reversible 
and the formation/dissolution of the polymer network can be controlled through the exposure or 
removal of the appropriate stimuli, be it pH, temperature, UV irradiation, or concentration among 
others.101,506-509  A full discussion of supramolecular polymers is beyond the scope of this document, 
however several reviews are available for interested readers.503-505,510-512 
As a result of the ability to control the formation of supramolecular polymers through stimuli, 
supramolecular polymers often demonstrate thixotropic properties.513-515  Supramolecular polymers 
are therefore attractive candidates for use in several biomedical applications such as drug delivery 
and tissue engineering.101,511,512,516,517  As an added advantage, the non-covalent interactions that make 
up supramolecular polymers also result in the formed polymer being much more biodegradable, 
neatly circumventing issues relating to waste management of conventional polymers.512,518,519 
4.2 Organogelators and organogels 
When a three-dimensional polymeric network forms throughout a liquid phase, it can trap the solvent 
molecules and prevent the solvent from flowing.132,520,521  The resultant material is referred to as a gel 
(from gelatine, coined by Thomas Graham in 1861).522 If the solvent used to form the gel is an organic 
solvent, the resultant gel is referred to as an organogel, and if water is the solvent gelled, a hydrogel 
is formed.142,521  
The organogel discussed in this chapter was formed by the self-assembly of small molecules into Self-
Assembled Fibrillar Networks (SAFINs).521,523-526  As these fibres form, they can intertwine into a three-
dimensional network and trap solvent molecules, immobilising them to form an organogel (Fig 4-9).  
As these networks are assembled using non-covalent interactions, they can be reversed or disrupted 
by external influences such as increased temperature (i.e. disruptions to the intermolecular 
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interactions), which causes the gel to break down and the solvent being allowed to flow once 
again.142,527 
 
Figure 4-9: Assembly of a gelator into fibrils and subsequent formation of a SAFIN resulting in gelation 
These small molecules are commonly referred to as Low Molecular Mass Organogelators (LMOGs) and 
have applications in fields as diverse as heavy metal remediation, oil spill remediation, drug delivery, 
pheromone release devices and chemical sensing.142,143,521,528,529   
There is a degree of uncertainty in the literature at what exactly constitutes a low molecular mass with 
some researchers classifying gelators with masses as high as 3000 amu as LMOGs.101,142,530  This 
document, however, will primarily focus upon LMOGs with molecular masses under 1000 amu.  
4.2.1  Physical properties and characterisation of organogels 
Several parameters are of interest when characterising organogels including the minimum gelating 
concentration, rheological strength and thermal characteristics. 
Typically, when using LMOGs to form organogels, a small amount of the gelator is mixed with the 
solvent to be gelled and the resulting solution is heated to ensure complete dissolution and 
dispersal.132,137,142  Upon cooling the solution “hardens” and the organogel is formed.  The minimum 
amount of LMOG required to ensure complete gelation of the solvent is referred to as the Minimum 
Gelation Concentration (MGC).531  This value is frequently expressed as either a wt% or as mg.mL-1 
and LMOGs capable of causing gelation at concentrations below 1 wt% (1 mg.mL-1) are referred to as 
supergelators.532-534 
As recognised by Lloyd in 1926, ‘the colloid state, the gel, is easier to recognise than define’ and to 
this day, a clear definition of what exactly constitutes a gel is still the subject of debate with Te 
Nijenhuis taking the approach that ‘a gel is a gel, as long as one cannot prove that it is not a gel’.535,536   
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One simple way of classifying a gel is known as the ‘six-hour inversion test’ in which a gel formed in a 
vial is inverted and left to stand upside down for a period of time.  If, at the end of the time period, 
the gelled solvent remains immobilised and has not shown any evidence of solvent flow, the test is 
passed and the term gel can be assigned with a degree of confidence.133,537  
Two additional properties commonly accepted as defining a gel are a three-dimensional network with 
macroscopic dimensions that exists for the duration of the measurement and despite being primarily 
liquid, the gel is solid-like in its rheological behaviour.101,132,142 
The three-dimensional network can be visualised by means of Scanning Electron Microscopy (SEM).538   
SEM imaging uses a beam of electrons to scan the surface of a substance.539  The signals produced by 
the interaction of the electrons and the surface atoms are then analysed to determine information 
regarding the composition and topology of the surface.  Other microscopy techniques such as 
Transmission Electron Microscopy (TEM) and Atomic Force Microscopy (AFM) have also been utilised 
however all three techniques suffer from a significant drawback in that they are unable to visualise 
the three-dimensional network (and its formation) in the gel itself.540-542  Both SEM and TEM also 
require operation under vacuum, conditions incompatible with the presence of the (often volatile) 
organic solvent trapped in the gel network.  Removal of the gelled solvent through drying frequently 
collapses the 3-Dimensional network, resulting in a xerogel (If the network does not collapse, the 
resultant material is known as an aerogel).543  Both techniques are therefore useful for visualising the 
fibres formed by the LMOGs but not for visualising the fibrillary networks as they exist in the gel itself.   
By drop-casting a solution onto a flat surface544, AFM is able to give a good representation of the 
network of the gel state, however, volatile solvents can cause changes in the sample over short time 
frames, meaning care needs to be taken when interpreting results.  A technique that is rapidly gaining 
popularity is Transmission Electron Cryomicroscopy (CryoTEM), which uses flash-freezing to preserve 
the gel network, thus avoiding the drawbacks associated with traditional TEM and SEM analysis.545 
Assessing the rheological properties of gels is a fundamental method of gel characterisation.546,547  In 
a strong gel, the storage modulus (G’), or energy stored in the sample being tested, is at least one 
order of magnitude greater than the loss modulus (G’’), or energy dissipated as heat. 
The temperature at which an organogel breaks down and returns to a liquid state is referred to as Tgel 
and is frequently determined using Differential Scanning Calorimetry (DSC).541,548  This test can be used 
to determine the reversibility of gelation, as well as the heat capacity of the gel.  A true organogel 
formed from an LMOG can be subject to multiple heating and cooling cycles, with the gel breaking 
down and reforming each time the temperature is increased above, then lowered below the Tgel. 
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LMOGs assembling through a wide variety of non-covalent interactions have been reported, from π-
π stacking to H-bond interactions to van der Waals forces and dipole-dipole interactions.133,142,521,526,549 
As a result of the range of non-covalent interactions used, organogels have been reported that are 
sensitive to pH changes, temperature changes, UV irradiation and oxidising agents.132,550,551 
The reversible assembly process leading to organogel formation has also allowed for the development 
of thixotropic materials, capable of repairing damage, either spontaneously or after the application of 
stimuli such as light, pH or temperature.552,553  One of the earliest examples of a LMOG that could 
display thixotropic properties, naphthalenediimide 238, was reported by Shinkai et al. in 2010 (Figure 
4-10).554  This LMOG could form gels at as low as 0.3 wt% and demonstrated thixotropic properties, 
that is, the gel-sol conversion occurred upon agitation, with the gel network reforming after rest.  
However, it was noted that after disruption of the gel network through vortexing, the repaired gel 
network only had 72% of the strength of the original.552,554 
 
Figure 4-10: An organogelator capable of forming a thixotropic gel reported by Shinkai et al.554 
Currently, most reports of thixotropic gels are polymer gels and examples of LMOGs that exhibit 
thixotropic properties are less common.  Thixotropic polymer gels have been reported that utilise a 
wide range of physical and chemical methods to repair damage, such as hydrophobic interactions, 
host:guest interactions, hydrogen bonds, disulphide bond formation, Diels-Alder reactions, imine 
bond formation and reversible radical reactions (Figure 4-11).553,555-562  As polymer gels are outside the 
scope of this work, they will not be considered further, however the following review provides an 
excellent starting point for interested readers.553 
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Figure 4-11: Interactions used to form thixotropic gels.  Reproduced with permission from ref.553 
4.3 Previous LMOGs in literature 
Considerable effort in recent years has been directed towards understanding the mechanics behind 
organogel formation in order to develop a theory capable of identifying the key structural features 
required for new gelators, a process known as rational design.563,564  However, despite some 
organogels being rationally designed, such examples frequently rely upon modifications to existing 
organogelators or combinations of components frequently occurring in existing organogelators such 
as long alkyl chains, peptide sequences (especially cyclic peptides), bis-urea groups or steroidal 
frameworks.  For this reason, the discovery of most novel organogelators in many instances is still 
serendipitous. 
Organogelators were first reported in the early 1900’s and then sporadically over the next 70 years; a 
most infamous example is napalm, a gel formed from gasoline by the aluminium salts of naphthenic 
and palmitic acids.   Another of the earliest organogelators was 12-hydroxystearic acid 239, reported 
in 1968 by Tachibana and Kambara to form gels or gel-like precipitates in paraffin oil (Nujol), benzene, 
carbon tetrachloride, chloroform and ethanol (Figure 4-12).  Similar results were also reported for the 
alkali salts of 239.565 
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Figure 4-12: Organogelator 12-hydroxystearic acid 249565 
In the 1980’s Weiss and co-workers began extensive investigations into LMOGs.  In 1987, it was 
observed that cholesterol based compound 240 was capable of gelating a wide range of alkane, 
alcohol or amine based solvents at concentrations as low as 0.25 wt% (Figure 4-13).566  This organogel 
was one of the first LMOGs to be reported that was capable of gelating solvent at these low 
concentrations, commonly referred to as a ‘supergelator’. 
 
Figure 4-13: LMOG supergelator reported by Weiss et al.566 
Of interest, Weiss and co-workers also reported the smallest reported organogelator, N,N’-
dimethylurea 241 (MW 88 Da).567  In 2005, a range of alkyl functionalised ureas and thioureas were 
identified as LMOGs and compound 241 was reported to gelate silicon oil and CCl4 at 2 wt% (Figure 4-
14). 
 
Figure 4-14: Low molecular weight organogelator reported by Weiss et al.567 
It was not until the 1990s that serious attention was devoted to the design of gels and their potential 
applications.  Hanabusa and co-workers, in a follow up report on a 1992 article detailing the 
serendipitous discovery of the gelating ability of L-alanine based amphiphile 242, performed a 
Structure-Activity Relationship (SAR) study in an attempt to identify the role of different amino acids 
and end groups upon gelating properties (Fig 4-15).531,568  During this study, valylvaline 243 was 
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reported as a very effective gelator, gelling a wide range of organic solvents from polar solvent to oils 
with MGCs ranging from 2 to 43 mg/mL.531 
 
Figure 4-15: a) L-Alanine based organogelator designed by Hanabusa et al. b) general structure of amino acid 
compounds investigated by Hanabusa et al. and c) valylvaline based organogelator 253.531 
The cholesterol-based organogelator 244, reported by Weiss and co-workers in 2005, displays 
thixotropic properties and thixotropic behaviour, with the gel network reforming after shear stress 
fracture (Figure 4-16).569,570  Interestingly, it was noted that related organogelator 245, did not display 
the same properties, instead undergoing phase separation upon shear stress fracturing.  This 
separation was attributed to the double bond present on the cholesterol framework of 245 which 
affected aggregation. 
 
Figure 4-16: Thixotropic organogelator 244 and analogue 245 which does not possess thixotropic properties reported by 
the Weiss group569,570 
Vidyasagar and co-workers reported a series of thixotropic supergelators, with sugar-based 
organogelators 246 and 247 being able to gel hydrocarbon solvents at concentrations as low as 2 wt% 
(Figure 4-17).571  The resultant organogels demonstrated remarkable thixotropic properties; a block of 
gel that was cut into two pieces ‘healed’ when the pieces were placed next to each other.  This 
thixotropic ability was attributed to the existence of an equilibrium between free monomers of the 
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organogelator in solution and assembled monomers making up the fibres in the three-dimensional 
network.  When the two pieces were joined back together, free monomers could cross the interface 
and promote fibre growth, thus healing the gel. 
 
Figure 4-17: Thixotropic supergelators reported by Vidyasagar et al.571 
Thixotropic gels are being investigated for a variety of applications such as switches controlling the 
hydrophobicity of a gel surface as reported by Yu et al., or the construction of new hybrid materials 
such as the quantum dot infused organogel network reported by the Bardelang and Yi groups.572-574  
Thixotropic gels have also been investigated for oil collection and environmental remediation such as 
the phase sensitive organogelator reported by Bhattacharya and Krishnan-Groth or the system for 
metal extraction reported by Awano et al. that could selectively remove mercury(II), nickel(II) or 
copper(II) ions from water with only 10 minutes of mixing required.575,576 
A family of organogelators capable of forming organogels upon completion of a chemical reaction has 
been reported by Van Esch and co-workers (Figure 4-18).577,578  These compounds start as carboxylate 
species, and upon reaction with dimethyl sulphide (DMS) (or methyl iodide [MeI] in a follow-up 
study)578, form methyl esters that assemble into fibrillar networks and form hydrogels.  Under basic 
aqueous conditions, these methyl esters are hydrolysed back to the carboxylate species and the gel 
network is dissipated.  However, if an excess of DMS or MeI “fuel” is present, the cycle continues, and 
the gel network can persist until the “fuel” source is depleted, at which time the gel network is broken 
down and remains in liquid form until a fresh “fuel” supply is added.  It was found that the lifetime of 
these gel networks could be controlled by both the pH (higher pH levels led to faster ester hydrolysis) 
and the amount of “fuel” present. 
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Figure 4-18: A family of “fuel”-driven, reversible organogelators reported by the Van Esch group.  Minimum gelator 
concentrations could not be determined due to the dynamic nature of the gels577,578 
4.3.3 Ionic LMOGs 
As ionic compounds are generally not soluble in organic solvents, there have been very few reports of 
ionic organogelators.  Most examples feature similar structural elements to non-ionic organogelators 
such as long alkyl chains, steroidal frameworks or large aromatic skeletons.  Several examples of ionic 
LMOGs also make use of organic counterions, for example, tetraalkylammonium salts, ultimately 
resulting in molecular masses over 500 Da and often over 1000 Da. 
One of the earliest ionic gels was reported by Lu and Wiess in 1995, when it was discovered that a 
range of trialkylchlosteranylammonium salts, (e.g. iodide salts 251:I and 252:I, Figure 4-19), were 
capable of forming gels in a variety of organic solvents.579  Iodide salt 252:I, containing an octadecane 
chain in place of a methyl group, was the most effective organogelator reported, forming a 
thermoreversible gel in methanol at 0.8 wt%. 
 
Figure 4-19: Ionic organogelators reported by Lu and Weiss579 
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An LMOG capable of gelling a wide range of solvents reported by Bardelang and co-workers was 
revealed to be a 1:1 mixture of 6-dimethoxynicotinic acid and its sodium salt (Figure 4-20).580  
Interestingly, it was observed that the 1:1 mixture was crucial for gelation as the free carboxylic acid 
253 did not display any gelating ability and the sodium salt 253:Na only displayed very poor gelating 
ability.  It was also reported that the 1:1 mix had to be preformed before attempting gelation as an 
attempt at in situ formation of the 1:1 mixture did not elicit gelation. 
 
Figure 4-20: a) Organogelating compounds reported by Bardelang et al. b) The 1:1 complex required for 
organogelation580 
In a 2003 paper Dastidar and co-workers reported that an imidazolium salt of a cyclobutane diacid 
was capable of gelling a range of aromatic solvents (Fig 4-21).581  In a series of follow-up papers, 
Dastidar and co-workers reported on a family of ionic LMOGs based upon alkyl ammonium salts of 
cinnamaldehyde.582  In doing so, the authors carried out in-depth investigations in order to determine 
the effects of different substituents of both the aromatic ring of the cinnamaldehyde framework as 
well as the alkyl substituents of the ammonium counterion, resulting in the discovery of several ionic 
organogelators including 256:257.  It was reported that the ability of the salts to form 1-Dimensional 
H-bonding networks was key to their ability to act as organogelators. 
 
Figure 4-21: Ionic organogelators reported by Dastidar et al.581,582 
A family of compounds based upon N-acyl-1,ω-amino acid was synthesised by Vogtle, Fages and co-
workers in 2001 and investigated for their organogelating ability.564  It was found that, while the 
carboxylic acid compounds were found to have little to no ability to form organogels, the 
corresponding carboxylic acid salts were much more potent with compound 258:Na being capable of 
gelating DMF at concentrations under 1 mg mL-1 (Fig 4-22).  While the reported sodium salts were 
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unable to cause gelation in apolar solvents such as cyclohexane and toluene on their own, addition of 
a small quantity of methanol (5-7 vol%) was found to induce instantaneous gelation. 
 
Figure 4-22: N-acyl-1,ω-amino acid  and ionic organogelator 258:Na reported by Vogtle et al.564 
A 2004 paper by Suzuki and co-workers detailed the synthesis and investigation of a range of 
amphiphilic LMOGs based upon L-lysine (Figure 4-23).583  Interestingly, potassium salt 259:K, was 
found to function as both an effective organogelator and hydrogelator being capable of causing 
gelation in water at 0.3 wt% as well as inducing gelation in toluene and nitrobenzene at 0.2 wt%. 
 
Figure 4-23: L-lysine based organogel scaffold and ionic organogelator 259:K reported by Suzuki et al.583 
4.4 Organogelating properties of 231:Na 
In this project, the investigation of the organogelating ability of a compact, ionic organogelator will be 
discussed and evaluated.  As mentioned in section 4.1.3, addition of small aliquots of a concentrated 
aqueous solution of 231:Na to a variety of organic solvents resulted in the rapid formation of a clear 
gel (Figure 4-24).  As 231:Na represents an unusual LMOG, both in part to its compact size and ionic 
nature, this discovery was of great interest and attention was immediately devoted towards fully 
understanding its gelating ability and properties.   
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Figure 4-24: A clear organogel formed by 231:Na in 1,4-dioxane (1 wt%) 
A range of solvents were tested by the addition of small aliquots (10 μL, corresponding to 1 wt%) of a 
3 M aqueous solution of 231:Na (formed by dissolving 500 mg of 231:Na in 500 μL of H2O) to 1 mL of 
an organic solvent and (i) heating the samples then (ii) sonicating the warm solution.  Upon cooling, 
immediate gelation was observed in several solvents, namely i-PrOH, THF and 1,4-Dioxane.  Slow 
formation of a gel was observed in n-BuOH.  Further investigation revealed that a gel could be formed 
in EtOH by dissolving 20 mg (2 wt%) of 231:Na in 1 mL of hot solvent.  The results of the gelation 
testing as well as limits of gelation are summarised in table 1.  All gels that passed the six hour inversion 
test are designated as gels (G), whereas gels that were observed to completely entrap the solvent but 
failed the six hour inversion test are designated weak gel (WG).  If not all the solvent was immobilised, 
the designation partial gel was used (PG) 
Table 2: Gelation of organic solvents by 231:Na (minimum gelation concentration) 
Solvent Observation 
Methanol D 
Ethanol Ga
 
(2 wt%) 
Isopropanol Ga (0.5 wt%) 
n-Butyl Alcohol Ga (0.5 wt%) 
1,4-Dioxane Gb (0.5 wt%) 
Tetrahydrofuran Gb (0.5 wt%) 
Diethyl Ether I 
Acetone WGa (1 wt%) 
Ethyl Acetate PG 
Dimethylformamide D 
Dimethyl sulfoxide D 
Acetonitrile A 
Chloroform WGb (1 wt%) 
Dichloromethane S 
Toluene A 
Pet. Spirits (40-60 °C) I 
Heptane I 
a) Gelator added as a powder, b) gelator added as a 5.0 M aqueous solution.  
G = Clear gel, WG = Weak gel, PG = Partial gel, S = Suspension, D = Dissolved, I = Insoluble, A = Aggregate, 
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It was observed that most gels could be formed using both the concentrated aqueous solution as well 
as by dissolving rigorously dried crystals of 231:Na, however the THF gel was only obtained through 
the addition of an aqueous solution of 231:Na as no gel was observed to form when the solid form of 
231:Na was used, likely due to the inability of 231:Na to dissolve and disperse through the solvent.  
Conversely, the EtOH gel could only be obtained when the solid form was used, and no gelation was 
observed upon addition of the concentrated aqueous solution.  Best results were obtained in oxygen 
containing solvents i-PrOH, n-BuOH, THF and 1,4-dioxane, all of which were gelled at a concentration 
of 0.5 wt% making 231:Na a supergelator. 
Formation of aggregates was initially observed in several solvents, namely acetone, EtOAc, MeCN, 
CHCl3 and PhMe, and after careful experimentation, weak gels were observed in acetone and CHCl3.  
Unfortunately, no gels could be formed in EtOAc, MeCN or PhMe despite repeated attempts. 
4.4.1  Analogues of 231:Na 
After the discovery of the potent organogelating ability of 231:Na, a range of analogues were 
synthesised and investigated in order to determine what structural features of 231:Na were 
responsible for its gelating ability.  Two main alterations were considered, (i) the replacement of the 
sodium counterion and (ii) alteration of the sidechain of the incorporated amino acid moiety (Figure 
4-25). 
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Figure 4-25: Modifications of 231:Na 
(i) Counterion modification: Two different kinds of counterions were investigated.  Firstly, other group 
I and II metal counterions were investigated, namely potassium, lithium and calcium.  The potassium 
salt 231:K was isolated in a similar fashion to 231:Na with a triphasic system forming upon treatment 
of an organic solution of 231 with saturated K2CO3.  The lithium salt 231:Li was not as easily isolated 
as the previous two salts, and could only be synthesised by combining a methanolic solution of 231 
with an aqueous solution of LiOH (1 equiv.) and stirring the solution overnight.  Removal of the solvent 
afforded the desired lithium salt in quantitative yield.  Unfortunately, the calcium salt could not be 
prepared, with all attempts to isolate it failing due to the insoluble nature of both the calcium base 
(CaOH2) used as well as the salt, 231:Ca. 
The second class of counterion investigated were organic.  It was hypothesised that replacement of 
the metal salt with an organic counterpart would increase the solubility of the formed salts in organic 
solvents and potentially allow for organogel formation in solvents that could not previously be gelled.  
Carboxylate salts containing four organic counterions (ammonium, tetramethylammonium [TMA] 
tetraethylammonium [TEA], and tetrabutylammonium [TBA]) were prepared in a similar fashion to 
231:Li although the tetraalkylammonium salts were methanol solutions as opposed to aqueous.  It 
was also observed that the tetraalkylammonium salts, especially 231:TEA were quite hygroscopic and 
required rigorous drying before the isolated salt could be tested. 
148 
Once the six salts were isolated and dried, they were evaluated for their organogelating ability against 
the same library of solvents as 231:Na.  Unfortunately, while the organic counterions made the 
subsequent salts highly soluble in organic solvents, no gelation was observed for any of the salts (For 
full results please refer to the paper attached in Appendix A).  Salts containing potassium counterions 
demonstrated some limited organogelating ability, however 231:K was not as effective as 231:Na 
(Table 2). 
Table 3: Full results of the assessment of the organogelating ability of 231:Na, 231:K and 231:Li (minimum gelation 
concentration) 
Solvent 231:Na 231:K 231:Li 
Methanol D D I 
Ethanol Ga
 
(2 wt%) D I 
Isopropanol Ga (0.5 wt%) TGb (2 wt%) I 
n-Butyl Alcohol Ga (0.5 wt%) TGb (2 wt%) I 
1,4-Dioxane Gb (0.5 wt%) A A 
Tetrahydrofuran Gb (0.5 wt%) I D 
Diethyl Ether I I I 
Acetone WGa (1 wt%) A I 
Ethyl Acetate PG A I 
Dimethylformamide D D D 
Dimethyl sulfoxide D D D 
Acetonitrile A I I 
Chloroform WGb (1 wt%) A I 
Dichloromethane S A I 
Toluene A S I 
Pet. Spirits (40-60 °C) I I I 
Heptane I I I 
The potassium salt was capable of forming a gel in both i-PrOH and n-BuOH, but only at 2 wt%, 
meaning that 231:K was not a supergelator, unlike 231:Na.  Additionally, the formed gels were turbid 
(non-transparent), unlike the clear gels observed when using 231:Na (Figure 4-26).  The lithium salt 
was even less effective than the potassium salt, only being able to form a gel-like aggregate in 1,4-
dioxane at 2 wt%, and only if 231:Li was rigorously dried beforehand and extreme care taken during 
handling to avoid the hygroscopic salt from absorbing water. 
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Figure 4-26: A turbid gel formed by 231:K in i-PrOH 
(ii) Sidechain modifications:  A number of amino acids were successfully incorporated into the 
norbornene framework using an analogous method as for 231:Na (however an extra equivalent of 
NEt3 was required to synthesise tyrosine containing compound 260) and the corresponding sodium 
salts were isolated.  It was noted that, while both the tyrosine and tryptophan functionalised 
norbornene salts were capable of forming aqueous biphasic systems, none of the salts were capable 
of inducing gelation in any of the tested solvents (For full results please refer to the paper attached in 
Appendix A).  Another analogue incorporating a pseudo amino acid, 4-aminobenzoic acid, similarly 
failed to elicit gelation in any organic solvent. 
4.4.2  Characterisation of the organogels 
Rheology and DSC Characterisation 
All organogels that were capable of passing the six hour inversion test were characterised using 
rheology and DSC, the results for a 1 wt% i-PrOH gel formed using 231:Na are shown in Figure 4-27.  
All gels demonstrated a higher G’ value than G’’ across the sweep of the experiment, an essential 
characteristic required for classification as an organogel.  For full characterisation results, please refer 
to the paper attached in Appendix A.  An additional rheological test, also shown in Figure 4-27, 
demonstrates the reversibility of the organogel as the gel was able to reform within 50 seconds after 
being subjected to sufficient shear strain to break the gel network. 
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Figure 4-27: Rheological and DSC characterisation of a 1 wt% i-PrOH gel formed from 231:Na (middle figure: rheology 
performed at a fixed strain of 1 Hz, bottom figure: theology performed from 0.01-100 % strain) 
No clear trend was apparent between the solvent gelled and the subsequent rheological strength of 
the gels (Table 4).  An increased G’ value was observed from the EtOH gel to the i-PrOH gel, however, 
when tested, the n-BuOH gel demonstrated a weaker G’ value than the i-PrOH gel.  The 1,4-dioxane 
gel demonstrated the strongest G’ value across all tested samples despite reporting one of the lowest 
yield strain values (σ*).  It was also noted that the gels formed by 231:K displayed a higher yield strain 
value than the corresponding 231:Na gels, meaning more force is required to break the 
supramolecular network of the 231:K gels than the 231:Na gels.  However, this effect can be 
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somewhat explained by the rapid formation of the gels by the 231:Na salt, whereby the rapid solvent 
immobilization prevents the networks from forming as strongly as those of the 231:K gels. 
Table 4: Dynamic rheology of 231:K and 231:Na (performed at a fixed strain of 1 Hz) 
Gel (wt%)/solvent G’ (Pa) 
Stiffness 
(G’/G’’) 
Pa)
231:K (2%)/i-PrOH 1.4×104 6.2 9.4% 
231:K (2%)/n-BuOH 7.3×104 7.3 9.8% 
231:Na (2%)/EtOH 6.9×103 7.7 5.6% 
231:Na (1%)/i-PrOH 3.8×104 7.6 7.5% 
231:Na (2%)/i-PrOH 1.1×105 10.1 15% 
231:Na (2%)/n-BuOH 2×104 3.8 8.6% 
231:Na (2%)/1,4-Dioxane 1.2×105 4.8 4.4% 
231:Na/CHCl3 1.6×104 4.6 4.5% 
While solvent choice does not directly correlate to the rheological properties of the gels, it does 
however appear that the solvent indirectly controls these properties through its effect upon the 
supramolecular network, as observed through SEM imaging (see below).  The gels formed by 231:K, 
as well as the gel formed by 231:Na in n-BuOH, demonstrated intertwined networks characteristic of 
organogels.  As a result, these three gels demonstrated high yield strain values than gels that did not 
display such a network.  While the 231:Na gel formed in i-PrOH did not display an intertwined network, 
evidence towards such a network (discussed in Section 4.4.3 Crystal structure and the assembly 
process) is supported by the high yield strain value (5% stronger than any other gel). 
The Tgel of all gels was around 25 °C lower than the boiling point of the solvent used and complete DSC 
results for gels formed by 231:Na and 231:K are displayed in Table 2. 
Table 5: Complete DSC results for all obtained organogels 
Gel (wt%)/solvent Sol-gel transition point (°C) 
231:K (1%)/i-PrOH 59 
231:K (1%)/n-BuOH 54 
231:Na (2%)/EtOH 48 
231:Na (1%)/i-PrOH 56 
231:Na (1%)/n-BuOH 58 
231:Na (1%)/1,4-Dioxane 73 
231:Na (1%)/THF  29 
231:Na (1%)/Acetone 32 
 
SEM Imaging 
The gels were also visualised using SEM imaging, by placing approximately 10 μL of the gelled solvent 
onto a silica wafer and spreading the sample into a thin film.  The film was left to dry for 12 hours 
before being completely dried under vacuum for 2 hours.  Finally, the resultant xerogel samples were 
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coated with gold by sputter coating.584  The SEM images of gels formed in solvents such as n-BuOH by 
both 231:Na (Figure 4-28) and 231:K (Figure 4-29) showed a fibrillar network, typical for SEM imaging 
of xerogels.543   
 
Figure 4-28: SEM analysis of a n-BuOH gel formed by 231:Na (1 wt%) 
 
 
 
Figure 4-29:  SEM analysis of a n-BuOH gel formed by 231:K (2 wt%) 
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However, when a 1 wt% i-PrOH gel formed by 231:Na was investigated via SEM (Figure 4-30), no sign 
of a fibrillar network was observed.  Instead, a fine mat-like residue was left behind, made of small 
fine needle-like fibrils, much smaller and thinner than the entangled fibrils observed in Figure 4-29. 
 
Figure 4-30: SEM analysis of a i-PrOH gel formed by 231:Na (1 wt%) 
The SEM sample preparation of the i-PrOH gel was repeated using a larger sample of gel (30 μL) in 
order to maximise the likelihood of a fibrillar network being observed.  However, instead of the 
expected fibrillar network, unusual hollow structures were observed (Figure 4-31).  These hollow 
structures appear to adopt a variety of sizes and conformations, with tubes ranging from cylindrical 
to octahedral with the larger tubes being the most clearly multi-faceted.   
 
Figure 4-31: SEM analysis of a larger sample of an i-PrOH gel formed by 231:Na (1 wt%) 
These hollow structures are quite rare in the literature, with only a few references available.  A 2015 
paper by the Hardie group reported a similar structure formed by the crystallisation of a copper:(±)-
tris(iso-nicotinoyl)cyclotriguaiacylene complex (Figure 4-32).585  It was proposed by the researchers 
that these hollow tubes were formed as a result of localised dissolution-recrystallization process, 
something that would seem unlikely in the case of 231:Na due to its low solubility in i-PrOH. 
154 
 
Figure 4-32: From left to right: Ligand 262, the Cu6:L6 macrocycle and the hollow tubular structures observed through 
SEM.  (Figures reproduced with permission from ref. 348) 
Another example of hexagonal microtubes visualised via SEM was reported by the Li group, who 
investigated the assembly of diphenylalanine 263 (Figure 4-33).586  This compound is especially 
relevant to this work as it bears a large degree of structural similarity to 231:Na, possessing two 
aromatic residues orientated away from a hydrophilic section.  The method of assembly of the hollow 
hexagonal tubes was attributed to the assembly of smaller nanotubes which spontaneously assemble 
into a helical structure.   
 
Figure 4-33: Left) Diphenylalanine 263 and crystal structure showing a similar conformation to that observed for 231:Na.  
Right) Hollow tubular structures observed using SEM imaging. (Figures reproduced with permission from ref. 570 
No results can be found on the formation of hollow tubular structures directly from the xerogel 
obtained from an organogel sample.  Instead, most previous research appears to use the organogel 
as a template for the assembly of hollow titanium or silica fibres, which can be obtained through 
annealing the organogelator molecule.587-590 
A number of other methods have been proposed for the formation of hollow tubular structures of 
organic compounds, such as preferential dissolution of the centre of solid rod-like crystals,586 
dissolution-recrystallization processes,591-593 solvent-solvate exchange,593 the rolling up of layered 
crystals594 or controlled crystal growth processes.585,595,596  As yet, none of these methods can be 
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confidently assigned as the driving force behind the assembly of the hollow tubes observed from 
231:Na which appears strongly dependent upon solvent choice as well as the counter cation used. 
No other combination of gelator and solvent was capable of producing these hollow tubular 
structures.  For full SEM analysis of all organogels please refer to the paper attached in Appendix A.  
Special mention needs to be made, however, of the SEM images produced from the gel formed by 
231:Li in 1,4-Dioxane.  It was observed that, as opposed to any fibrous structures, small hexagonal 
microcrystals were apparent, although these hexagonal crystals were solid, unlike the hollow 
structures shown in Figure 4-31 (Figure 4-34). 
 
Figure 4-34: SEM analysis of a 1,4-Dioxane gel of 231:Li (2 wt%) 
 
4.4.3  Crystal structure and the assembly process 
It was observed over a period of several weeks that long, extremely fine, needle-like crystals started 
to form in the 1 wt% 231:Na 1,4-dioxane gel (Figure 4-35).  After approximately two months 
crystallisation was complete and the gel network completely collapsed resulting in the solvent once 
again becoming free flowing.  This crystallisation process could be greatly sped up by facilitating 
solvent evaporation (removal of vial cap), which resulted in the crystallisation process occurring over 
a timeframe of days rather than weeks/months, and similar crystallisation was also observed in gels 
formed in THF and i-PrOH. 
  
Figure 4-35: Partial and complete crystallisation observed in a 1,4-dioxane gel (1 wt% 231:Na) 
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A crystal structure was successfully obtained from the thin needles formed in the i-PrOH gel and 
several interesting features were identified (Figure 4-36).  It was observed that one molecule of 
deprotonated 231 had one unique coordinating sodium counterion.  Interestingly, the sodium cation 
possessed an irregular six-coordinate geometry with four coordination sites being occupied by the 
carboxylate groups (two to the unit molecule of 231, and one each to two neighbouring molecules), 
one being occupied by a water molecule (omitted for clarity) and one site coordinated by the imide 
oxygen syn to the chiral centre. 
 
Figure 4-36: Crystal structure of 231:Na 
The coordination between the sodium cation and the imide oxygen as well as the neighbouring 
carboxylate moieties result in each sodium cation coordinating to three different molecules.  This 
assembly results in the formation of long chains, which intertwine into triple helix to form tubular 
assemblies (Figure 4-37).  The tubular assembly is amphiphilic in nature, with the norbornene and 
aromatic ring moieties facing outwards towards the organic solvent and the carboxylate moieties 
associating on the inside of the tubular assemblies along with the water molecule.  The helical tubes 
assemble tightly together with no apparent pores or voids.  The resultant helix has a pitch of 19.8 Å 
and a diameter of 19.6 Å, with 6 monomer residues per complete turn, resulting in a hexagonal 
assembly.  Each additional monomer therefore represents a 60° turn in the helix and a 3.2 Å translation 
along the helical axis. 
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Figure 4-37: The helical tubular structures formed by the assembly of 231:Na 
In order to determine the importance of chirality upon the assembly process, the (R) enantiomer of 
231:Na, was synthesised using D-phenylalanine.  As expected, (R)231:Na behaved identically to 
(S)231:Na in all respects, including formation of an aqueous biphasic system and organogelating 
ability.  A crystal structure was obtained in an identical fashion to (S)231:Na and revealed that, as 
expected, (R)231:Na had an identical crystal structure to (S)231:Na, albeit with a mirror image 
relationship (Figure 4-38).  Further investigation revealed that the tubular helical assemblies also 
possessed a mirror image relationship to that formed by (S)231:Na. 
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Figure 4-38: Comparison of the crystal structure and helical assemblies formed by (S)231:Na (left) and (R)231:Na (right) 
It was also noted that the aromatic ring of the phenylalanine moiety was positioned underneath one 
end of the alkene section of the norbornene framework, something that had previously been deduced 
from the 1H NMR spectra discussed in section 3.5.  This provides a strong indication that 231:Na adopts 
a similar conformation in the solid state as it does in solution, and therefore, likely also in the gel state.  
As such, it is hypothesised that an assembly process similar to that seen in the crystal structure takes 
place to immobilise the solvent in the gel. 
As previously mentioned when discussing the formation of the aqueous biphasic system by 231:Na, 
the assembly of the individual molecules into a supramolecular polymer that promotes phase 
separation was determined the most likely explanation.  The formation of this supramolecular 
polymer is neatly explained by the aforementioned helical assembly process and the ability of 231:Na 
to maintain the assembly process while completely solvated demonstrates both the strength and 
favourability of the process as well as the poor solvation and subsequent strongly chaotropic nature 
of the salt. 
A racemic mixture was prepared, both by using a 1:1 mix of D- and L-phenylalanine in the synthesis of 
231 and by combining equimolar amounts of (S)231:Na and (R)231:Na.  In both instances, no sign of 
gelation was observed and forming concentrated aqueous solutions (> 3M) of racemic 231:Na resulted 
in precipitation, despite being a clear solution when heated.  The failure of the racemic mix to induce 
gelation underlines the importance of chirality and structure in the assembly of fibrils and subsequent 
gel formation. 
While 231:TEA did not induce gelation in any of the tested solvents, a crystal suitable for X-ray analysis 
was obtained from THF and upon analysis, showed a marked difference to that of 231:Na, with no 
helical assembly observed.  This is primarily due to the TEA counterion which is much more loosely 
bound than the sodium cation, and does not coordinate to adjacent molecules (Figure 4-39).  Instead, 
a “water-mediated ribbon” was observed in the expanded crystal structure with cyclic tetramers of 
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water being linked by two molecules of 231:TEA.  The TEA cations do not assist in the assembly 
process, but instead lie above the plane of the ribbon and have been omitted for clarity. 
 
Figure 4-39: The crystal structure of 231:TEA and the ribbon assembly observed in the expanded crystal structure 
 
4.5  Summary 
A small ionic phenylalanine-functionalised norbornene 231:Na has been discovered to form ABSs 
when mixed with kosmotropic salts at high concentrations (> 5 M).  Concentrated aqueous solutions 
(> 2 g/mL) of 231:Na were also found to form hydrogels, believed to be the result of a supramolecular 
polymer formation.  During characterisation of the ABS, 231:Na was found to possess gelating abilities 
in a range of organic solvents at concentrations as low as 0.5 wt%.  During characterisation of the gel, 
unusual hollow hexagonal crystals were observed in an i-PrOH xerogel. 
 
4.6  Future work 
More in-depth investigations into the aqueous biphasic system formed by 231:Na and kosmotropic 
salts are required as well as comparisons between the aqueous biphasic systems formed by 231:Na 
and 231:K.  As discussed in section 4.1, aqueous biphasic systems have applications in a range of 
separations and purifications, ranging from peptide and protein purification to removal of heavy 
metals from waste water.  The synthesis of 231:Na is simple and cheap, and also amenable to large 
scale synthetic techniques, making this compound an attractive candidate for further investigation 
into these fields.  Additionally, the suspected supramolecular polymer formed by 231:Na in water 
requires further investigation and characterisation in order to understand its potential applications in 
fields such as protein and enzyme extraction and metal remediation. 
Further study into the exact method of the assembly of 231:Na into fibrils and subsequent formation 
into hollow nanotubes is also required.  Techniques such as Small-Angle Neutron Scattering, Small-
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Angle X-ray Scattering and AFM could all provide information relating to the formation of the 3-
Dimensional gel network.  Additionally, in-depth study through TEM techniques, especially cryo-TEM 
are also required. 
A more in-depth understanding of the method of assembly of 231:Na in hollow tubes could result in 
the ability to control the growth and size of the nanotubes.  Nanotubes are of interest for applications 
in fields such as inclusion chemistry, catalysis and molecular electronics and it is anticipated that being 
able to control the growth of the hollow nanotubes formed by 231:Na could enable exciting new 
research possibilities in these areas.597,598 
Finally, positive early results have been obtained by combining the works of chapters 2 and 4.  A series 
of 1 wt% i-PrOH gels using 231:Na were formed and doped with a variety of dyes (Figure 4-40).  
Complete diffusion of the dyes throughout the gels was observed within 1-2 days.  Addition of a slurry 
of host 185:Zn(II)2 to the doped gels resulted in a clear colour change occurring as the host diffused 
through the gel.  Interestingly, it was noted that, while both the dye and host 185:Zn(II)2 were both 
capable of diffusing entirely through the gel, the gel:dye complex, once formed, was no longer capable 
of diffusion as evidenced by the failure of the gel:dye complex to permeate the entirety of the gel.  
Addition of ppi to gel resulted in gel breakdown, indicating that ppi is unable to diffuse through the i-
PrOH gel.  The ability of the gels formed by 231:Na to allow for the diffusion of small molecules 
throughout the gels could allow for possible applications in drug delivery and diagnostics (for instance, 
application of a doped gel to a surface, followed by gel breakdown upon exposure to moisture, could 
result in a controlled release vehicle for drugs or therapeutics), however more work is needed to 
determine the tolerance of the gels to small anionic molecules such as ppi. 
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Figure 4-40: Diffusion of Pyrogallol Red throughout a 1 wt% i-PrOH gel (231:Na) and subsequent formation of 
185:Zn(II)2:Pyrogallol Red complex 
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5. Conclusion 
 
In this work, aqueous applications of norbornenes and fused [n]polynorbornanes in supramolecular 
chemistry were investigated.  The ability to functionalise these scaffolds with a range of functional 
groups makes them attractive for supramolecular explorations with metals and as such, three facets 
of research were pursued in which metals were combined with norbornylogous frameworks, i) anion 
binding through zinc:dipicolylamino binding units, ii) coordination complex formation using 
polynorbornane dicarboxylate ligands and a range of transition metals (Zn, Fe, Cu, Co and Ni) and iii) 
a norbornane based ionic organogelator that required sodium to elicit gel formation. 
 
A family of fused [n]polynorbornanes functionalised with bis-Zn(II):dipicolylamino binding groups 
were synthesised and investigated for their anion binding abilities. Next the hosts were investigated 
for their ability to function as indicator displacement assays through the incorporation of colorimetric 
and fluorescent dyes.  A strong response to pyrophosphate and weak responses to citrate, ADP and 
ATP were observed when these anions were tested against the assay.  While the precise interactions 
of ppi with the hosts is not yet fully understood, owing to an apparent complicated host:guest 
stoichiometry, the results are a good starting point for more in-depth investigations.  No response was 
seen for the other assessed anions (phosphate, sulphate, carbonate, acetate, terephthalate and AMP.  
Pleasingly, the IDAs were water soluble and were able to function in buffered aqueous solutions 
clearly indicating their potential to function in biological systems. 
 
The ability of fused [n]polynorbornanes to act as ligands for metals was investigated by the 
development of a family of bis-amino acid functionalised [5]polynorbornanes.  These ditopic ligands 
were investigated for their ability to form larger complexes when combined with a range of transition 
metals.  The formation of a M2L2 metallocycle demonstrated that these frameworks are well suited as 
ligands for the formation of metal-organic complexes.  However, the curvature of [5]polynorbornane 
framework appeared to favour the formation of 1:1 complexes, and so a larger, more linear framework 
will need to be investigated.  Pleasingly, most of the ligands showed good solubility in aqueous 
solutions. 
 
During the above study, a phenylalanine functionalised norbornene was synthesised and found to 
possess several interesting properties when investigated as its sodium salt.  The salt was found to form 
aqueous biphasic systems when mixed at high concentration with kosmotropic salts.  Additionally, the 
phenylalanine-based salt was found to be extremely soluble in water, believed to be caused by the 
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formation of a supramolecular polymer.  The formation of a 3 g/mL solution was accomplished by the 
application of heat, and the compound appeared to stay in solution indefinitely, with no sign of 
precipitation/crystallisation, even after a 12 month period.  Finally, the salt was found to be a potent 
organogelator, capable of gelling several organic solvents at concentrations as lows as 0.5 wt%.  During 
characterisation of the organogels, unusual hollow hexagonal microcrystalline structures were 
observed using SEM as well as an interesting sodium-mediated helical assembly in the crystal 
structure.     
 
All three projects resulted in the synthesis of water-soluble norbornene or polynorbornane 
frameworks through the complexation with metal ions and demonstrate the potential of 
norbornylogous frameworks for the development of aqueous-based supramolecular applications. 
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6. Experimental 
6.1 General experimental data 
6.1.1 Instrumentation 
All 1H NMR and 13C NMR spectra were recorded on either a JEOL JNM-EX 270 MHz FT-NMR, a JEOL 
JNM-Eclipse+ 400 MHz FT-NMR or a Bruker AVANCE III 500 MHz FT-NMR as indicated.  Samples were 
dissolved in either deuterated chloroform (CDCl3), deuterated DMSO (DMSO-d6), deuterated water 
(D2O) or deuterated acetonitrile (CD3CN) and the relevant solvent peaks (CDCl3: δH 7.26 ppm; DMSO-
d6: δH 2.50 ppm, D2O: δH 4.80 ppm, CD3CN: δH 1.94 ppm) used as an internal reference.  The template 
for reporting proton spectra is as follows: chemical shift δ (ppm), (integral, multiplicity (s = singlet, br 
s = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant J (Hz), 
assignment). 
All mass spectral and high resolution mass spectral data was collected on an Agilent Technologies 
LC/MSD TOF mass spectrometer, an Applied Biosystems QTOF-MS, or an AB SCIEX TripleTOF 5600 
MS under the following conditions: gas temperature (350 °C), vaporiser (28 °C), nitrogen drying gas 
(7.0 L/min), capillary voltage (3.0 kV), cone voltage (40 V), and nebuliser (15 psi). Analyte solutions 
were prepared in HPLC grade acetonitrile or methanol (conc. ~1 nM). 
All microwave reactions were performed using a CEM Discover S-Class Explorer 48 Microwave reactor, 
with an operational frequency of 50–60 Hz and continuous irradiation power ranging from 0–300W.  
All reactions were performed in either a 10 mL or 35 mL vial (as specified) sealed with ‘snap’ caps. 
All specific optical rotations were determined using a Jasco P-2000 polarimeter in acidic MeOH 
(prepared by diluting 200 μL of 37% HCl to 20 mL with MeOH) or DMSO as specified.  A minimum of 3 
concordant results were obtained and averaged in order to calculate the specific optical rotation. 
 
6.1.2 Chromatography 
Column chromatography was performed using silica gel 60 (230–400 mesh). All solvents used were 
Analytical Grade.  Pet.  Spirits refers to the fraction boiling between 40–60°C. 
All thin layer chromatography (TLC) was performed using aluminium-backed Merck TLC Silica gel 60 
F254 plates.  Samples were visualised using 254 nm light and/or potassium permanganate oxidising dip 
(1:1:100 KMnO4:K2CO3:H2O w/w) and/or ninhydrin dip (1.5 g ninhydrin in i-PrOH:AcOH 100:3). 
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6.1.3 Reagents  
Preparation of anhydrous t-BuOOH in PhMe solution was performed from a 70% aqueous solution 
according to the method of Sharpless.599  Distillation of commercially provided DMAD was 
accomplished using a Kugelrohr short path vacuum distillation apparatus at 70 °C at 5 mbar.  
Sublimation of commercially provided t-BuOK was achieved using a cold finger apparatus under 
vacuum at 220 °C at 2 mbar.  The ruthenium catalyst for the Mitsudo reaction, RuH2(CO)(PPh3)3, was 
prepared following the method of Ahmad et al.600  All other specialist reagents were obtained from 
commercial suppliers and used without further purification.* 
 
6.1.4 Nomenclature 
All norbornane and fused [n]polynorbornane-based compounds are named according to the Von-
Baeyer system of nomenclature as (multiplier)cyclo[X,Y,Z]hydrocarbon where X ≥ Y > Z > 0.198  The 
stereodescriptors syn/anti are used to refer to substituents on the Z bridge that are located on the 
same/opposite side as the X bridge.  The stereodescriptors α/β are used to refer to the configuration 
of substituents on the X and Y bridges.601 The norbornane system is numbered to allow for the longest 
possible chain before numbering bridges. An example is shown with (1α,2α,6α,7α)-4-
oxatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione 
 
 
6.1.5 1H NMR Titration method 
All 1H NMR spectroscopy titration experiments were carried out using a JEOL JNM-EX 270 MHz FT-
NMR spectrometer or a Bruker AVANCE III 500 MHz FT-NMR.  All titrations of the bis:DPA 
functionalised frameworks with Zn(NO3)2·6H20 were performed by transferring a 600 µL sample from 
a host stock solution of 2.5 x 10-3 M in DMSO-d6 into a NMR tube.  An initial spectrum was collected 
                                                          
* Unless specified, all solutions used in work ups are aqueous. 
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and the chemical shifts and integrations of the relevant peaks recorded.  Following each addition of 
guest from a stock solution of 3.0 x 10-2 M in DMSO-d6 as detailed in Appendix B, the spectrum was 
taken and the chemical shifts and peak integrations again recorded.  
All titrations of the host:Zn(II)2 complexes with anions were performed by transferring a 600 µL sample 
from a host stock solution of 2.5 x 10-3 M in DMSO-d6:D2O (1:2) into a NMR tube.  Following each 
addition of guest from a stock solution of 3.0 x 10-2 M in DMSO-d6:D2O (1:2) as detailed in Appendix 
B, the spectrum was taken and the chemical shifts and peak integrations were again recorded. 
 
6.1.6 UV-Vis titration method 
The host:indicator UV:Vis titrations were carried out using an Agilent Technologies Cary Series 300 
UV-Vis Spectrophotometer.  The titrations were carried out by transferring 2500 μL of 20 μM indicator 
solution to a cuvette and an initial reading was obtained.  Following the addition of a host solution 
(1020 μM of host with 20 μM indicator) and stirring for 30 seconds, the reading was again taken.  A 
full list of additions is supplied in Appendix C. 
The host:indicator:guest UV:Vis titrations were carried out using an Agilent Technologies Cary Series 
300 UV-Vis Spectrophotometer.  The titrations were carried out by transferring 2500 μL of 20 μM 
host:indicator solution to a cuvette and an initial reading was obtained.  Following the addition of a 
host solution (2020 μM of host with 20 μM host:indicator) and stirring for 30 seconds, the reading was 
again taken.  A full list of additions is supplied in Appendix C. 
 
6.1.7 Fluorescent titration method 
The host:indicator fluorescent titrations were carried out using an Agilent Technologies Cary Eclipse 
Fluorescent Spectrophotometer, with an excitation wavelength of 395 nm and emission scan from 
400 – 700 nm.  The titrations were carried out by transferring 2500 μL of 20 μM indicator solution to 
a cuvette and an initial reading was obtained.  Following the addition of a host solution (1020 μM of 
host with 20 μM indicator) and stirring for 30 seconds, the reading was again taken.  A full list of 
additions is supplied in Appendix C. 
The host:indicator:guest fluorescent titrations were carried out using an Agilent Technologies Cary 
Eclipse Fluorescent Spectrophotometer, with an excitation wavelength of 395 nm and emission scan 
from 400 – 700 nm.  The titrations were carried out by transferring 2500 μL of 20 μM host:indicator 
solution to a cuvette and an initial reading was obtained.  Following the addition of a guest solution 
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(2020 μM of host with 20 μM host:indicator) and stirring for 30 seconds, the reading was again taken.  
A full list of additions is supplied in Appendix C. 
6.2 Chapter 2  
Carbonyldihydrotris(triphenylphosphine)ruthenium(II)600 (82) 
 
To a refluxing solution of triphenylphosphine (25.1 g, 95.8 mmol) in ethanol (1.12 L) was added a 
solution of ruthenium trichloride (4.2 g, 20 mmol) in ethanol (160 mL), a solution of potassium 
hydroxide (4.8 g, 85.6 mmol) in ethanol (160 mL) and 40% formaldehyde in H2O (160 mL, 0.4 mmol).  
The solution was stirred under reflux for 15 minutes before being allowed to cool.  The precipitate 
was collected via vacuum filtration and washed with EtOH (1 × 25 mL), H2O (1 × 25 mL), EtOH (1 × 
25 mL) and Pet. Spirits (1 × 25 mL) to afford 9.49 g (63%) of the desired compound as a dark grey 
powder. 
mp: > 170 °C (decomp.) (lit. 161–163 °C )600; 
1H NMR (270 MHz; CDCl3): δ 6.85-7.23 (45H, m, 9 × Ph), -6.89 (1H, tdd, J = 30.5, 15.0, 6.3 Hz, Hb), -8.85 
(1H, dtd, J = 33.7, 18.2, 6.3 Hz, Ha); 
13C NMR (100 MHz; CDCl3): δ 206.0, 138.9 (td, J = 20.8, 2.5 Hz), 132.8, 127.3, 126.2; 
31P NMR (500 MHz; CDCl3): 57.1, 44.6; 
m/z (ESI): 918.19 (C55H47OP3Ru M requires 918.18); 
 
(1α,2α,6α,7α)-4-Oxatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione202 (70) 
 
In a 50 mL round-bottomed flask, maleic anhydride 68 (14.96 g, 152.6 mmol) was dissolved in a 1:1 
solution of EtOAc:Pet. Spirits (65 mL).  The solution was cooled to 0 °C before cyclopentadiene 69 (15 
mL, 178 mmol) was added dropwise via syringe.  The reaction was stirred for 2 h whilst slowly warming 
to 21 °C, during which time a white precipitate was formed.  The flask was then heated in order to 
dissolve the precipitate before being allowed to sit undisturbed for 12 h.  The long opaque crystals 
that formed were collected by vacuum filtration.  The filtrate was collected and the solvent was 
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removed and the remaining solid was recrystallised from hot EtOAc and minimum Pet. Spirits to afford 
a second crop of product (total yield 21.34 g, 85%). 
mp: 163.1–164.5 °C (Lit. 164–165 °C)202;  
1H NMR (270 MHz; CDCl3): δ 6.30 (2H, t, J = 2.0 Hz, H8,9), 3.55-3.60 (2H, m, H2,6)*, 3.47-3.53 (2H, m, 
H1,7), 1.76 (1H, t, J = 9.2 Hz, H10a), 1.58 (1H, d, J = 8.9 Hz, H10s); 
13C NMR (67.5 MHz; CDCl3): δ 171.0, 135.6, 52.9, 47.1, 46.2; 
HRMS m/z (ESI): 165.0519 (C9H9O3 [M + H]+ requires 165.0546);  
* Due to complex splitting patterns, not all coupling constants could be accurately determined.  All 
spectra are in accordance with those previously reported in the literature. 
 
tert-Butyl-N-(2-aminoethyl) carbamate602 (198) 
 
A solution of ethylene diamine 196 (12.4 mL, 185 mmol) in THF (50 mL) was cooled in an ice bath.  A 
solution of di-tert-butyl decarbonate 197 (10.7 g, 49.0 mmol) in THF (50 mL) was then added in a 
dropwise manner over a 20 min period.  The ice bath was removed and the reaction left to stir for 
17 h during which time, a white precipitate formed.  The precipitate was dissolved by addition of 
EtOAc (30 mL) and the solvent was removed under reduced pressure to afford the desired compound 
as a clear, viscous oil (7.5 g, 97%). 
1H NMR (270 MHz; CDCl3): δ 5.08 (1H, br s, NH), 3.14 (2H, q, J = 5.9 Hz, CH2NH2), 2.75 (2H, t, J = 6.1 Hz, 
CH2NH), 1.72 (2H, s, NH2), 1.39 (9H, s, t-Bu); 
13C NMR (67.5 MHz; CDCl3): δ 171.4, 135.6, 52.9, 47.2, 46.2, 31.1; 
HRMS m/z (ESI): 161.1306 (C7H17N2O2 [M + H]+ requires 161.1285); 
 
(1α,2α,6α,7α)-4-(2’-(tert-Butoxycarbonylamino)ethyl)-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-
dione205 (190) 
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A solution of anhydride 70 (3.62 g, 22.0 mmol), amine 198 (6.00 g, 37.4 mmol) and PhMe (22 mL) was 
combined in a 35 mL microwave vial containing a magnetic stirrer bar and subjected to microwave 
irradiation at 100 °C for 30 mins.  The reaction vial was then allowed to cool before the contents were 
transferred to a separatory funnel.  The organic layer was washed with brine (5 × 15 mL) and the 
aqueous portion was extracted with CH2CL2 (2 × 15 mL).  The combined organics were washed with 
2M HCl (2 × 15mL) and Na2CO3 (2 × 10 mL) before being dried (MgSO4), filtered and the solvent 
removed under reduced pressure to yield the crude product.  The crude material was recrystallised 
from hot EtOAc and minimum Pet Sp. to give pure white crystals that were collected by means of 
vacuum filtration (4.84 g, 72%). 
mp: 127.7–129.1 °C (Lit 129.2–131.5 °C)205; 
1H NMR (270 MHz; CDCl3): δ 6.10 (2H, s, H8,9), 4.63 (1H, br s, NH), 3.49 (2H, m, CH2N(CO)2), 3.35-3.39 
(2H, m, H2,6), 3.26 (2H, m, H1,7), 3.22-3.28 (2H, m, CH2NH), 1.71 (1H, d, J = 9.2 Hz, H10a), 1.52 (1H, d, 
J = 8.9 Hz, H10s), 1.41 (9H, s, t-Bu); 
13C NMR (100 MHz; CDCl3): δ 177.9, 155.8, 134.6, 79.5, 52.3, 45.9, 45.0, 39.3, 37.9, 28.4; 
m/z (ESI): 329.15 (C16H22N2O4Na [M + Na]+ requires 329.15); 
 
Dimethyl (1α,2α,6α,7α,8β,11β)-3,5-dioxo-4-(2’-(tert-butoxycarbonylamino)ethyl)-4-azatetracyclo 
[5.4.1.02,6.08,11]dodeca-9-ene9,10-dicarboxylate205 (191) 
 
In a 35 mL microwave vial containing a magnetic stirrer bar, imide 190 (500 mg, 1.65 mmol), DMAD 
84 (0.50 mL, 4.10 mmol), RuH2(CO)(PPh3)3 82 (150 mg, 0.15 mmol) and DMF (2.5 mL) were combined.  
The reaction mix was then heated to 100 °C for 2 min.  After this time, the solution was cooled and 
then passed through a silica plug using 1:1 EtoAc:Pet. Spirits as the eluent (Rf = 0.31) and the solvent 
removed under reduced pressure.  The crude product was then purified using column 
chromotography (EtOAc:Pet. Spirits 1:1, Rf = 0.31).  The desired fractions were combined and the 
solvent removed under reduced pressure to afford the title compound as a white powder (530 mg, 
72%). 
mp: 156.3–157.6 °C (Lit 152.6–153.9 °C)205; 
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1H NMR (270 MHz; CDCl3): δ 4.70 (1H, s, NH), 3.76 (6H, s, 2 × OMe), 3.57-3.61 (2H, m, CH2N(CO)2), 
3.30-3.33 (2H, m, CH2NH), 3.23 (2H, s, H2,6), 2.83 (2H, s, H1,7), 2.79 (2H, s, H8,11), 1.72 (1H, d, J = 11.6 
Hz, H12a), 1.49 (1H, d, J = 11.1 Hz, H12s), 1.37 (9H, s, t-Bu);  
13C NMR (100 MHz; CDCl3): δ 177.0, 160.7, 156.0, 141.3, 79.7, 52.1, 47.6, 42.5, 39.1, 38.3, 36.1, 34.4, 
28.4; 
m/z (ESI): 471.19 (C22H28N2O8Na [M + Na]+ requires 471.17); 
 
Dimethyl (1α,2β,3α,5α,6β,7α,8α,12α)-9,11-dioxo-10-(2’-(tert-butoxycarbonylamino)ethyl)-4-oxa-
10-aza-pentacyclo[5.5.1.02,6.03,5.08,12]tridecane-3,5-dicarboxylate205 (189) 
 
A solution of anhydrous THF (100 mL) containing diester 191 (500 mg, 1.12 mmol) was cooled to 0 °C 
before anhydrous t-BuOOH (1.25 mL, 3.78 M, 4.10 mmol) was added.  After 10 min, NaOtBu* (20 mg, 
0.21 mmol) was then added and the solution stirred vigorously for a further 10 min, after which time, 
the solution was removed from the ice and left to stir at room temperature for 48 h.  An aqueous 
solution of 10% sodium thiosulfate (10 mL) was added and the solution was left to stir for 30 min.  The 
reaction mixture was concentrated to one third of its original volume under reduced pressure.  The 
mixture was transferred to a separatory funnel and extracted with chloroform (4 × 25 mL).  The organic 
layers were combined, dried (MgSO4), filtered and the solvent removed under reduced pressure to 
yield a white residue.  The crude material was recrystallised from hot EtOAc and minimum Pet. Spirits 
to yield the desired product as white crystals (270 mg, 52%). 
mp: 179.5–182.3 °C (Lit 191.2–192.7 °C);205 
1H NMR (270 MHz; CDCl3): δ 4.71 (1H, s, NH), 3.78 (6H, s, 2 × OMe), 3.53 (2H, m, CH2N(CO2)2), 3.32 
(2H, m, CH2NH), 3.24 (2H, s, H2,6), 3.16 (2H, s, H1,7), 2.36 (2H, s, H8,12), 2.10 (2H, d, J = 8.3 Hz, H13a), 
1.73 (1H, d, J = 8.4 Hz, H13s), 1.39 (9H, s, t-Bu); 
13C NMR (100 MHz; CDCl3): δ 176.7, 163.9, 156.0, 79.7, 63.6, 53.0, 47.7, 45.8, 39.0, 38.8, 38.6, 37.0, 
28.4; 
m/z (ESI): 487.18 (C22H28N2O9Na [M + Na]+ requires 487.17); 
                                                          
* KOtBu can also be employed in this reaction. 
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Tetramethyl tetracyclo[4.4.1.02,5.07,10]undeca-3,8-diene-3,4,8,9-tetracarboxylate603 (193) 
 
In a pressure vessel containing a magnetic stirrer bar, quadricyclane 62 (2.1 mL, 22 mmol), DMAD 84 
(3.0 mL, 24 mmol) and DMF (5.0 mL) were combined.  The vessel was sealed and heated at 110 °C for 
4 h.  After this time, additional 195 (3.5 mL, 28 mmol), RuH2(CO)(PPh3)3 82 (160 mg, 0.18 mmol) and 
DMF (3.0 mL) was also added.  The vessel was resealed and heated at 100 °C for 4 days.  The vessel 
was then allowed to cool.  The tube was unsealed and the crystals was collected by vacuum filtration 
and washed with DMF to afford the desired product as yellow crystals (2.65 g).  The filtrate was then 
collected and the DMF was removed in vacuo.  The resulting solid was dissolved in hot methanol and 
cooled to room temperature before being placed on ice.  The solution was allowed to sit overnight 
and the resultant crystals again collected.  The crystals were washed with MeOH (1 × 25 mL) and 
allowed to dry giving yellow crystals (4.35 g) in a combined yield of 7.00 g (83%)  
mp: 135.9–137.1°C (Lit 142–143 °C)603; 
1H NMR (270 MHz; CDCl3): δ 3.77 (12H, s, 4 × OMe), 2.74 (4H, s, H2,5,7,10), 2.41 (2H, s, H1,6), 1.35 
(2H, s, H11); 
13C NMR (67.5 MHz; CDCl3): δ 161.4, 142.6, 52.2, 46.1, 31.8, 23.7; 
m/z (ESI): 377.12 (C19H21O8 [M + H]+ requires 377.12); 
 
Tetramethyl 4,10-dioxahexacyclo[5.5.1.02,6.03,5.08,12.09,11]trideca-3,5,9,11-tetracarboxylate226 (92) 
 
A solution of anhydrous THF under N2 containing tetraester 193(2.00 g, 5.44 mmol) was cooled to 0 °C 
before anhydrous t-BuOOH (4.5 ml, 3.78 M, 17.0 mmol) was added and the solution stirred for 10 min.  
After this time, t-BuONa (150 mg, 1.56 mmol) was added and the solution was stirred vigorously for a 
further 10 minutes.   The solution was then removed from the ice and left to stir for 12 h at ambient 
temp.   An aqueous solution of 10% sodium thiosulfate (25 mL) was added to quench and the solution 
left to stir for a further 30 min.  Approximately two-thirds of the solvent was removed under reduced 
pressure before the remaining solution was transferred to a separatory flask and extracted with CHCl3 
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(4 × 25 mL).  The organic portions were combined, dried (MgSO4) filtered and the solvent removed 
under reduced pressure.  The resulting solid was triturated using i-PrOH to give the desired compound 
as a white solid (1.23 g, 56%). 
mp: 181.4–183.7 °C (dec.) (Lit 196–198 °C)227; 
1H NMR (270 MHz; CDCl3): δ 3.82 (12H, s, 4 × OMe), 3.28 (4H, s, H2,6,8,12), 2.27 (2H, s, H1,7), 1.90 
(2H, s, H13); 
13C NMR (100 MHz; CDCl3): δ 164.3, 64.4, 52.9, 48.9, 36.5, 28.6; 
m/z (ESI): 431.10 (C19H20O10Na [M + Na]+ requires 431.09); 
 
Dimethyl (1α,2α,3α,4α,7α,8β,9β,10α)-pentacyclo[6.4.0.02,10.03,7.04,9]dodeca-5,11-diene-8,9-
dicarboxylate352 (195) 
 
A 2 L, 2-necked round bottom flask was dried and flushed with nitrogen before being equipped with 
a nitrogen inlet and stirrer bar.  A solution of NaH (60% in mineral oil, 8.8 g, 220 mmol) in anhydrous 
THF (100 mL) was added to the flask and cooled to 0 °C.  A round bottom flask under an inert 
atmosphere was charged with cyclopentadiene 68 (18.6 mL, 221 mmol) in anhydrous THF (50 mL) and 
cooled to -95 °C.  The cyclopentadiene was transferred via cannula into the NaH solution over a 90 
minute period in order to avoid excess foaming.  The solution was then stirred at 21 °C for an hour 
before being cooled to -95 °C.  A solution of iodine (27.8 g, 109 mmol) was dissolved in anhydrous THF 
(50 mL) and added dropwise over a 90 minute period.  The solution was stirred for 10 minutes at -95 
°C before a rapid dropwise addition of DMAD 84 (15.6 mL, 127 mmol).  The solution was stirred at -95 
°C for 30 minutes and then at 21 °C for 4 hours.  The solution was then filtered through celite and 
concentrated in vacuo at 21 °C.  The reaction mixture was taken up in diethyl ether (100 mL) and 
stirred for 15 minutes before being filtered through celite and concentrated in vacuo at 21 °C.  The 
reaction mixture was dissolved in MeOH (100 mL), fitted with a thermometer and cooled to -12 °C 
before a cold solution of KOH (10 g dissolved in 20 mL H2O) was added dropwise, taking care to keep 
the temperature of the reaction under 0 °C.  The reaction was then stirred for 2 h at 0 °C and then a 
further 1 h at 21 °C before being filtered through celite.  The solution was concentrated in vacuo at 21 
°C and extracted with Pet. Spirits (6 × 60 mL).  The organics were combined and concentrated in vacuo 
at 21 °C before being washed with saturated Na2S2O3 (1 × 80 mL) and brine (1 × 100 mL).  The organics 
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were dried and concentrated in vacuo at 21 °C before being purified by column chromatography 
(EtOAc:Pet. Spirits 1:3, Rf = 0.35) to afford the desired compound as a yellow oil (1.25 g, 4.2%) 
1H NMR (270 MHz; CDCl3): δ 6.00 – 5.88 (m, 4H, H5,6,11,12)*, 3.48 (s, 6H, 2 × OMe), 3.20 (dd, J = 1.9, 
0.7 Hz, 4H, H1,4,7,10), 2.40 (s, 2H, H2,3); 
13C NMR (67.5 MHz; CDCl3): δ 172.6, 132.6, 69.4, 64.3, 58.8, 51.5; 
HRMS m/z (ESI): 161.1306 (C7H17N2O2 [M + H]+ requires 161.1285); 
* Due to complex splitting patterns, not all coupling constants could be  accurately determined.  All 
spectra are in accordance with those previously reported in the literature. 
 
Dimethyl (1α,2β,3α,4α,8α,9α,10β,11α,12β,13α,14α,18α,19α,20β)-5,7,15,17-tetraoxo-6-16-bis(2’-
(tert-butoxycarbonylamino)ethyl)-21-oxa-6,16-
diazaoctacyclo[9.9.11,11.13,9.113,19.02,10.04,8.012,20.014,18]tricosane -1,11-dicarboxylate217 (188) 
 
 
In a 10 mL microwave vial containing a magnetic stirrer bar, epoxide 189 (200 mg, 0.43 mmol) and 
imide 190 (131.6 mg, 0.43 mmol) were combined with DMF (2 mL) and subjected to microwave 
irradiation at 160 °C for 5 min.  The solvent was removed under reduced pressure before the crude 
was resuspended in EtOAc (20 mL) and washed with H2O (2 × 10 mL).  The organics were then dried 
(MgSO4), filtered and solvent removed under reduced pressure to yield the desired compound as a 
white powder (248 mg, 65%).  
mp: 132.9–137.6 °C (Lit 178 °C (dec.))217;  
1H NMR (400 MHz; DMSO-d6): δ 6.82 (2H, t, br, 2 × NH), 3.80 (6H, s, 2 x OMe), 3.38 (4H, m, 2 × CH2N), 
2.98 (8H, s, 2 × CH2NH and H4,8,14,18), 2.37 (4H, s, H3,9,13,19), 2.26 (2H, s, J = 9.5 Hz, H22a,23a), 1.89 
(4H, s, H2,10,12,20), 1.36 (18H, s, 2 × t-Bu), 1.15 (2H, d, J = 9.5 Hz, H22s,23s); 
13C NMR (100 MHz; DMSO-d6): δ 177.4, 168.4, 156.1, 90.1, 78.4, 53.0, 50.4, 48.1, 40.9, 38.5, 37.6, 37.4, 
28.7; 
HRMS m/z (ESI): 788.3690 (C38H54N5O13 [M + NH4]+ requires 788.3713); 
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Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-
7,9,21,23-tetraoxo-8,22-bis(2’-(tert-butoxycarbonylamino)ethyl)-30,32-dioxa-8,22-
diazadodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate208 (192) 
 
 
In a 10mL microwave vial containing a magnetic stirrer bar, bis–epoxide 92 (200 mg, 0.49 mmol) and 
imide 190 (450 mg, 1.47 mmol) were combined in 2 mL of DMF.  The reaction mixture was then heated 
by microwave irradiation at 140 °C for 30 min.  The mixture was allowed to cool before the solvent 
was removed under reduced pressure.  The crude product was purified by column chromatography 
(EtOAc, Rf = 0.40) to yield a white powder that was then precipitated using a 1:1 EtOAc/Pet. Spirits 
mixture to yield a pure white powder (349 mg, 70%). 
mp: 307.6–309.8 °C (dec.) (Lit >170 °C (slow dec.))208;  
1H NMR (400 MHz; DMSO-d6): δ 6.62 (2H, s, br, 2 × NH), 3.77 (12H, s, 4 x OMe), 3.45 (4H, m, 2 × 
CH2N(CO2)2), 3.03 (4H, m, 2 × CH2NH), 2.98 (4H, s, H6,10,20,24), 2.34 (4H, s, H5,11,19,25), 2.24 (2H, d, 
J = 9.5 Hz, H31a,33a), 2.09 (4H, s, H4,12,18,26), 1.88 (4H, s, H2,14,16,28), 1.74 (2H, s, H1,15), 1.59 (2H, 
s, H29), 1.37 (18H, s, 2 × t-Bu), 1.12 (2H, d, J = 9.5 Hz, H31s,33s); 
13C NMR (100 MHz; DMSO-d6): δ 177.4, 168.8, 156.2, 89.9, 78.5, 54.1, 52.8, 51.0, 48.2, 38.2, 38.1, 37.5, 
28.7; 
m/z (ESI): 1038.47 (C51H68N5O18 [M + NH4]+ requires 1038.46); 
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Hexamethyl 
(1α,2β,3α,4α,5α,6α,7β,8α,9β,10α,11α,15α,16α,17β,18α,19β,20α,21β,22β,23α,24β,25α,26β,27α,2
8α,32α,33α,34β)-12,14,29,31-tetraoxo-8,22-bis(2’-(tert-butoxycarbonylamino)ethyl)-35,37-dioxa-
13,30-
diazapentadecacyclo[23.9.11,25.18,18.110,16.127,33.02,24.03,21.04,23.05,20.06,22.07,19.09,17.011,15.026,34.028,32]oct
atriacontane-1,8,18,21,22,25-hexacarboxylate351 (194) 
 
In a 10 mL microwave vial containing a magnetic stirrer bar, monoepoxide 189 (1.00 g, 2.15 mmol) 
and diene 195 (280 mg, 1.03 mmol) were combined in 4 mL of DMF.  The reaction mixture was then 
heated by microwave irradiation at 150 °C for 15 min.  The mixture was allowed to cool before the 
solvent was removed under reduced pressure.  The crude product was purified by column 
chromatography (EtOAc, Rf = 0.35) to yield a white powder that was then precipitated using a 1:1 
EtOAc/Pet. Spirits mixture to yield a pure white powder (750 mg, 61%). 
mp: >260 (dec.), (Lit >260 °C (dec.))349; 
1H NMR: (270 MHz, DMSO-d6): δ 6.85 (d, J = 29.7 Hz, 2H, 2 × NH), 3.84 – 3.72 (s, 12H, 4 × exo OMe), 
3.53 (s, 6H, 2 × endo OMe), 3.43 (s, 4H, 2 × CH2N(CO)2), 3.00 (m, 8H, H11,15,28,32 and 2 × CH2NH), 
2.50 (6H, H2,4,5,7,19,24)* 2.39 – 2.23 (m, 6H, H10,16,27,33 and H36s,38s), 2.13 (s, 4H, H3,6,20,23), 
1.88 (s, 4H, H9,17,26,34), 1.34 (s, 18H, 2 × t-Bu), 1.15 (d, J = 9.7 Hz, 2H, H36a,38a); 
* Protons obscured by residual DMSO solvent peak, and confirmed through 2D NMR experiments 
(COSY, HSQC and HMBC) 
13C NMR (100 MHz; DMSO-d6): δ 177.3, 170.5, 168.5, 156.0, 90.3, 78.3, 59.4, 56.9, 53.0, 52.0, 50.0, 
48.6, 48.0, 44.6, 40.8, 38.4, 37.6, 37.2, 28.6; 
m/z (ESI): 1223.45587 (C60H72N4O22Na [M + Na]+ requires 1223.45304); 
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Dimethyl (1α,2β,3α,4α,8α,9α,10β,11α,12β,13α,14α,18α,19α,20β)-5,7,15,17-tetraoxo-6-16-bis(2’-
(di-(pyridin-2-ylmethyl)amino)ethyl)-21-oxa-6,16-diaza-
octacyclo[9.9.11,11.13,9.113,19.02,10.04,8.012,20.014,18]tricosane-1,11-dicarboxylate (185) 
 
The Boc-protected [3]polynorbornane framework 188 (230 mg, 0.29 mmol) was dissolved in 
20% TFA/CH2Cl2 (5 mL) and stirred while being monitored by TLC.  After the reaction had proceeded 
to completion (≈4 h), the solvent was removed, and the solid residue repeatedly (3 times) dissolved in 
PhMe and solvent removed to ensure complete removal of the TFA.  The crude amine was dissolved 
in CH2Cl2 (5 mL) under N2 before 2-pyridine carboxaldehyde (0.08 mL, 0.90 mmol) was added.  The 
reaction mixture was left to stir for 15 min before sodium triacetoxyborohydride (569 mg, 2.69 mmol) 
was added.  The reaction was left to stir for 36 h before being filtered through a silica plug (EtOAc as 
the eluent) and the solvent removed.  The crude reaction mixture was then dissolved in CHCl3 (15 mL) 
and extracted with 0.5 M HCl (2 × 10 mL).  The aqueous layers were combined, carefully basified to 
pH 8 (1 M NaOH) and extracted with CHCl3 (3 × 15 mL).  The organic layers were combined, dried 
(MgSO4), and filtered before the solvent was removed under reduced pressure to yield an orange oil 
containing approx. 10–15% 2-pyridinemethanol.  This alcohol was removed by Kügelrohr distillation 
(1 mBar, 80 °C) to afford the desired product as a viscous orange oil (204 mg, 73%) 
mp: 83.2–87.6 °C; 
1H NMR (400 MHz; CDCl3): δ 8.50 (4H, d,  J = 4.9 Hz, H6’), 7.63 (4H, td, J = 7.7, 1.8 Hz, H4’), 7.45 (4H, d, 
J = 7.8 Hz, H3’), 7.25 (4H, dd, J = 4.9, 1.9 Hz, H5’), 3.83 (14H, s, 2 x OMe and 4 x NCH2Ar), 3.62 (4H, t, J 
= 6.2 Hz, 2 × CH2N(CO)2), 2.85-2.90 (4H, m, H4,8,14,18), 2.74 (4H, t, J = 6.0 Hz, 2 × CH2N(CH2)2), 2.61 
(2H, d, J = 10.7 Hz, H22a,23a), 2.52 (4H, s, H3,9,13,19), 1.94 (4H, s, H2,10,12,20), 1.19 (2H, d, J = 10.8 
Hz, H22s,23s); 
13C NMR (100 MHz; CDCl3): δ 176.4, 167.7, 159.0, 148.9, 136.5, 123.1, 122.3, 90.2, 59.9, 52.6, 50.7, 
50.0, 48.2, 40.9, 37.9, 36.3; 
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HRMS m/z (ESI): 468.2110 (C52H56N8O9 [M + 2H]+2 requires 468.2080), 935.4141 (C52H55N8O9 [M + H]+ 
requires 935.4087), 957.3968 (C52H54N8O9Na [M + Na]+ requires 957.3906); 
 
All zinc salts were formed by dissolving 1 equiv. of the bis-DPA compound in MeOH before dropwise 
addition of ZnNO3.6H2O in H2O.  The solution was left to stir for 12 hours before the solvent was 
removed to afford the desired salt in quantitative yield as indicated by 1H NMR. 
Dimethyl (1α,2β,3α,4α,8α,9α,10β,11α,12β,13α,14α,18α,19α,20β)-5,7,15,17-tetraoxo-6-16-bis(2’-
(di-(pyridin-2-ylmethyl)amino)ethyl)-21-oxa-6,16-diaza-
octacyclo[9.9.11,11.13,9.113,19.02,10.04,8.012,20.014,18]tricosane-1,11-dicarboxylate biszinc(II) tetranitrate 
(185:Zn(II)2) 
 
mp: > 260 °C (Decomp.) 
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1H NMR (500 MHz; DMSO-D6:D20 1:1): δ 8.65 (4H, app. s,  H6’), 8.13 (4H, app. t, J = 7.4 Hz, H4’), 7.66 
(8H, app. d, J = 6.5 Hz, H3’ and H4’), 4.54 (4H, d, J = 15.4 Hz,  Ha), 4.21 (4H, d, J = 16.1 Hz,  Hb),3.92 
(10H, m, 2 x OMe and  2 × CH2N(CO)2), 3.13 (4H, m, 2 × CH2N(CH2)2), 2.63 obs. (4H, H4,8,14,18), 2.74 
(4H, t, J = 6.0 Hz, 2 × CH2N(CH2)2), 2.52 (4H, s, H3,9,13,19), 2.36 (2H, d, J = 10.7 Hz, H22a,23a), 2.13 
(4H, s, H2,10,12,20), 1.19 (2H, d, J = 10.8 Hz, H22s,23s); 
 
Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-
7,9,21,23-tetraoxo-8,22-bis(2’-(di-(pyridin-2-ylmethyl)amino)ethyl)-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (186) 
 
The Boc-protected [5]polynorbornane framework 192 (200 mg, 0.19 mmol) was dissolved in 20% 
TFA:CH2Cl2 (5 mL) and stirred.  After the reaction had proceeded to completion (≈4 h), the solvent was 
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removed, before being repeatedly (3 times) dissolved in PhMe and solvent removed to ensure 
complete removal of the TFA.  the solvent was concentrated in vacuo and the resulting diamine was 
dissolved in CH2Cl2 (5 mL) under N2 before 2-pyridine carboxaldehyde (0.05 mL, 0.59 mmol) was 
added.  The reaction mixture was left to stir for 15 min before sodium triacetoxyborohydride (373.6 
mg, 1.76 mmol) was added.  The reaction was left to stir for 24 h before being filtered through a silica 
plug (EtOAc as the eluent) and the solvent removed.  The crude reaction mixture was then dissolved 
in CHCl3 (15 mL) and extracted with 0.5 M HCl (2 × 10 mL).  The aqueous layers were combined, 
carefully basified to pH 8 (1 M NaOH) and extracted with CHCl3 (3 × 15 mL).  The organic layers were 
combined, dried (MgSO4), and filtered before the solvent was removed under reduced pressure to 
yield an orange oil containing approx. 10–15% 2-pyridinemethanol.  This alcohol was removed by 
Kugelrohr distillation (1 mBar,  80 °C) to afford the title compound as a viscous orange oil (210 mg, 
89%). 
mp: 103.4–107.2 °C;  
1H NMR (400 MHz; CDCl3): δ 8.55 (4H, d,  J = 5.1 Hz, H6’), 7.69 (4H, td, J = 7.7, 1.5 Hz, H4’), 7.51 (4H, d, 
J = 7.6 Hz, H3’), 7.21 (4H, dd, J = 5.6, 1.6 Hz, H5’), 3.92 (8H, s, NCH2Ar), 3.79 (12H, s, 4 x OMe), 3.65 
(4H, t, J = 5.2 Hz, 2 × CH2N(CO)2), 2.92 (4H, m, s, H6,10,20,24), 2.86 (4H, t, J = 5.0 Hz, 2 × CH2N(CH2)2), 
2.49 (6H, m, H31a,33a and H5,11,19,25), 1.88 (4H, s, H4,12,18,26), 1.83 (2H, s, H1,15), 1.71 (2H, s, 
H29), 1.65 (4H, s, H2,14,16,28), 1.17 (2H, d, J = 10.9 Hz, H31s,33s)*; 
13C NMR (100 MHz; CDCl3): δ 176.8, 168.3, 158.4, 149.0, 136.8, 123.6, 122.5, 89.9, 59.3, 54.5, 52.5, 
52.4, 51.0, 50.9, 48.3, 40.9, 40.5, 37.8, 36.3; 
HRMS m/z (ESI): 593.2476 (C64H70N8O18 [M + 2H]+2 requires 593.2500), 1185.4881 (C64H69N8O18 [M + 
H]+ requires 1185.4928), 1207.4720 (C64H68N8O18Na [M + Na]+ requires 1247.4747); 
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use of 2D NMR experiments. 
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1H NMR (500 MHz; DMSO-D6:D20 1:1): δ 8.50 (4H, app. s,  H6’), 8.13 (4H, app. t, J = 7.4 Hz, H4’), 7.66 
(8H, app. d, J = 6.5 Hz, H3’ and H4’), 4.54 (4H, d, J = 15.4 Hz,  Ha), 4.21 (4H, d, J = 16.1 Hz,  Hb),3.92 
(10H, m, 2 x OMe and  2 × CH2N(CO)2), 3.65 (4H, t, J = 5.2 Hz, 2 × CH2N(CO)2), 2.92 (4H, m, s, 
H6,10,20,24), 2.86 (4H, t, J = 5.0 Hz, 2 × CH2N(CH2)2), 2.49 (6H, m, H31a,33a and H5,11,19,25), 1.88 
(4H, s, H4,12,18,26), 1.83 (2H, s, H1,15), 1.71 (2H, s, H29), 1.65 (4H, s, H2,14,16,28), 1.17 (2H, d, J = 
10.9 Hz, H31s,33s)*; 
 
Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-
7,9,21,23-tetraoxo-8,22-bis(2’-(di-(pyridin-2-ylmethyl)amino)ethyl)-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate biszinc(II) tetranitrate (186:Zn(II)2) 
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mp: > 290 °C (Decomp.) 
 
1H NMR (500 MHz; D20): δ 8.64 (4H, app. s,  H6’), 8.11 (4H, app. t, J = 7.5 Hz, H4’), 7.63 (8H, app. d, J = 
7.4 Hz, H3’ and H4’), 4.49 (4H, d, J = 16.4 Hz,  Ha), 4.18 (4H, d, J = 15.8 Hz,  Hb),3.89 (20H, m, 4 x OMe 
and  2 × CH2N(CO)2), 3.14 (4H, d, J = 9.6 Hz, 2 × CH2N(CO)2), 2.73 (4H, m, s, H6,10,20,24), 2.51 (4H, s, 2 
× CH2N(CH2)2), 2.29 (2H, d, J = 9.9 Hz, H31a,33a), 1.99-1.81 (10 H, m, H1,15, H4,12,18,26 and 
H2,14,16,28), 1.69 (2H, s, H29), 1.24 (2H, d, J = 10.9 Hz, H31s,33s); 
 
Hexamethyl 
(1α,2β,3α,4α,5α,6α,7β,8α,9β,10α,11α,15α,16α,17β,18α,19β,20α,21β,22β,23α,24β,25α,26β,27α,2
8α,32α,33α,34β)-12,14,29,31-tetraoxo-8,22-bis(2’-(di-(pyridin-2-ylmethyl)amino)ethyl)-35,37-
dioxa-13,30-
diazapentadecacyclo[23.9.11,25.18,18.110,16.127,33.02,24.03,21.04,23.05,20.06,22.07,19.09,17.011,15.026,34.028,32]oct
atriacontane-1,8,18,21,22,25-hexacarboxylate (187) 
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The Boc-protected [6]polynorbornane framework 194 (500 mg, 0.42 mmol) was dissolved in 20% 
TFA:CH2Cl2 (5 mL) and stirred for 4 h.  After completion (monitored by TLC), The solvent was 
concentrated in vacuo and the resulting diamine was dissolved in CH2Cl2 (5 mL) under N2 before 
2-pyridine carboxaldehyde (0.25 mL, 2.50 mmol) was added.  The reaction mixture was left to stir for 
15 min before sodium triacetoxyborohydride (794 mg, 3.75 mmol) was added.  The reaction was left 
to stir for 24 hours before being filtered through a silica plug (EtOAc as the eluent) and the solvent 
removed.  The crude reaction mixture was then dissolved in CHCl3 (15 mL) and extracted with 0.5 M 
HCl (2 × 10 mL).  The aqueous layers were combined, carefully basified to pH 8 (1 M NaOH) and 
extracted with CHCl3 (3 × 15 mL).  The organic layers were combined, dried (MgSO4), and filtered 
before the solvent was removed under reduced pressure to yield an orange oil containing approx. 10–
15% 2-pyridinemethanol.  This alcohol was removed by Kugelrohr distillation (1 mBar, 80 °C) to afford 
the title compound as an orange solid (345 mg, 59%). 
mp: 123.3 – 128.5 °C  
1H NMR (500 MHz, DMSO-d6): δ 8.48 (d, J = 4.6 Hz, 4H, H6’), 7.72 (dd, J = 7.7, 1.7 Hz, 4H, H4’), 7.33 (d, 
J = 7.8 Hz, 4H, H3’), 7.26 (dd, J = 4.9, 1.7 Hz, 4H, H5’), 3.80 (s, 12H, 4 × exo OMe), 3.68 (s, 8H, 4 × 
NCH2Ar), 3.54 (s, 4H, 2 × CH2N(CO)2), 3.04 (s, 6H, H11,15,28,32 and H4,5), 2.94 (s, 6H, 2 × endo OMe), 
2.67 (s, 4H, 2 × CH2N(CH2)2), 2.47 (s, 4H, H2,6,20,23), 2.37 (app. d, J = 17.8 Hz, 6H, H10,16,27,33 and 
H36s,38s)*, 2.08 (s, 4H, H9,17,26,34), 1.17 (d, J = 9.0 Hz, 2H, H36a,38a); 
13C NMR (126 MHz, DMSO-d6): δ 177.4, 170.1, 168.6, 158.5, 149.1, 136.7, 123.7, 122.6, 90.5, 59.4, 
58.7, 57.0, 53.0, 51.6, 51.5, 49.9, 48.4, 48.0, 44.7, 41.0, 37.5, 36.3; 
HRMS m/z (ESI): 683.2716 (C74H78N8O18 [M + 2H]+2 requires 683.2712), 1365.5350 (C74H77N8O18 [M + 
H]+ requires 1365.5354), 1387.5164 (C74H68N8O18Na [M + Na]+ requires 1387.5170); 
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use of 2D NMR experiments. 
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Hexamethyl 
(1α,2β,3α,4α,5α,6α,7β,8α,9β,10α,11α,15α,16α,17β,18α,19β,20α,21β,22β,23α,24β,25α,26β,27α,2
8α,32α,33α,34β)-12,14,29,31-tetraoxo-8,22-bis(2’-(di-(pyridin-2-ylmethyl)amino)ethyl)-35,37-
dioxa-13,30-
diazapentadecacyclo[23.9.11,25.18,18.110,16.127,33.02,24.03,21.04,23.05,20.06,22.07,19.09,17.011,15.026,34.028,32]oct
atriacontane-1,8,18,21,22,25-hexacarboxylate biszinc(II) tetranitrate (187:Zn(II)2) 
 
mp: >330 °C (Decomp.) 
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1H NMR (500 MHz; DMSO-D6:D20 1:1): δ 8.63 (d, J = 4.0 Hz, 4H, H6’), 8.12 (dd, J = t, 7.4 Hz, 4H, H4’), 
7.71-7.54 (m, 8H, H3’ and H5’), 4.36 (d, J = 16.1 Hz, 4H, Ha), 4.04 (d, J = 15.7 Hz, 4H, Hb), 3.85-3.72 (m, 
16H, 4 × exo OMe and 4 × NCH2Ar), 3.61 (s, 4H, 2 × CH2N(CO)2), 3.07 (s, 6H, H11,15,28,32 and H4,5), 
2.75 (s, 4H, 2 × CH2N(CH2)2), 2.51 obs. (s, 6H, 2 × endo OMe), 2.34 (s, 4H, H2,6,20,23), 2.17 (app. d, J = 
17.8 Hz, 6H, H10,16,27,33 and H36s,38s)*, 1.91 (s, 4H, H9,17,26,34), 1.17 (d, J = 9.0 Hz, 2H, H36a,38a); 
 
6.4 Chapter 3 
 
(1α,2α,6α,7α)-4-(α-Carboxymethyl)-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione604 (229) 
 
A solution of anhydride 70 (5.00 g, 30.5 mmol), glycine (2.38 g, 30.5 mmol), NEt3 (0.51 mL, 3.7 mmol) 
and PhMe (30 mL) was refluxed at 110 °C for 16 hours.  After cooling, the solvent was removed and 
the crude mixture dissolved in EtOAc (20 mL).  The solution was transferred to a separatory funnel 
and the organic layer was washed with 0.2M HCl (2 × 15 mL) before being dried (MgSO4), filtered and 
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the solvent removed under reduced pressure to yield the crude product.  The crude material was 
recrystallised from EtOAc and Pet Sp. to give pure white crystals that were collected by means of 
vacuum filtration (4.41 g, 65%). 
mp: 151.2–154.6 °C (lit. 151–153 °C)604; 
1H NMR (270 MHz; CDCl3): δ 11.15 (1H, s, OH), 6.10 (2H, s, H8,9), 4.12 (2H, s, Hα), 3.40 (2H, m, H2,6), 
3.35 (2H, m, H1,7), 1.72 (1H, d, J = 8.9 Hz, H10a), 1.56 (1H, d, J = 8.8 Hz, H10s); 
13C NMR (67.5 MHz; CDCl3): δ 177.1, 171.6, 134.6, 52.3, 46.2, 45.0, 35.9;  
HRMS m/z (ESI): 222.0765 (C11H12NO4 [M + H]+ requires 222.0761), 244.0590 (C11H11NO4Na [M + Na]+ 
requires 244.0580); 
 
(1α,2α,6α,7α)-4-[(S)-α-Carboxyethyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione605 (230) 
 
A solution of anhydride 70 (1.00 g, 6.10 mmol), L-alanine (271 mg, 6.10 mmol), NEt3 (0.10 mL, 0.65 
mmol) and PhMe (10 mL) was refluxed at 110 °C for 12 hours.  After cooling, the solvent was removed 
and the crude mixture dissolved in EtOAc (20 mL).  The solution was transferred to a separatory funnel 
and the organic layer was washed with 0.2 M HCl (2 × 15 mL) and sat. NaHCO3 (2 × 15 mL) before being 
dried (MgSO4), filtered and the solvent removed under reduced pressure to yield the crude product.  
The crude material was recrystallised from EtOAc and Pet Sp. to give pure white crystals that were 
collected by means of vacuum filtration (990 mg, 69%). 
mp: 143.6–149.5 °C (lit. 136–137 °C)605; 
1H NMR (500 MHz, CDCl3): δ 9.12 (s, 1H, COOH), 6.14 – 6.10 (m, 2H, H8,9), 4.69 (q, J = 7.2 Hz, 1H, Hα), 
3.46 – 3.38 (m, 2H, H1,7)*, 3.33 (qd, J = 7.6, 4.3 Hz, 2H, H2,6), 1.75 (dt, J = 7.7 Hz, 1H, H10a), 1.56 (d, J 
= 8.8 Hz, 1H, H10s) 1.44 (d, J = 7.2 Hz, 3H, Hβ); 
13C NMR (67.5 MHz; CDCl3): δ 176.8, 176.7, 174.5, 134.6, 134.3, 52.2, 47.3, 45.9, 45.7, 45.2, 45.0, 14.3;  
HRMS m/z (ESI): 236.0917 (C12H14NO4 [M + H]+ requires 236.0924), 258.0737 (C12H13NO4Na [M + Na]+ 
requires 258.0744); 
[𝛂]𝐃
𝟐𝟖 = -20° (5.2 mg/mL, MeOH) 
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* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks 
were assigned through the use to 2D NMR experiments. 
 
(1α,2α,6α,7α)-4-[(S)-α-Carboxy-α-benzylmethyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione494 
(231) 
 
A solution of anhydride 70 (1.00 g, 6.10 mmol), L-phenylalanine (1.01 g, 6.10 mmol), NEt3 (0.1 mL, 0.61 
mmol) and PhMe (10 mL) was refluxed at 110 °C for 12 hours.  After cooling, the solvent was removed 
and the crude mixture dissolved in EtOAc (20 mL).  The solution was transferred to a separatory funnel 
and the organic layer was washed with 0.2M HCl (2 × 15 mL) before being dried (MgSO4), filtered and 
the solvent removed under reduced pressure to yield the pure product as a yellow amorphous solid 
(923 mg, 46%). 
mp: 145.7–150.2 °C (lit. 148–149 °C)494; 
1H NMR (500 MHz, CDCl3): δ 7.23 – 7.02 (m, 5H, Ar), 5.62 (s, 1H, H9), 5.33 (s, 1H, H8), 4.96 (dd, J = 11.7, 
5.1 Hz, 1H, Hα), 3.40 (dd, J = 14.7, 5.0 Hz, 1H, Hβ1), 3.27 (dd, J = 14.3, 12.1 Hz, 1H, Hβ2), 3.13 (app. dd, 
J = 13.7, 6.0 Hz, 3H, H1,2,7)*, 3.04 (dd, J = 7.1, 4.6 Hz, 1H, H6), 1.51 (d, J = 8.7 Hz, 1H, H10a), 1.35 (d, J 
= 8.6 Hz, 1H, H10s); 
13C NMR (126 MHz, CDCl3): δ 177.3, 177.1, 173.1, 136.3, 134.3, 134.1, 129.1, 128.4, 126.9, 52.7, 52.1, 
45.9, 45.7, 44.9, 44.6, 33.6; 
m/z (ESI): 312.35 (C18H18NO4 [M + H]+ requires 312.34); 
[𝛂]𝐃
𝟐𝟕 = -78° (4.9 mg/mL, MeOH) 
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use to 2D NMR experiments. 
 
(1α,2α,6α,7α)-4-[δ-Carboxyphenyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione606 (232) 
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A solution of anhydride 70 (2.00 g, 12.2 mmol), 4-aminobenzoic acid (1.84 g, 13.8 mmol), NEt3 (1.50 
mL, 14.0 mmol) and DMF (30 mL) was refluxed at 130 °C for 12 hours.  After cooling to room 
temperature, the solvent was removed and the crude mixture dissolved in EtOAc (20 mL).  The solution 
was transferred to a separatory funnel and the organic layer was washed with brine (1 × 15 mL), and 
0.2M HCl (2 × 15 mL) before being extracted with sat. NaHCO3 (1 × 15mL).  The basic aqueous phase 
was then acidified to pH 2 with conc. HCl and then extracted with CHCl3 (3 × 25 mL).  The combined 
organics were dried (MgSO4), filtered and the solvent removed under reduced pressure to yield the 
crude product.  The crude material was recrystallised from EtOAc and Pet Sp. to give clear crystals that 
were collected by means of vacuum filtration (2.93 g, 86%). 
mp: 233.6–240.1 °C (Lit. 229 °C)606; 
1H NMR (500 MHz, CDCl3): δ 8.18 (d, J = 8.5 Hz, 2H, H2’), 7.32 (d, J = 8.5 Hz, 2H, H1’), 6.30 (s, 2H, H8,9), 
4.82 (br. s, 1H, OH), 3.55 (s, 2H, H1,7), 3.51 – 3.45 (m, 2H, H2,6), 1.83 (d, J = 8.9 Hz, 1H, H10a), 1.65 (d, 
J = 8.9 Hz, 1H, H10s); 
13C NMR (126 MHz, CDCl3): δ 176.4, 170.3, 136.5, 134.7, 131.0, 129.2, 126.5, 52.4, 45.9, 45.6;  
m/z (ESI): 284.17 (C16H14NO4 [M + H]+ requires 284.29);  
 
 
Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis[α-carboxymethyl]-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (233) 
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A solution of norbornene amino acid 229 (542 mg, 2.45 mmol) and bisepoxide 92 (500 mg, 1.22 mmol), 
in DMF (3 mL) was subjected to microwave irradiation at 140 °C for 30 mins.  After cooling, the solvent 
was removed and the crude mixture was triturated in IPA (10 mL) and washed with cold IPA (2 × 3 mL) 
and cold Et2O (3 × 3 mL) to afford an off-white powder (370 mg, 44%). 
mp: > 270 °C (decomp.); 
1H NMR (500 MHz, DMSO-d6): δ 13.29 (s, 2H, 2 × OH), 4.03 (s, 4H, 2 × Hα), 3.77 (s, 12H, 4 × OMe), 3.09 
(s, 4H, H6,10,20,24), 2.38 (s, 4H, H5,11,19,25), 2.23 (m, 6H, H31a,33a and H4,12,18,26)*, 1.92 (s, 4H, 
H2,14,16,28), 1.74 (s, 2H, H1,15), 1.59 (s, 2H, H29), 1.15 (d, J = 9.7 Hz, 2H, H31s,33s); 
13C NMR (67.5 MHz; DMSO-d6): δ 176.6, 168.8, 168.3, 89.3, 54.5, 52.3, 50.5, 47.7, 40.5, 40.1, 40.0, 
37.3, 30.7; 
HRMS m/z (ESI): 851.2512 (C41H43N2O18 [M + H]+ requires 851.2508);   
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use to 2D NMR experiments. 
 
Bis Sodium Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis[α-carboxylatomethyl]-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (233:Na2) 
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mp: > 350 °C 
 
 
 
Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis[(S)-α-carboxyethyl]-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (234) 
 
A solution of norbornene amino acid 230 (1.00 g, 4.25 mmol) and bisepoxide 82 (869 mg, 2.12 mmol), 
in DMF (6 mL) was subjected to microwave irradiation at 140 °C for 30 mins.  After cooling, the solvent 
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was removed and the crude mixture was triturated in IPA (10 mL) and washed with cold IPA (2 × 3 mL) 
and cold Et2O (3 × 3 mL) to afford an off-white powder (167 mg, 19%). 
mp: > 230 °C (decomp); 
1H NMR (500 MHz, DMSO-d6): δ 13.12 (s, 2H, 2 × OH), 4.65 (d, J = 7.2 Hz, 2H, 2 × Hα), 3.81 – 3.74 (m, 
12H, 4 × OMe), 3.11 (dd, J = 9.2, 5.4 Hz, 2H, H10,24), 3.00 (dd, J = 9.3, 5.3 Hz, 2H, H6,20), 2.38 (d, J = 
5.3 Hz, 2H, H11,25), 2.34 (d, J = 5.3 Hz, 2H, H5,19), 2.26 (m, 4H, H12,26 and H31a,33a)*, 2.02 (d, J = 
6.6 Hz, 2H, H2,16), 1.97 (d, J = 6.2 Hz, 2H, H4,18), 1.92 (d, J = 6.7 Hz, 2H, H14,28), 1.72 (s, 2H, H1,15), 
1.60 (s, 2H, H29), 1.35 (d, J = 7.0 Hz, 6H, 2 × Hβ), 1.13 (d, J = 9.5 Hz, 2H, H31s,33s); 
13C NMR (126 MHz, DMSO-d6): δ 177.1, 176.5, 171.2, 168.9, 168.7, 90.0, 89.9, 54.0, 52.7, 52.6, 51.2, 
50.5, 48.2, 47.7, 41.3, 41.0, 40.4, 37.7, 28.9, 22.9, 19.7, 14.3, 14.2; 
HRMS m/z (ESI): 879.2815 (C43H47N2O18 [M + H]+ requires 879.2825);   
[𝛂]𝐃
𝟐𝟖 = -20° (5.6 mg/mL, MeOH) 
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use to 2D NMR experiments. 
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Bis Sodium Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis[(S)-α-carboxylatoethyl]-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (234:Na2) 
 
mp: > 350 °C 
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Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis[(S)-α-carboxy-α-benzylmethyl]-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (235) 
 
A solution of norbornene amino acid 231 (915 mg, 2.94 mmol) and bisepoxide 82 (600 mg, 1.70 mmol), 
in DMF (5 mL) was subjected to microwave irradiation at 140 °C for 30 mins.  After cooling, the solvent 
was removed and the crude mixture was triturated in IPA (10 mL) and washed with cold IPA (2 × 3 mL) 
and cold Et2O (3 × 3 mL) to afford an off-white powder (263 mg, 26%). 
mp: >275 °C (Decomp.); 
1H NMR (500 MHz, DMSO-d6): δ 7.20 (m, 10H, 2 × Ar), 4.83 (dd, J = 10.5, 5.1 Hz, 2H, 2 × Hα), 3.81 – 
3.73 (m, 12H, 4 × OMe), 3.47 – 3.40 (m, 2H, Hβ1)*, 3.30 – 3.21 (m, 2H, Hβ2), 2.96 (dd, J = 9.6, 5.2 Hz, 
2H, H10,24), 2.88 (dd, J = 9.5, 5.4 Hz, 2H, H6,20), 2.38 – 2.31 (m, 6H, H,5,11,12,19,25,26), 2.29 (d, J = 
10.0 Hz, 2H, H31a,33a), 2.03 (d, J = 6.4 Hz, 2H, H4,18), 1.97 (d, J = 6.7 Hz, 2H, H2,16), 1.91 (d, J = 6.6 
Hz, 2H, H14,28), 1.77 (s, 2H, H1,15), 1.62 (s, 2H, H29), 1.13 (d, J = 7.0 Hz, 2H, H31s,33s); 
13C NMR (126 MHz, DMSO-d6): δ 176.9, 176.3, 170.0, 168.7, 168.6, 138.1, 129.1, 128.7, 126.8, 90.1, 
90.0, 54.6, 54.5, 53.6, 52.2, 51.4, 50.7, 48.0, 47.6, 41.4, 41.0, 40.5, 37.6, 33.9, 28.9; 
HRMS m/z (ESI): 1031.3441 (C55H55N2O18 [M + H]+ requires 1031.3451);   
[𝛂]𝐃
𝟐𝟖 = -44° (5.2 mg/mL, DMSO) 
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use to 2D NMR experiments. 
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Bis Sodium Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis[(S)-α-carboxylato-α-benzylmethyl]-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (235:Na2) 
 
mp: > 350 °C 
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(Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis(δ-carboxyphenyl)-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (236) 
 
A solution of norbornene amino acid 232 (693 mg, 2.44 mmol) and bisepoxide 82 (500 mg, 1.22 mmol), 
in DMF (3 mL) was subjected to microwave irradiation at 150 °C for 30 mins.  After cooling, the solvent 
was removed and the crude mixture was triturated in IPA (10 mL) and washed with cold IPA (2 × 3 mL) 
and cold Et2O (3 × 3 mL) to afford an off-white powder (306 mg, 31%). 
mp: > 300 °C (decomp.); 
1H NMR (500 MHz, DMSO-d6): δ 8.07 (d, J = 8.5 Hz, 4H, 4 × H2’), 7.45 (d, J = 8.4 Hz, 4H, 4 × H1’), 3.79 
(s, 12H, 4 × OMe), 3.22 (s, 4H, H6,10,20,24), 2.47 (s, 4H, H5,11,19,25), 2.35 (d, J = 9.7 Hz, 2H, H31a,33a), 
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2.17 (s, 4H, H2,14,16,28), 2.12 (s, 4H, H4,12,18,28), 1.79 (s, 2H, H29), 1.68 (s, 2H, H1,15), 1.22 (d, J = 
9.6 Hz, 2H, H31s,33s); 
13C NMR (126 MHz, DMSO-d6): δ 176.4, 168.7, 167.1, 136.2, 131.2, 130.4, 127.8, 90.0, 53.9, 52.8, 50.8, 
48.4, 41.2, 40.5, 37.7, 29.1; 
HRMS m/z (ESI): 975.2838 (C51H47N2O18 [M + H]+ requires 975.2825);   
 
Bis Sodium (Tetramethyl 
(1α,2β,3α,4β,5α,6α,10α,11α,12β,13α,14β,15α,16β,17α,18β,19α,20α,24α,25α,26β,27α,28β)-8,22-
bis(δ-carboxylatophenyl)-7,9,21,23-tetraoxo-30,32-dioxa-8,22-diaza-
dodecacyclo[13.13.11,15.13,13.15,11.117,27.119,25.02,14.04,12.06,10.016,28.018,26.020,24]tritriacontane-
3,13,17,27-tetracarboxylate (236:Na2) 
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mp: > 350 °C 
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6.5 Chapter 4 
 
 
(1α,2α,6α,7α)-4-[(S)-Carboxymethyl-α-((1H-indol-3-yl)methyl)]-4-azatricyclo[5.2.1.02,6]deca-8-ene-
3,5-dione607 (261) 
 
A solution of norbornene anhydride 70 (3.00 g, 18.3 mmol), L-tryptophan (4.10 g, 20.1 mmol), NEt3 
(0.51 mL, 4.57 mmol) and PhMe (30 mL) was refluxed at 110 °C for 16 hours.  After cooling, the solvent 
was removed and the crude mixture dissolved in EtOAc (20 mL).  The solution was transferred to a 
separatory funnel and the organic layer was washed with 0.2M HCl (2 × 15 mL) before being dried 
(MgSO4), filtered and the solvent removed under reduced pressure to yield the crude product as a 
maroon amorphous solid(4.80 g, 75%). 
1H NMR (500 MHz, CDCl3) δ 8.39 (s, 1H, OH), 7.45 (d, J = 7.9 Hz, 1H, H2’), 7.24 (d, J = 8.1 Hz, 1H, H7’), 
7.11 – 7.03 (m, 1H, H4’)*, 7.01 (d, J = 7.1 Hz, 2H, H5’,6’), 5.36 (dd, J = 5.3, 2.7 Hz, 1H, H9), 5.27 (dd, J = 
5.4, 2.6 Hz, 1H, H8), 4.99 (dd, J = 10.3, 6.1 Hz, 1H, Hα), 3.65 (q, J = 7.0 Hz, 1H, H6), 3.45 (dd, J = 16.5, 
10.1 Hz, 2H, Hβ), 3.18 – 2.96 (m, 3H, H1,5,6), 2.88 (dd, J = 7.3, 4.6 Hz, 1H, H7), 1.43 (d, J = 8.7 Hz, 1H, 
H10a), 1.31 – 1.20 (m, 1H, H10s). 
13C NMR (126 MHz, CDCl3) δ 177.6, 177.6, 172.3, 136.1, 134.0, 133.8, 127.5, 123.1, 122.0, 119.4, 118.6, 
111.3, 110.5, 58.4, 52.5, 46.0, 45.7, 44.9, 44.7, 18.0. 
m/z (ESI): 350.42 (C20H18N2O4 [M + H]+ requires 350.37); 
[𝛂]𝐃
𝟐𝟕 = -71° (5.4 mg/mL, MeOH) 
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use to 2D NMR experiments. 
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*Similar to 231, 261 was also an amorphous solid that proved resistant to complete solvent removal.  
No trace of solvent was observed upon conversion to 261:Na. 
Sodium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-((1H-indol-3-yl)methyl)]-4-
azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione (261:Na) 
 
mp: 75.6 – 82.5 °C 
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(1α,2α,6α,7α)-4-[(S)-Carboxymethyl-α-(4-hydroxybenzyl)]-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-
dione608 (260) 
 
A solution of norbornene anhydride 70 (2.00 g, 12.2 mmol), L-tyrosine (2.43 g, 13.4 mmol), NEt3 (2.10 
mL, 17.1 mmol) and PhMe (20 mL) was refluxed at 110 °C for 12 hours.  After cooling, the solvent was 
removed and the crude mixture dissolved in EtOAc (20 mL).  The solution was transferred to a 
separatory funnel and the organic layer was washed with 0.2 M HCl (2 × 15 mL) and sat. NaHCO3 (2 × 
15 mL) before being dried (MgSO4), filtered and the solvent removed under reduced pressure to yield 
the crude product.  The crude material was recrystallised from CHCl3 to give pure yellow crystals that 
were collected by means of vacuum filtration (2.71 g, 67%). 
mp: 101.5 – 107.9 °C 
1H NMR (500 MHz, DMSO-d6): δ 11.59 (s, 1H, COOH), 7.32 – 7.10 (m, 5H, ArH × 4 & ArOH), 5.70 (d, J = 
4.4 Hz, 1H, H9), 5.38 (d, J = 4.0 Hz, 1H. H8), 5.06 (dd, J = 11.7, 5.1 Hz, 1H, H1’α), 3.49 (dd, J = 14.7, 4.9 
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Hz, 1H, Hβ), 3.34 (dd, J = 14.5, 11.9 Hz, 1H, Hβ), 3.21 (app. dd, J = 11.8, 4.7 Hz, 3H, H1,2 and 7)*, 3.12 
(dd, J = 6.6, 4.9 Hz, 1H, H6), 1.58 (d, J = 8.6 Hz, 1H, H10a), 1.43 (d, J = 8.6 Hz, 1H, H10s). 
13C NMR (67.5 MHz; DMSO-d6): δ 177.1, 176.9, 170.3, 156.3, 134.7, 134.1, 130.3, 127.4, 115.3, 79.6, 
53.1, 52.0, 45.5, 45.4, 32.87, 31.2;  
HRMS m/z (ESI): 328.1179 (C18H18NO5 [M + H]+ requires 328.1185  
[𝛂]𝐃
𝟐𝟕 = -68° (5.2 mg/mL, MeOH) 
* Due to overlapping peaks, not all coupling constants could be accurately determined.  All peaks were 
assigned through the use to 2D NMR experiments. 
 
Sodium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-(4-hydroxybenzyl)]-4-azatricyclo[5.2.1.02,6]deca-
8-ene-3,5-dione (260:Na) 
 
mp: >300 °C (Decomp.) 
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(1α,2α,6α,7α)-4-[(R)-Carboxymethyl-α-benzyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione493 
 
Compound (R)231 was synthesised in an analogous fashion to compound (S)231, using D-
phenylalanine in place of L-phenylalanine.  Upon characterisation, (R)231 was found to be identical in 
all respects to (S)231 except for its optical rotation. 
[𝛂]𝐃
𝟐𝟕 = +85° (5.2 mg/mL, MeOH) 
 
All sodium and potassium salts were formed by dissolving the desired carboxylic acid in EtOAc and 
transferring to a separatory funnel.  The organic phase was then extracted with excess sat. Na2CO3.  
After this time, a triphasic mixture was observed to have formed and the middle layer was isolated 
and concentrated to dryness.  The resultant solid was obtained in quantitative yields and was found 
to be of sufficient purity by NMR analysis for testing purposes.   
All other salts were formed by dissolving 1 equiv. of 231 in i-PrOH and adding in a solution consisting 
of 1 equiv. of the desired counterion as a hydroxide dissolved in H2O.  The combined solution was then 
stirred overnight before being concentrated to dryness to afford the desired salts.  The 
tetraalkylammonium salts were found to be extremely hygroscopic and as such, reliable melting points 
could not be obtained. 
 
 
 
 
 
 
 
 
 
202 
(1α,2α,6α,7α)-4-[(S)-α-Carboxy-α-benzylmethyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione 
(231:Na) 
 
mp: >300 °C (Decomp.) 
 
The potassium and lithium salts of 231 were found to possess and identical NMR spectra to 231:Na 
and as such, their spectra have not been reported here. 
 
Potassium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-benzyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-
3,5-dione (231:K) 
 
mp: >300 °C (Decomp.) 
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Lithium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-benzyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-
dione (231:Li) 
 
mp: >300 °C (Decomp.) 
 
Ammonium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-benzyl]-4-azatricyclo[5.2.1.02,6]deca-8-ene-
3,5-dione (231:NH4) 
 
mp: 185.3 – 191.3 °C 
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Tetramethylammonium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-benzyl]-4-
azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione (231:TMA) 
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Tetraethylammonium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-benzyl]-4-
azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione (231:TEA) 
 
 
 
 
 
 
 
 
 
 
 
 
206 
Tetrabutylammonium (1α,2α,6α,7α)-4-[(S)-Carboxylatomethyl-α-benzyl]-4-
azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione (231:TBA) 
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Appendix B – NMR Titrations 
 
Appendix B-1: Guest Additions of 1H NMR Titration Experiments 
Addition number Aliquot vol. added 
(μL) 
Cumulative vol. 
added (μL) 
Equiv. added in 
aliquot 
Cumulative 
Equiv. added 
0 0 0 0 0 
1 5 5 0.1 0.1 
2 5 10 0.1 0.2 
3 5 15 0.1 0.3 
4 5 20 0.1 0.4 
5 5 25 0.1 0.5 
6 5 30 0.1 0.6 
7 5 35 0.1 0.7 
8 5 40 0.1 0.8 
9 5 45 0.1 0.9 
10 5 50 0.1 1.0 
11 5 55 0.1 1.1 
12 5 60 0.1 1.2 
13 5 65 0.1 1.3 
14 5 70 0.1 1.4 
15 5 75 0.1 1.5 
16 5 80 0.1 1.6 
17 5 85 0.1 1.7 
18 5 90 0.1 1.8 
19 5 95 0.1 1.9 
20 5 100 0.1 2.0 
21 5 105 0.1 2.1 
22 5 110 0.1 2.2 
23 5 115 0.1 2.3 
24 5 120 0.1 2.4 
25 5 125 0.1 2.5 
26 5 130 0.1 2.6 
27 5 135 0.1 2.7 
28 5 140 0.1 2.8 
29 5 145 0.1 2.9 
30 5 150 0.1 3.0 
31 10 160 0.2 3.2 
32 10 170 0.2 3.4 
33 10 180 0.2 3.6 
34 10 190 0.2 3.8 
35 10 200 0.2 4.0 
36 50 250 1.0 5.0 
37 50 300 1.0 6.0 
38 50 350 1.0 7.0 
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Titration of DPA-Hosts with Zn(II) 
DPA-Host 185 with Zn(II) 
 
DPA-Host 186 with Zn(II) 
7.0 Equiv 
 
4.0 Equiv 
 
 
3.0 Equiv. 
 
 
2.5 Equiv 
 
 
2.0 Equiv. 
 
 
 
1.5 Equiv. 
 
 
 
1.0 Equiv 
 
 
0.5 Equiv. 
 
 
0.0 Equiv 
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DPA-Host 187 with Zn(II) 
 
 
 
7.0 Equiv 
 
4.0 Equiv 
 
 
3.0 Equiv. 
 
 
2.5 Equiv 
 
 
2.0 Equiv. 
 
 
 
1.5 Equiv. 
 
 
 
1.0 Equiv 
 
 
0.5 Equiv. 
 
 
0.0 Equiv 
7.0 Equiv 
 
4.0 Equiv 
 
 
3.0 Equiv. 
 
 
2.5 Equiv 
 
 
2.0 Equiv. 
 
 
 
1.5 Equiv. 
 
 
 
1.0 Equiv 
 
 
0.5 Equiv. 
 
 
0.0 Equiv 
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Titration of Zn:DPA-Hosts with ppi 
Host 185:Zn(II)2 with ppi
 
Host 186:Zn(II)2 with ppi  
7.0 Equiv 
 
4.0 Equiv 
 
 
3.0 Equiv. 
 
 
2.5 Equiv 
 
 
2.0 Equiv. 
 
 
 
1.5 Equiv. 
 
 
 
1.0 Equiv 
 
 
0.5 Equiv. 
 
 
0.0 Equiv 
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Host 187:Zn(II)2 with ppi  
  
7.0 Equiv 
 
4.0 Equiv 
 
 
3.0 Equiv. 
 
 
2.5 Equiv 
 
 
2.0 Equiv. 
 
 
 
1.5 Equiv. 
 
 
 
1.0 Equiv 
 
 
0.5 Equiv. 
 
 
0.0 Equiv 
7.0 Equiv 
 
4.0 Equiv 
 
 
3.0 Equiv. 
 
 
2.5 Equiv 
 
 
2.0 Equiv. 
 
 
 
1.5 Equiv. 
 
 
 
1.0 Equiv 
 
 
0.5 Equiv. 
 
 
0.0 Equiv 
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Host 185:Zn(II)2 with guests 
Terephthalate 
 
Biphenyl dicarboxylate 
  
Azobenzene dicarboxylate 
  
272 
Isoterephthalate 
 
Sodium dihydrogen phosphate 
 
Napthalene dicarboxylate 
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Host 186:Zn(II)2 with guests 
Terephthalate 
 
Biphenyl dicarboxylate 
  
Azobenzene dicarboxylate 
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Isoterephthalate 
 
Sodium dihydrogen phosphate 
 
Naphthalene dicarboxylate 
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 Host 187:Zn(II)2 with guests 
Terephthalate 
 
Isoterephthalate 
 
Sodium dihydrogen phosphate 
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Appendix C – UV-Vis and Fluorescence Titrations 
 
Host:indicator titrations 
Appendix C-1: Host Additions of Indicator-Host Titration Experiments 
Addition number Aliquot vol. added 
(μL) 
Cumulative vol. 
added (μL) 
Equiv. added in 
aliquot 
Cumulative 
Equiv. added 
0 0 0 0 0 
1 5 5 0.1 0.1 
2 5 10 0.1 0.2 
3 5 15 0.1 0.3 
4 5 20 0.1 0.4 
5 5 25 0.1 0.5 
6 5 30 0.1 0.6 
7 5 35 0.1 0.7 
8 5 40 0.1 0.8 
9 5 45 0.1 0.9 
10 5 50 0.1 1.0 
11 10 60 0.2 1.2 
12 15 75 0.3 1.5 
13 25 100 0.5 2.0 
14 50 150 1.0 3.0 
15 50 200 1.0 4.0 
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185:Zn(II)2:pyrogallol red 
 
185:Zn(II)2:pyrocatechol violet 
 
185:Zn(II)2:eosin Y 
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186:Zn(II)2:pyrogallol red 
 
186:Zn(II)2:pyrocatechol violet 
 
186:Zn(II)2:eosin Y 
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187:Zn(II)2:pyrogallol red 
 
187:Zn(II)2:pyrocatechol violet 
 
187:Zn(II)2:eosin Y 
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Host:indicator:ppi titrations 
Appendix C-2: ppi Additions of Host:Indicator:ppi Titration Experiments 
Addition number Aliquot vol. added 
(μL) 
Cumulative vol. 
added (μL) 
Equiv. added in 
aliquot 
Cumulative 
Equiv. added 
0 0 0 0 0 
1 2.5 5 0.1 0.1 
2 2.5 10 0.1 0.2 
3 2.5 15 0.1 0.3 
4 2.5 20 0.1 0.4 
5 2.5 25 0.1 0.5 
6 2.5 30 0.1 0.6 
7 2.5 35 0.1 0.7 
8 2.5 40 0.1 0.8 
9 2.5 45 0.1 0.9 
10 2.5 50 0.1 1.0 
11 12.5 60 0.5 1.5 
12 12.5 75 0.5 2.0 
13 25 100 1.0 3.0 
14 25 150 1.0 4.0 
15 50 200 2.0 6.0 
16 50 10 2.0 8.0 
17 50 15 2.0 10.0 
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185:Zn(II)2:pyrogallol red:ppi 
 
185:Zn(II)2:pyrocatechol violet:ppi 
 
185:Zn(II)2:eosin Y:ppi 
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186:Zn(II)2:pyrogallol red:ppi 
 
186:Zn(II)2:pyrocatechol violet:ppi 
 
186:Zn(II)2:eosin Y:ppi 
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187:Zn(II)2:pyrogallol red:ppi 
 
187:Zn(II)2:pyrocatechol violet:ppi 
 
187:Zn(II)2:eosin Y:ppi 
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Host:indicator:guest titrations 
Appendix C-3: Guest Additions of Host:Indicator:Guest Titration Experiments 
Addition number Aliquot vol. added 
(μL) 
Cumulative vol. 
added (μL) 
Equiv. added in 
aliquot 
Cumulative 
Equiv. added 
0 0 0 0.0 0 
1 25 25 1.0 1.0 
2 25 50 1.0 2.0 
3 25 75 1.0 3.0 
4 25 100 1.0 4.0 
5 50 150 2.0 6.0 
6 50 200 2.0 8.0 
7 50 250 2.0 10.0 
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185:Zn(II)2:pyrogallol red titrations 
Acetate      Carbonate 
Citrate      Phosphate 
 
Sulfate     Terephthalate 
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Wavelength (nm) 
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ATP      
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185:Zn(II)2:pyrocatechol violet titrations 
Acetate      Carbonate 
Citrate      Phosphate 
 
Sulfate     Terephthalate 
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Addition of 10 equiv. of guest 
Addition of 1 equiv. of guest 
Wavelength (nm) 
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185:Zn(II)2:eosin Y titrations 
Acetate      Carbonate 
Citrate      Phosphate 
 
Sulfate     Terephthalate 
 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
294 
  
Wavelength (nm) 
Fl
u
o
re
sc
en
ce
 In
te
n
si
ty
 (
a.
u
.)
 
Wavelength (nm) 
Fl
u
o
re
sc
en
ce
 In
te
n
si
ty
 (
a.
u
.)
 
295 
AMP         ADP 
 
ATP 
 
  
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
Fl
u
o
re
sc
en
ce
 in
te
n
si
ty
 (
a.
u
) 
296 
  
Wavelength (nm) 
Fl
u
o
re
sc
en
ce
 In
te
n
si
ty
 (
a.
u
.)
 
Wavelength (nm) 
Fl
u
o
re
sc
en
ce
 In
te
n
si
ty
 (
a.
u
.)
 
297 
186:Zn(II)2:pyrogallol red titrations with guests 
Acetate      Carbonate 
Citrate     Phosphate 
 
Sulfate     Terephthalate 
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Addition of 10 equiv. of guest 
Addition of 1 equiv. of guest 
Wavelength (nm) 
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AMP          ADP 
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Addition of 10 equiv. of guest 
Addition of 1 equiv. of guest 
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186:Zn(II)2:pyrocatechol violet titrations 
Acetate      Carbonate 
Citrate      Phosphate 
 
Sulfate     Terephthalate 
 
302 
  
Wavelength (nm) 
A
b
so
rb
an
ce
 (
a.
u
.)
 
Wavelength (nm) 
A
b
so
rb
an
ce
 (
a.
u
.)
 
303 
 
AMP      ADP 
 
ATP      
 
  
304 
 
Addition of 1 equiv. of guest 
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186:Zn(II)2:eosin Y titrations 
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Addition of 1 equiv. of guest
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Addition of 10 equiv. of guest.
Pyrophosphate Phosphate Terephthalate Citrate Acetate
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Pyrophosphate Phosphate Terephthalate Citrate Acetate Sulfate Carbonate
Restoration of fluorescence at 550 nm
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Addition of 10 equiv. of guest
Pyrophosphate AMP ADP ATP
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187:Zn(II)2:pyrogallol red titrations 
Acetate      Carbonate 
Citrate      Phosphate 
 
Sulfate     Terephthalate 
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Pyrophosphate Phosphate Terephthalate Citrate Acetate Sulfate Carbonate
Residual absorbance at 572 nm
Addition of 1 equiv. of guest 
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187:Zn(II)2:pyrocatechol violet titrations 
Acetate      Carbonate 
Citrate      Phosphate 
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Pyrophosphate Phosphate Terephthalate Citrate Acetate Sulfate Carbonate
Restoration of fluorescence at 550 nm
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Pyrophosphate AMP ADP ATP Phosphate
Restoration of fluorescence at 550 nm
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Binding constant determinations through BindFit software 
185:Zn(II)2 with ppi 
  
186:Zn(II)2 with ppi 
 
322 
187:Zn(II)2 with ppi 
 
185:Zn(II)2:Pyrogallol red with ppi 
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185:Zn(II)2:Pyrcatechol violet with ppi 
 
187:Zn(II)2:Pyrogallol red with ppi 
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187:Zn(II)2:Pyrocatechol violet with ppi 
 
187:Zn(II)2:Pyrogallol red with ppi 
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187:Zn(II)2:Pyrocatechol violet with ppi 
 
 
